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Investigating the impact of a spinal mobilisation intervention in 
people with multiple sclerosis. 
 
Background: Multiple Sclerosis (MS) has many disabling symptoms due to weakened 
signal propagation in the central nervous system. Manual therapeutics are often seen 
to have a positive effect on these symptoms with limited information as to why. The 
purpose of this project was to investigate a spinal mobilisation intervention, 
objectively measuring the changes it may be causing to muscle quality and movement 
patterns as a contribution to research in MS therapeutics.  
Methods: A series of 3 studies were designed to investigate the effects of a spinal 
mobilisation intervention on muscle quality and movement patterns. Study 1 tested 
people with lower back pain (LBP) as a pilot population (n=40), testing for an 
immediate effect on muscle quality. Study 2 replicated this with MS patients (n=20) 
assessing muscle quality, balance, and pain. Study 3 tested the intervention in a 
longer-term 4 bout study (n=20), assessing muscle quality, balance, pain, and fatigue.  
Results: Significant muscle stiffness reductions were seen in the LBP population post 
the intervention (p = 0.01, η2partial = 0.15). Baseline stiffness was found as a significant 
contributor (p = 0.002, R2 = 0.22). These muscular results were not replicated with 
the MS population. However, significant improvements in self-reported pain as a 
result of the intervention were revealed (p = 0.008, η2partial = 0.33). Study 3 findings 
demonstrated significant improvements from baseline in balance and fatigue 
measures as a result of the intervention. High variability in the data are seen within 
the MS population.  
Conclusions: Four sessions were not sufficient to elicit a significant response in 
muscle quality as a result of the intervention in an MS population. However, 
significant improvements in balance and fatigue were revealed. Given the variability 
from the MS population, it is necessary to undertake a longer-term study and 
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1.0 An Introduction to Multiple Sclerosis 
As a chronic and inflammatory disease of the central nervous system (CNS) and 
affecting millions of people across the globe, the impact of multiple sclerosis (MS) as 
a condition is substantial and a critical area to research (Backus et al., 2016). Although 
known to be caused by autoimmune demyelination of the CNS, there are many 
complexities around the specifics of why this occurs (Compston & Coles, 2008; 
O’Gorman et al., 2012; Ziemann et al., 2011). MS is the most common cause of 
neurological disability in young adults not including traumatic injury worldwide and 
highly prevalent in Scotland (Dimitrov & Turner, 2014; Mackenzie et al., 2014; Wallin 
et al., 2019b).  
The manifestation of symptoms in the individual are dependent on the affected 
pathways of the CNS (Langdon et al., 2012; Sumowski et al., 2018). There is a large 
degree of variation between patients in terms of the symptoms they experience and 
therefore, the required treatment to address these symptoms. Therapeutics aimed 
to help within the management of the range of symptoms experienced by patients 
can vary amongst oxygen therapy, manual therapy, exercise therapy, orthosis, 
speech and language therapy, and others (Feinstein et al., 2015; Khan et al., 2007; 
Langdon & Thompson, 1999; Patti et al., 2002). Key practitioners in decision making 
around the management and care are General Practitioners (GPs), neurological 
consultants and MS nurses. 
1.0.1 Symptom Management 
Many symptoms can persist that lead to limited function and disability, even with 
pharmacological treatment (Crabtree-Hartman, 2018). Although symptoms can 
manifest very differently in every individual, mobility is often affected in many 
different ways and is highly important to quality of life (QoL) due to its association 
with independence and physical health, and the harmful effects of physical 
deconditioning (Langdon & Thompson, 1999; McCullagh et al., 2008; Ottenbacher et 




centred approach, as well as regular monitoring due to the individual and progressive 
nature of the disease (Dimitrov & Turner, 2014; Khan et al., 2007; Kehoe et al., 2015). 
1.0.2 Physiotherapy Measurement 
Physiotherapy is a therapeutic treatment tool that has been recommended for MS 
patients due to specific functions it can target while also focussing on whole-body 
mobility. The wide range of potential therapeutics involved aim to maintain function 
within the musculoskeletal system. However, the subjective nature of the application 
and assessment of these treatments have resulted in limited information for the 
mechanism and effectiveness (Etoom et al., 2018b). The effectiveness of an 
intervention can be measured by performance tasks such as muscle strength ability, 
speed of walking and joint range of motion (RoM). Elements that are sometimes 
subjectively assessed are pain and stiffness; key contributors to functional movement 
and independence (Giovannelli et al., 2007; Gordon et al., 2015). The following 
chapters will describe the biomechanical measurement forms that are used to define 
and analyse physiotherapy interventions in literature, with focus on objective muscle 
response and movement patterns.  
Due to the multifactorial nature of MS symptoms and their effect on an individual’s 
life, symptom management plans may constantly change. The following chapters 
examine the literature on symptom management investigations and the outcomes 
that have resulted. The analysis adopted in this investigation used both objective and 
self-reported measures, due to their contributions to a fuller analysis. This will help 
to examine specific benefits in muscle and movement response. This also contributes 
to the formation of patient centred therapeutic treatment, and addressing the most 
critically disruptive symptoms that are reported by MS patients: stiffness, pain and 
fatigue (Backus et al., 2016).   
1.1 Thesis Aims    
The aim of this thesis was to provide a thorough investigation of a spinal mobilisation 
intervention within the context of MS symptom management and rehabilitation. The 
findings from the investigation will provide novel data characterising and 
investigating a manual therapeutic tool used for MS symptom management and the 




knowledge around physiotherapy research and the measurement of intervention 
impact.  
1.2 Rationale Development    
The rationale for this investigation was developed by Pacla Medical Ltd. and the 
physiotherapy work they have been carrying out for several years, largely with MS 
patients. They developed an intervention using spinal mobilisations in a specific 
manner for a 30-minute treatment period. This works at a slower rate, and for a 
longer time than any spinal mobilisation intervention described in the literature 
(Chiradejnant et al., 2003; Jowsey & Perry, 2010; Pecos-Martín et al., 2017; Pentelka 
et al., 2012; Thomson et al., 2009; Willett et al., 2010). Anecdotally patients reported 
reduced experiences of pain and stiffness after receiving this spinal mobilisation 
intervention. Both the patients and the physiotherapist reported improvements in 
whole-body mobility as well as motor refined movements, which could be connected 
to a reduced experience in pain and stiffness.  
In a collaboration formed between Pacla Medical Ltd., Medical Research Scotland and 
Edinburgh Napier University, the project was developed to investigate this 
intervention scientifically, and the impact that it may be have on people with MS and 
their overall symptoms management. 
1.3 Thesis Outline  
The six chapters of this thesis outline the course of this investigation over a four-year 
period. The literature around MS pathophysiology, risk factors, diagnosis, symptoms, 
interventions, spinal therapeutics, and biomechanical measurement methods are 
described in chapter two. This literature provided validated methods for 
measurement of physiotherapy interventions, their impact and their importance.  
The following three chapters report on the series of studies that were designed, to 
investigate the effects of the spinal mobilisation intervention on an MS population.  
This includes a pilot study (n = 40) reported in chapter three which was completed in 
the first year of the PhD. This was completed with a lower back pain (LBP) population 
rather than an MS population for ethical reasons, due to the lack of MS data and 
mobilisation interventions. This pilot study tested the efficacy and feasibility of the 




people with MS. This was based on the similarities described between the 
populations of increased levels of spinal stiffness and decreased levels of spinal 
mobility (Giesser et al., 2007; Shum et al., 2013).  
Two MS studies (study two: n = 20, study three: n = 20) were carried out over the 
remaining time on the PhD and are reported in chapters four and five. Study two was 
designed as an MS feasibility study with information based on the pilot study and 
study three was designed as a randomised control trial based on the information 
from both previous studies. A summary of these results combined from all three 
studies is reported in chapter six with recommendations for future research. This 
incorporates results discussed in objective muscle response, objective balance 









This chapter provides an overview of the literature covering an overview of MS as a 
condition, symptoms and symptom management interventions; an aspect that is 
repeatedly reported as a key element for treatment in people with MS (Backus et al., 
2016; Crabtree-Hartman, 2018; Visaria et al., 2018). The literature review will also 
cover the measurement and possible effects of physiotherapy-based interventions, 
with focus on lumbar spinal mobilisations.  The research around MS rehabilitation is 
extensive and involves many different treatments and therapies. However, due to a 
person’s individual needs, specific benefits and the efficacy of these treatments are 
difficult to determine (Donzé, 2015). Research to better this knowledge is ongoing, 
therefore this chapter will provide an updated review of physical interventions, spinal 
mobilisations, and their relationship to MS symptom management. An overview of 
methodological factors and biomechanical measurements concerned with the 
project are also included.  
A large body of evidence demonstrates the collective acceptance of a general benefit 
from manual therapy for a wide variation of people groups. This is particularly 
relevant in conditions affecting the musculoskeletal system with reported 
improvements in pain, mobility and overall wellbeing (Krouwel et al., 2010; Nougarou 
et al., 2016; Willett et al., 2010). Much of this evidence stems from anecdotal and 
observational evidence over the years, supporting its use around the globe, 
particularly for the lumbar back (Clark & Horton, 2018; Hartvigsen et al., 2018; Hoy 
et al., 2010). However, there remains a lack of understanding in the scientific 
mechanism underlying the benefit of manual therapy (Chiradejnant et al., 2003; 
Pickar, 2002; Nougarou et al., 2016; Triano, 2001; Willet et al., 2010). 
The review of this literature was based around searches from databases, PubMed, 
Science Direct, Ovid, Medline, Google Scholar and the Cumulative Index to Nursing 




and in the English language. Keywords were searched under the following 3 fields and 
using a variety of combinations:  
• ‘Multiple Sclerosis’ AND, OR, ‘rehabilitation’, ‘therapeutics’, ‘intervention’, 
‘physiotherapy’, ‘symptom management’, ‘quality of life’, ‘gait’, ‘mobility’, 
‘disability’, ‘balance’, ‘assessment’, ‘gender’. 
• ‘Manual therapy’ AND, OR, ‘spinal’, ‘manipulation’, ‘mobilisation’, ‘lumbar’, 
‘lower back’, ‘stiffness’, ‘pain’. 
• ‘Biomechanical analysis’ AND, OR, ‘forward lunge’, ‘force plate’, ‘stability’, 
‘body sway’, ‘sit-to-stand’, ‘kinetics’, ‘myometer’, ‘myoton pro’, ‘muscle 
stiffness’, ‘muscle tone’, ‘muscle elasticity’.  
The articles were hand searched and chosen based on their subject relevance to the 
project from the information in the abstract. Citations used within relevant chosen 
articles were also included if they contributed viable content to the gathering of 
knowledge for the literature review. This was an ongoing process throughout the PhD 
project with the intention of keeping up with new peer reviewed research, 
particularly within the field of MS therapeutic interventions as an evolving field of 
study.  
This chapter aims to consolidate information from the investigations already carried 
out in spinal physiotherapy and MS rehabilitation. The following chapters will provide 
a thorough overview of the methodologies used in this investigation with due 
consideration of the feasibility of working with an MS clinical population and 
gathering objective and accurate information on such a population. In doing so, this 
investigation aims to provide information on the areas where there is minimal 
literature, or insufficient scientific integrity or validity and which need more clarity 
requiring further investigations. 
2.1 Multiple Sclerosis Overview  
Multiple Sclerosis is known to be a chronic complex autoimmune condition that 
results in inflammatory damage to the CNS causing demyelination and potentially 
long-term neurodegeneration. There are over 2 million people around the world 




globally and between sexes. The cause of the condition is likely to be multifactorial 
and may even represent a spectrum of diseases that result in inflammation of nerve 
tissue and demyelination. A combination of genetic, environmental, and life-style 
factors are said to contribute to the susceptibility of the condition, though none are 
the definitive cause and the condition has no cure. Treatments are based around 
management of symptoms and of the inflammatory attacks. The symptoms caused 
by neural degeneration are widespread and clinically present in many ways including 
physical, mental, visual, and emotional disabilities. The result of this condition has a 
high social cost (greater than stroke and Alzheimer’s) due to the longevity of the 
disease and the varied age groups to which it can affect (Compston & Coles, 2008; 
Huang et al., 2017; Lassmann, 2018).     
2.1.1 Pathophysiology 
As a chronic autoimmune disorder, MS is characterised by degradation of myelin 
sheaths and neurons in the CNS due to a malfunction in the immune system targeting 
healthy nerve tissue. Immune cells infiltrate the CNS by crossing the blood brain 
barrier (BBB) through tight junctions they should not normally be able to permeate. 
Their activation leads to a cascade of events causing neural inflammation, 
demyelination, gliosis, and neural degradation. The most important aspect of these 
events is demyelination due to the destruction and loss of oligodendrocytes. Myelin 
sheaths are formed by oligodendrocytes from a mix of proteins and phospholipids, 
acting as an insulator covering the nerve axons. The sheaths protect the neuron and 
aid the conduction of impulses travelling down the nerve axon. This assists the 
process of signal transmission from one neuron to another, between peripheral 
nerves, the brain, and the spinal cord. 
T-cell (immune system lymphocytes that fight harmful elements) infiltration induces 
a secretion of cytokines that promote further degradation of the BBB, making it more 
permeable, and recruit other immune cells (B-cells and macrophages). These cells 
degrade the myelin sheaths by antibody secretion and phagocytosis. The cytokine 
secretion causes damage to oligodendrocytes also amplified by the binding of Fas 
ligands produced that promote apoptosis (demonstrated in fig. 2.1). During the initial 




damage recovery. However, the degradation of oligodendrocytes causes 
remyelination reduction and a proliferation of astrocytes causes the build up of 
scarred plaques. Remyelination is then overpowered by the immune system in a 
process that is perpetuated from recruiting additional cells, resulting in neural 
inflammation, demyelination and disruption of neural signalling (Ghasemi et al., 
2017; Huang et al., 2017; Lassmann, 2018).  
 
Figure 2. 1 Immune cell infiltration into CNS demonstrating an antigen presenting cell (APC) and 
potential pathogen interaction, resulting in T-cell activation and secretion of cytokines involved in 
demyelination. The result is oligodendrocyte degradation, demyelination and neural inflammation 
(Ghasemi et al., 2017).  
The resultant disruption can affect signalling in the CNS and subsequently the 
mediation through to the peripheral nervous system (PNS), responsible for peripheral 
tissue communication to the brain and spinal cord. A below normal functioning of the 
sympathetic nervous system (SNS) has been revealed within the MS condition, which 
could alter the body’s state of alertness. As part of the autonomic nervous system, 
the release of noradrenaline from peripheral neurons causes a cascade of events 
responsible for the fight or flight response and includes regulation of blood flow, 
heart rate and respiratory rate (Sternberg, 2012). The potential symptoms because 
of disruption in CNS signalling and PNS communication can vary widely from person 
to person, however, can often be clinically manifested as muscle weakness, loss of 




2.1.2 Research Development  
Since many MS symptoms are shared with other conditions, early cases of the 
condition were attributed to nervousness, stress, pain or fatigue (Weiner, 2005). 
Medical historians have found reports of possible MS cases dating back to the early 
19th century based on clinical similarity and progression from modern MS case 
reports (Compston & Coles, 2008; Thompson et al., 2018; Weiner, 2005). Then in 
1868, Dr Jean-Martin Charcot gave the definitive description of the disease and 
related the clinical symptoms to plaque like scarring on the brain because of 
inflammation (Vollmer, 2007). Much of his published works are still referred to today 
in the characterisation of the disease (Compston & Coles, 2008; Dimitrov & Turner, 
2014; Weiner, 2005).  
Fuelled by advances in microscope technology, further associations between MS and 
the fatty protein, myelin, were then identified in the early 20th century. This was due 
to the increased number of studies on human brains, focusing on the effects of 
damage to myelin structures. It was then identified as an autoimmune disease in the 
mid-20th century and prevalence data for different global regions started to develop 
(Rosati, 2001; Weiner, 2005).  
2.1.3 Risk Factors and Epidemiology  
For many years, the cause of MS has been investigated and research continues 
looking into genetic susceptibility, viral infections, environmental triggers, 
deficiencies and hormonal influences among others (Harbo et al., 2013; Wallin et al., 
2019b). The exact cause of the condition is not known despite being one of the most 
common neurological disorders in the Western Hemisphere (Bishop & Rumrill, 2015). 
The discrepancies in global prevalence of the condition reveal that people in 
countries further from the equator have a higher likelihood of developing MS. The 
continents with the highest prevalence (per 100, 000) are North America (140) and 
Europe (108), and regions with the lowest prevalence are South East Asia (2.2) and 
sub-Saharan Africa (2.1). Though part of the reason for these differences may be due 
to lack of data reported, the large discrepancy between these numbers is indicative 




Within Europe, the UK has the highest prevalence of the condition, and within the 
UK, Scotland has the highest prevalence. The disease prevalence number in Scotland 
is constantly changing however the most recently published by Public Health England 
is 290 per 100, 000. Even within Scotland, the prevalence number doubles in the 
northerly part of the country in Orkney (Szczepaniak et al., 2018). These numbers 
have led to investigations into vitamin D deficiencies and ancestry likelihood of the 
condition (Leray et al., 2016; Mackenzie et al., 2014; Pugliatti et al., 2006; Thompson 
& Banek, 2013).  
Vitamin D has an important role within the body particularly in gene expression and 
regulation of immunity. It’s essential for B-cell and cytokine regulation, important 
factors within the pathogenesis of MS. Vitamin D is produced by the skin in ultraviolet 
radiation and is therefore produced more in areas with greater sun exposure. Low 
levels of vitamin D in the blood stream has been associated with high incidence of 
MS, also linked with the geographical prevalence distribution (Ghasemi et al., 2017; 
Munger & Ascherio, 2012). Trials for Vitamin D supplementation as a therapeutic 
benefit are under way and may help to regulate the relapses due to regulation of the 
immune system malfunction. However, the metabolic processes concerning Vitamin 
D may also be under an element of genetic control and less effective for therapeutic 
benefits in some (Jagannath et al., 2010; Munger & Ascherio, 2012; Smolders et al., 
2008).  
The geographical distribution of the disease is also linked to disease genetic 
susceptibility with over 200 genes with identified associations with MS. One of the 
most recent studies investigating genetic likelihoods used a meta-analysis of familial 
risk studies with a total of 18 family and twin studies on genetic prevalence of MS. 
The reported risk of someone from the general population developing the condition 
is approximately 0.1%, the risk of a child who has a parent with MS is 2%, the risk of 
the condition with a sibling with MS is 2.7%, and the risk of the condition with an 
identical twin is 20% (O’Gorman et al., 2012). Since identical twins share 100% of their 
genetic material, the resulting 20% genetic contribution of MS is likely required to be 
combined with environmental risk factors in order for the condition to develop 




small risk associated with the development of MS, but continued research into these 
genes and relative risk of MS can help to identify further risk factors and potentially 
a cause (Multiple Sclerosis Genetics Consortium et al., 2018).  
The resulting cause of the condition appears due to complex interactions with 
potential environmental or lifestyle risk factors. Several viruses have been 
investigated as potential triggers for development of MS with interest in the Epstein-
Barr Virus (EBV), commonly known as the cause of glandular fever. High numbers of 
people with MS have also been revealed to have previously had the EBV, though it 
may have been non-symptomatic (O’Gorman et al., 2012). Potential lifestyle risk 
factors include smoking and obesity, which has been linked to CNS vulnerability to 
attack from immune cells (O’Gorman et al., 2012; Westerlind et al., 2014). Although 
none of these have proven theories, development in their research is ongoing and a 
lot more is known now around the combination of risk factors that are likely to be 
involved in the development of MS (Compston & Coles, 2008; Ghasemi et al., 2017). 
A lot of literature exists on gender differences in MS for disease prevalence, type of 
disease, type of symptoms and response to interventions (Harbo et al., 2013; 
Houtchens & Bove, 2018; Mackenzie et al., 2014; O’Gorman et al., 2012; Pugliatti et 
al., 2006). Males present a higher prevalence of more progressive forms of the 
disease compared to women (Tremlett et al., 2010; Wallin et al., 2019a). The female-
to-male MS prevalence ratios vary across the world. However, globally and locally in 
the UK, the trend tends to stay around 2.4:1 (Ahlgren et al., 2011; Harbo et al., 2013; 
Mackenzie et al., 2014). This implies that the disease can manifest differently with 
regards to sex, as well as develop differently. The variation in outcomes according to 
gender suggest that there are still further investigations possible in this area to 
decipher the role and predictive nature of gender on both symptom manifestation 
and response to interventions.   
2.1.4 Diagnosis and Prognosis  
Technological developments in the late 20th century allowed for the characterisation, 
diagnosis, and progression of the disease to be better investigated. For example, 
lumbar punctures facilitate the collection of spinal fluid which can be analysed for 




then allowed the development and progression of plaques to be visualised, providing 
information on the rate of disease progression alongside clinical symptoms. However 
magnetic resonance imaging now provides more clear visuals with markers that help 
identify where scarring has occurred (Donzé, 2015; Weiner, 2005). With this 
technology also came developments in the Macdonald criteria for MS patients, 
allowing accurate clinical guidelines for efficient diagnosis (Gafson et al., 2012; 
Polman et al., 2011). These criteria, most recently updated in 2017, now state that 
evidence must be present for CNS damage over a recorded period, indicating the 
development of lesions over time, for MS diagnosis to be applicable. This means that 
MRI scans are heavily relied upon for efficient diagnosis and upkeep of the 
Macdonald criteria (Bove & Hauser, 2018; Thompson et al., 2018).  
The requirements for both clinical symptom manifestation and visible lesions means 
that the diagnosis process can be prolonged. If an MS diagnosis is confirmed, a 
patient can then be classified into different MS types, describing the different forms 
of disease progression. For patients who are diagnosed with relapse-remitting MS 
(RRMS), neurological symptoms tend to be manifested in an inflammatory attack, 
with a period of recovery in between. These attacks are defined by symptoms 
associated with an inflammatory response and dependent on the nervous system 
pathway affected (Compston & Coles, 2008). A relapse can be entirely random or can 
be triggered by stress or other stimuli such as heat. These are referred to as a pseudo-
relapse where triggers can also worsen symptoms (Vollmer et al., 2002). People with 
MS can be in this stage for many years with attacks such as numbness, tingling, blurry 
vision, or severe fatigue occurring spontaneously or in a triggered manner. Symptom 
management strategies then become important both to micro manage the symptom, 
and macro manage to maintain a good QoL (Visaria et al., 2018; Wallin et al., 2019b).  
Progressive MS describes the stage of the disease where neurological deterioration 
is constant, resulting in a progressive increase of disability (Dimitrov & Turner, 2014). 
This is often seen clinically with worsening symptoms and less recovery time between 
relapses. These relapses can manifest as increasing problems in the whole body and 
refined motor function as well as other areas such as memory, continence, and 




different stages of neurological deterioration. Primary progressive MS (PPMS) is a 
form of the disease progressive from the point of diagnosis, whereas secondary 
progressive (SPMS) develops as a progressive condition after initial diagnosis with the 
relapse-remitting form of the disease. Around 10-15% of people with MS are 
diagnosed PPMS, the rest are diagnosed RRMS.  Around 50% of those diagnosed with 
RRMS go on to develop SPMS after approximately 10 years from point of diagnosis 
(Dimitrov & Turner, 2014; Visaria et al., 2018).  
2.2 Multiple Sclerosis Symptoms 
Due to the debilitating nature of MS symptoms, rehabilitative interventions will span 
the lifetime of a patient post-diagnosis. MS symptoms are both broad in nature and 
unpredictable, posing challenges for rehabilitation interventions aimed to suit the 
whole MS population. Certain symptoms may be triggered, some may be affected 
indirectly, and some may appear randomly. Many functions can be affected such as 
muscle strength, coordination, vision, cognition, balance, stability and mobility 
(Feinstein et al., 2015; Wallin et al., 2019b). To improve all of these, a combination of 
intervention types can be utilised, as well as providing advice for family and friends 
involved in the life of the patient. Multidisciplinary programmes have shown 
beneficial results for improvements in level of activity participation and good 
satisfaction rates. However, they require more investigation and constant re-
evaluation due to the complex and multifactorial elements they entail (Khan et al., 
2007; Langdon & Thompson, 1999; Sumowski et al., 2018).    
2.2.1 Symptom Variation  
Though the variation of clinical symptoms presented in patients is vast, 
commonalities have been shown in initial symptoms such as weakness of the limbs, 
blurred vision, numbness, tingling, double vision, and vertigo. These are likely to be 
some of the most noticeable neurological symptoms when first experiencing 
demyelinating episodes (Vollmer et al., 2002). Walking difficulties is reported as one 
of the most common symptoms and can affect many aspects of daily life with 
subsequent effects on cardiovascular health, muscle and joint health and mental 
health (Crenshaw et al., 2006; Halabchi et al., 2017). Problems in gait often arise as 




damaging cycle of muscle and joint disuse, as well as reduction in independent 
function ability (Patti et al., 2002).  
Fatigue is a common symptom with around 90% of patients reporting this (Crenshaw 
et al., 2006; Dimitrov & Turner, 2014; Vollmer et al., 2002). This can cause severe 
tiredness, mental blocking and has a substantial effect on many people’s daily 
activities, social activities, and relationships. Despite a large effect on QoL, there are 
no drugs licenced to treat MS fatigue and people are often recommended treatment 
based on avoidance of potential fatigue triggers. These can range from sleep 
deprivation, hot environments, medication side effects, infections, high stress levels 
and low mood levels. However, some of these may be unavoidable with an MS 
diagnosis and may therefore perpetuate each other (D’Arcy, 2007; Heine et al., 2015; 
Rumrill et al., 2004).  
Other highly disabling symptoms reported are painful sensations, loss of sensation, 
and loss of proprioception, all affecting mobility and subsequently QoL (Crenshaw et 
al., 2006; Halabchi et al., 2017; Patti et al., 2002). These are caused by nerve damage 
and can lead to various manifestations of neuropathic pain such as pins and needles, 
burning, hypersensitivity, numbness, or tightness. Although drugs to treat 
neuropathic pain are available, they often have undesirable side effects that can 
negatively influence QoL.  
Disruption to upper motor neurons can also lead to the motor disorder, spasticity. 
The motor nerve disruption can cause an imbalance in inhibitory and excitatory 
signals to muscles, and result in intermittent or sustained involuntary muscle activity 
(Pandyan et al., 2005). Over time this can lead to abnormally high levels of muscle 
stiffness and tone, uncontrolled and painful spasms, reduced RoM and reduced 
control of voluntary movement. This not only affects muscles, but also ligaments and 
other soft tissues, impacting overall mobility and QoL (D’Arcy, 2007; Losseff et al., 
1996).  
Loss of the ability for small and intricate movements as well as whole body 
movements have vast consequences on functional independence and can affect 
aspects such as self-esteem, self-worth, mood and motivation (Jarret, 2010). The 




pharmacological as well as physically based. Although, the side effects associated 
with drugs for spasticity are often undesirable (drowsiness, dizziness, nausea). 
Therefore effective physiotherapy management is highly beneficial due to the 
reduced risk of side effects (D’Arcy, 2007).    
A range of cognitive symptoms experienced by people with MS can be seen in a 
decline of memory, reduced processing speed, reduced attention, efficiency of 
information processing and executive functioning. There are associations between 
higher levels of cognitive disability and lower levels of social and vocational activity, 
employment, and household tasks (Compston & Coles, 2008; Demaree et al., 1999). 
Kalmar et al. (2008) found a correlation between objective assessment of everyday 
activities and cognitive performance, and subjective assessment of functional activity 
was correlated with emotionally distressing symptoms. Patients with greater 
cerebellar symptoms (such as tremors) have shown less progression in recovery, 
particularly in daily activities and can affect the level of the individual’s independence 
(Langdon & Thompson, 1999). The most common cognitive symptom reported is 
short-term memory problems, which can also be affected by fatigue. Cognitive 
problems can alter someone’s ability to learn something new, quality and speed of 
information processing, attention, and concentration. Symptoms of this kind can 
affect someone’s ability to take on information about their condition and about 
interventions to manage symptoms. Therefore, cognitive symptoms are important to 
be aware of for the individuals symptom management (O’Brien et al., 2008).  
Around 30% of people with MS develop speech and swallowing difficulties and can 
impact both the mental health of someone with MS as well as their physical safety in 
terms of eating and drinking (Poorjavad et al., 2010). Other symptoms include 
bladder and bowel incontinence which can also affect someone physically, socially 
and psychologically and often requires a specialist in this area for an assessment 
(Griffith, 2002). Evidence has previously suggested that urinary tract infections (UTIs) 
are the most common admittance in hospital for people with MS. UTIs can often be 
avoided by completing a programme of pelvic floor exercises and lifestyle health 
advice. QoL could then be improved reducing pain and discomfort for the individual 




Demyelination in brain regions can contribute to depressive symptoms in some 
patients. Depressive symptoms have been linked to a 7-fold increase of suicide rates 
(Compston & Coles, 2008; Vollmer et al., 2002) and therefore a key factor to be aware 
of and incorporate into a rehabilitative programme (Chiaravalloti & Deluca, 2008). An 
Intervention to monitor and treat MS related depression has previously revealed 
significant improvements after 6 months. Though fatigue and anxiety were not 
significantly affected, this study demonstrated significant impact on a large aspect of 
mental health by using a mental health evaluation service (Askey-Jones et al., 2012).  
Visual problems and optic neuritis can be a problematic symptom if optic nerves are 
damaged in the individual. People can experience vision blurring, reduced vision, 
double vision, vision pain, colour blindness and can contribute to balance problems 
and nausea (National Institute for Health and Clinical Excellence, 2003). Sexual 
dysfunction can be problematic for people with MS and has a substantial effect on 
QoL. It is also a symptom that individuals can find difficult to discuss and therefore 
has limited information on management and treatments that can help individuals 
(National Institute for Health and Clinical Excellence, 2003).     
2.2.2 Symptom Measurement  
Since there is not only variation in the symptoms experienced, but also in the type of 
MS condition, the individual experience of MS lies on a broad spectrum and requires 
further detailed definition. For this reason, the Expanded Disability Status Scale 
(EDSS) was developed in the 1980s (Kurtzke, 1983) and has been used as part of MS 
diagnosis, treatment and research since. (Benedetti et al., 1999; Boes et al., 2012; 
Caminero & Bartolomé, 2011; Comi et al., 2017; Freeman et al., 1997; Jagannath et 
al., 2010). The EDSS has been used extensively throughout studies to categorise level 
of disability of patients (Benedetti et al., 1999; Boes et al., 2012; Caminero & 
Bartolomé, 2011; Comi et al., 2017; Crenshaw et al., 2006; Demaree et al., 1999; 
Freeman et al., 1997; Kobelt et al., 2017; Martin et al., 2006). This quantifies disabling 
symptoms and their effects on aspects of daily life and certain physical capabilities. 
This is done on a scale from 0 to 10, using several categories called ‘functional 
systems’ as the main descriptor. The scale spans from 0 (no clinical disability and 




EDSS was reviewed by Meyer-Moock et al., (2014) assessing 120 publications on the 
assessment tools of MS. They determined the scale as suitable and the most 
preferred tool for measuring the effectiveness of clinical interventions and 
monitoring of disease progression. Though it has some limitations in reliability and 
sensitivity to change, its international acceptance as a measurement tool and wide 
use amongst clinical trials in MS research, allows for cross study comparisons (Meyer-
Moock et al., 2014).   
With the development of the EDSS scale, came further advancements in the 
measurement of clinical symptoms. Level of spinal activity has been linked to clinical 
disability in MS patients, specifically correlated to spinal atrophy using medical 
imaging. Spinal cord atrophy has also been correlated with duration of MS condition 
(Evangelou et al., 2005). The manifestation of spinal cord atrophy is seen clinically in 
symptoms such as leg weakness, movement difficulties and refined motor function 
difficulty, all contributing heavily to impaired functional independence and daily 
activity competency (Yamout et al., 2013). Bernitsas et al. (2015) showed a significant 
correlation between spinal atrophy and disability based on EDSS. This was seen for 
both progressive and relapsing MS. They investigated the cross-sectional area at C2 
level of the spinal cord and found this to be significantly correlated with EDSS (r = -
0.75, p ˂ 0.0001). This was a significant predictor of disability, irrespective of disease 
duration or disease type. These studies suggest that spinal health in a person with 
MS is a major element in their level of disability and subsequently their QoL. Other 
variables such as disease duration and type were less significant. This then tends to 
be related to symptoms relating to lower extremity weakness, tingling, numbness, 
coordination, and balance. Gender and age were not significant factors in EDSS rating 
(Bernitsas et al., 2015).  
2.3 Multiple Sclerosis Treatment Interventions 
With developments over the years in MS diagnostics and the use of neuroimaging, 
early diagnosis can allow for early preventative treatment to prevent neurological 
decline (Compston & Coles, 2008). This includes the use of disease modifying 
therapies (DMTs) available for patients and can alter the course of the disease if taken 
early enough. They specifically target inflammation within the CNS by interacting with 




DMTs however are only helpful for early stages of the condition, and not 
administered for progressive patients. Treatments for progressive patients are 
mainly aimed to minimise and manage symptoms (Sumowski et al., 2018; 
Wingerchuk & Carter, 2014).   
While rehabilitation is important for the management of symptoms for many 
conditions, for MS this is particularly crucial because of the magnitude of disabling 
and fatiguing symptoms and the longevity of the disease. It requires an individualised 
approach to address the person’s needs (Dimitrov & Turner, 2014; Khan et al., 2007). 
A systematic approach for treatment structure can be beneficial to the MS population 
to an extent. However, due to the wide range of symptoms experienced, each 
individual may have to address specific symptoms and a multi-disciplinary approach 
is often recommended (D’Arcy, 2007).     
2.3.1 Exercise Interventions 
Physical rehabilitation has been part of the MS treatment journey from early 
descriptions of the condition. However, the first randomised controlled trial was 
published as recently as 1996. This concluded that physical activity posed no risk to 
patients and had positive effects on their overall well-being (Petajan et al., 1996). The 
variables with positive results included maximal aerobic capacity (V02max), isometric 
strength, body composition, blood lipids, daily activities, mood, fatigue, social 
interaction, home management and emotional behaviour disease status. Following 
this, other studies have displayed similar results revealing improvements in aspects 
of physical health, fatigue and overall QoL, implying there is a considerable potential 
benefit for MS patients from exercise-based interventions (Cruickshank et al., 2015; 
Freeman et al., 1997; Garrett et al., 2013; Kehoe et al., 2015; Patti et al., 2002).  These 
study results have not shown improvement in EDSS or neurological impairment, but 
rather significant improvements in a wide range of health outcomes, involving 
physical functioning, general health, social functioning, and mental health. Particular 
focus on walking ability is often placed on these interventions due to its significant 
contribution to MS QoL results (Kehoe et al., 2015). 
Though exercise and movement therapy has been shown to be successful in MS 




previous studies (Feinstein et al., 2015; Heine et al., 1996; McCullagh et al., 2008). 
Community-based exercise interventions have had success in improving this element. 
Indeed, results support these as being a predictor of the physical impact of the MS 
condition. Results have shown that community-based group activities were 
successful and led to significant improvements, regardless of the type of exercise 
activity. This implies the type of exercise is not a key component in results, however, 
a community focus is (Garrett et al., 2013; Kehoe et al., 2015). This is supported by 
the systematic review results on different forms of exercise treatments with MS 
patients with neither strength, aerobic, stretching, endurance or mixed exercise 
interventions showing more benefit than the other (Heine et al., 2015; Rietberg et 
al., 2005). The success of community-based group exercises and the impact on MS 
symptoms could imply that the community focus may be more important than the 
type of exercise.  
The overall improvements in both physical and psychological factors from simple 
exercise routines have considerable benefit for people with MS. This has opened 
potential for further research to develop physical interventions with this group of 
people with a vast number of studies reporting positive outcomes in similar variables. 
Exercise interventions can be manageable with little side effects compared to 
pharmacological interventions (Rietberg et al., 2005), therefore further research in 
this area as a treatment for the variables above could have great benefit for symptom 
management in people with MS.    
2.3.2 Balance and Gait Interventions 
Abnormal balance control is a common symptom in people with MS, leading to an 
overall reduction in physical activity and affecting various aspects of daily life (Motl, 
2014; Van Emmerik et al., 2010). Interventions based on balance focussed activity 
have demonstrated positive results for improvement in these areas (Cattaneo et al., 
2006; Gandolfi et al., 2015; Kanekar et al., 2013). Abnormal balance is likely to 
increase risk of falling and can lead to further injuries and lack of confidence in 
movement (Soyuer et al., 2006). Therefore, it’s important to decipher and try to 




Significant differences have been found between people with MS and healthy 
controls for slower walking speed, weaker leg strength and more gait variability 
(Bowser et al., 2015; Cattaneo et al., 2006; Martin et al., 2006; Soyuer et al., 2006). 
Even within the MS population, there are significant differences in leg strength 
indicating that varying degrees of disability can manifest within the condition and 
should be accounted for within gait investigations. Bowser et al. (2015) revealed a 
significant correlation between leg strength and EDSS score, with a weaker leg 
strength group reporting an average of 2.5 times higher in EDSS than the MS group 
with better leg strength. The results of reduced leg strength led to compensation in 
other movements when performing important daily tasks such as walking, turning 
and moving from sitting to standing (Bowser et al., 2015; Hansen et al., 2014). 
Therefore, MS programmes promoting leg extensor strength and power, may lead to 
improved performance in key functional activities for patients (Cameron & Wagner, 
2011; Stevens et al., 2013).  
Balance differences between MS patients have been found based on their disease 
type and severity, with progressive forms of MS revealing significantly greater levels 
of impairment compared to RRMS, demonstrating a greater risk of falling as a 
consequence (Soyuer et al., 2006). However, even in the less impaired MS population 
(EDSS 2 or below), muscle recruitment abnormalities have been revealed through 
electromyographic (EMG) recordings with early recruitment and late relaxation of leg 
muscles (Benedetti et al., 1999). The balance and gait abnormalities for not only MS 
patients compared to a healthy population but within the condition are therefore 
important to recognise and their impact on daily movements. This could be important 
to incorporate from early on in the condition (Bernardi et al., 2004; Büla et al., 2011; 
Cruickshank et al., 2015).  
As well as the breakdown in neurological processes, gait and balance can be affected 
by psychological state and heavily influenced by fatigue. As well as significant 
differences in gait abnormalities, MS patients have shown greater fatigue measures 
compared to healthy controls (Crenshaw et al., 2006). Therefore, fatigue could play 
a part in the variability seen within MS gait measures and could also affect variables 




indicator of other psychological factors affecting gait and balance such as mobility 
confidence as well as physical factors. Understanding the relationship between 
fatigue and the effect it will have on gait and balance outcome measures will aid the 
interpretation of changes that may be occurring due to an intervention.  
Neural plasticity is the adaptive process in the CNS to re-organise neural connections, 
responding to other neural inputs or influences, according to the surrounding 
environment. To maximise this process within rehabilitation interventions, balance 
specific exercises can help neural re-organisation of sensory integration within the 
CNS and lead towards improved muscle recruitment pathways for small movements 
as well as motor learning (Morgen et al., 2004; Tomassini et al., 2011). Although 
neuroplasticity is believed to be more beneficial in people at earlier stages of their 
MS condition, evidence has shown there is still capacity for neural plasticity in later 
stages of the condition also and therefore an essential element for their balance 
rehabilitation (Feinstein et al., 2015). Task-orientated therapeutic approaches involve 
practicing certain movements that can subsequently lead to their improvement, with 
a common aim to improve movements used in a person’s daily routine. Application 
of both external and internal stimuli help to reinforce the specific neural pathways 
associated with these movements and potentially improve muscle memory. 
Therefore, someone can learn by repeating a certain task in changed environments 
and under changed conditions (Heine et al., 2015; Stevens et al., 2013; Straudi et al., 
2014). This is helpful for movements not only associated with postural sway and 
balance, but other aspects of daily life. The learning process in performing these tasks 
in different environments and improving awareness, may be more important than 
the actual quality of the task (Sumowski et al., 2018).  
Proprioceptive interventions have revealed improvements in stability and posture 
with varying levels of intervention (Stevens et al., 2013). Improvements in body sway, 
stability and posture have been demonstrated from a basic intervention with finger 
touch application (Kanekar et al., 2013). Equine-based therapy using horse riding has 
shown benefits in MS therapy showing muscle strengthening, balance and mobility 
measures and psycho-emotional benefits with improved QoL (Bronson et al., 2010; 




proprioceptive and sensory feedback as well as the psychological benefits seen from 
animal interaction (Hammer et al., 2005). The use of activities with proprioceptive 
feedback appear to have good outcome results for balance deficits and could even 
be combined with animal-based therapy for greater impact on QoL.  
The variety of therapeutics available for balance and gait is vast and the use of 
combining rehabilitation therapy types can not only help to improve balance, 
mobility and coordination but also to build tolerance for activities through improved 
cardiovascular fitness and reduction in stiffness and spasticity (Khan et al., 2007; 
Rietberg et al., 2005). New therapeutics with use of robotics, tele-rehabilitation, 
virtual reality and games are areas under development for modern forms of therapy 
and could be useful tools for the future of MS rehabilitation (Donzé, 2015). Some of 
these new forms of therapeutic interventions have not been in standard practice for 
long, or long enough to be part of MS based therapeutic investigations, therefore 
information about their specific benefits are limited. However, the studies that have 
reported on these task-based exercises in combination with standard physical based 
exercises are very promising (Feinstein et al., 2015; Freeman et al., 2012; Khan et al., 
2007). Many of the benefits seen in exercise-based interventions, could also be 
brought into balance and gait improvements, given the strength and muscle 
recruitment memory they can instil. These results are particularly strong in lower 
limb strength exercises due to the muscle work necessary in many aspects of gait and 
balance.  
2.3.3 Quality of Life Impact 
The concept of physical rehabilitation and its connection with QoL has not always 
been part of MS treatment. Knowledge around this has been improving with the 
understanding of the individualised nature of the condition and the effect this has on 
an individual’s QoL. Developments for health and well-being and improving QoL for 
MS patients became more prevalent in the 1990s (Freeman et al., 1997; Langdon & 
Thompson, 1999; Patti et al., 2002; Petajan et al., 1996; Schapiro et al., 1988). The 
measurement of QoL has also been developed in terms of how best to describe the 
many different contributing factors. This includes all areas around general health and 




However, clinical assessments for this are still limited and the need for more methods 
around this area are becoming apparent and QoL assessments are said to be a 
standard element of all MS based trials. In order to get a complete view of QoL, more 
than one of these scales will be required (Halabchi et al., 2017; Kobelt et al., 2017; 
McCullagh et al., 2008; Patti et al., 2002).  
Many authors report effects of intervention on QoL, even though this is not the main 
outcome of the investigation (Bernitsas et al., 2015; Cattaneo et al., 2006; Kehoe et 
al., 2015; Petajan et al., 1996), giving an insight into the importance of this aspect 
within various types of MS research. The multifactorial nature of QoL means that this 
can be difficult to quantify whilst still being completely represented. Measures for 
lifestyle, physical function, psychological state and social function are often 
represented using complex scales, some of which have been described below in table 
2.1, as well as other scales and questionnaires used within MS research to assess 
health and well-being (Gandolfi et al., 2015; Langdon & Thompson, 1999; McCullagh 
et al., 2008; Yamout et al., 2013).  
Table 2. 1 Health and well-being scales and questionnaires previously used in multiple sclerosis 
research.  
Scale Outcome Measures  Reference 
Beck Depression 
Inventory 




Brief Pain Inventory Level of pain based on physical 
symptoms. 
(Kean et al., 
2016) 
Expanded Disability 
Status Scale (EDSS) 
Level of disability based on physical 
function. 
(Meyer-Moock 
et al., 2014) 
Fatigue Impact Scale 
(FIS) 






General QoL assessment based on 
physical symptoms, emotional well-






Level of independent function based 
on physical, psychological and social 
components. 
(Barnes et al., 
2010) 
Fatigue Severity Scale Level of fatigue based on physical 
symptoms. 




Emotional well-being assessment 
based on mood and fatigue. 





Health Related Quality 
of Life 
Health and well-being assessment 
based on physical, mental, emotional 
and social functioning.  




Level of functional ability based on 
physical, social and economic 
elements.  





Physical and psychological impact of 
MS symptoms.  
(Garrett et al., 
2013) 
Multiple Sclerosis 
Quality of Life -54 
Health and well-being assessment, 






Health and well-being assessment 
based on physical, psychological and 
social components.  




Measure of social experience based 
on daily function.  
(Patti et al., 
2002) 
Visual Analogue Scale 
(VAS) 
Self-perceived measurement of pain 
(global or local). 
(Vucic et al., 
2010) 
 
The SF-36 survey has excellent reliability from previous studies including those 
investigating interventions with MS patients and is highly used for this reason (Backus 
et al., 2016; Garrett et al., 2013; Laucis et al., 2015; Rietberg et al., 2005; Savigny et 
al., 2009). However, due to the number of questions used in the form, it can often be 
too time consuming for some studies to incorporate and can result in a low response 
rate. Therefore, analysis of these results is often limited. Shorter versions of the form 
also exist which can be more appropriate for some studies, though would not give 
the full general health assessment it is known for (Farinotti et al., 2007; Khan et al., 
2007; Patti et al., 2002).  
As two commonly reported symptoms, fatigue and pain are very important to 
monitor within MS therapeutic interventions. They are also known to be very difficult 
to monitor due to the subjective nature of their experience as well as their complexity 
and their influence on other symptoms. Fatigue is not only poorly understood but has 
very high associations with QoL and therefore requires further development and 
monitoring (Crenshaw et al., 2006; Kawada, 2017; Kehoe et al., 2015; Polman et al., 
2011; Vucic et al., 2010). Though pain is also a very complex neurological process, its 
main method for measurement within therapeutic setting is in a self-perceived scale. 




symptoms. Although information is known about nociceptive pathways that cause 
pain, monitoring this during therapeutic treatment and its potential mechanism is 
lacking (Feinstein et al., 2015; Patti et al., 2002; Smith et al., 2016). 
A rehabilitation intervention was assessed by Patti et al. (2002) and demonstrated 
significant improvements in several aspects contributing to QoL, by allocating 
therapies based on their individual needs from a baseline assessment. This 
incorporated specific needs for symptom management and QoL. These included 
therapies such as physiotherapy, occupational, speech, music, mirror, video, group, 
and goal orientated therapies. Compared to a control group, MS patients allocated 
to a therapy intervention showed significant improvements in physical functioning, 
body pain, general health, and social functioning, all contributing to their overall QoL 
score with an analysis using several different QoL scales. In a similar manner to other 
study results, the EDSS levels were unchanged (Patti et al., 2002). Therefore, 
addressing potential benefits in specific aspects of symptom management, can help 
with long-term improvements in QoL, regardless of their MS neurological 
impairments.    
2.3.4 Gender Differences in Intervention Response 
Gender differences in muscle mass and composition are well established and have 
been identified in some physiotherapy-based studies. They have been well reported 
in injury prevention literature, with differences found in muscle mass production, 
muscle to fat ratio, muscle distribution, joint anatomy, joint kinematics as well as pain 
thresholds (Granata et al., 2002a; Granata et al., 2002b; Kristianslund et al., 2012; 
Pruyn et al., 2015). However, gender differences for biomechanical analysis of muscle 
in relation to active and passive stiffness has been less well researched and reported 
(Bailey et al., 2013; Granata et al., 2002a; Granata et al., 2002b; Mauvais-Jarvis, 
2015). These well-known gender differences in musculoskeletal injuries could 
provide further insight in passive and active states of muscle tissue.     
Where active muscle stiffness is because of the sarcomere unit in muscle tissue 
contracting and creating a forceful tension in order to move skeletal muscles, passive 
muscle stiffness is created by resistance stretching. This allows muscle fibres to 




generated (Naraoka et al., 2017). Granata et al. (2002a and 2002b) revealed gender 
to be a significant factor in active muscle stiffness outcomes. The study also found 
males to have significantly higher levels of agonist and antagonist activity, relating to 
active muscle stiffness. As expected, greater levels of muscle activation, would be 
likely to arise from greater muscle mass and create greater levels of active muscle 
stiffness (Granata et al., 2002a; Granata et al., 2002b). 
The differences between sexes and how they phenotypically present with MS and 
respond to therapeutics has led to studies investigating this more thoroughly. There 
was a suggestion by Kehoe et al. (2015) that female gender explained 57% of the 
variance in results testing a 10-week exercise intervention. They found gender to be 
a significant predictor in the physical impact outcomes using MSIS-29 (table 2.1) 
specifically looking at daily activities, mobility, refined movements, fatigue and 
walking ability. Females in the study had a lower physical impact of MS score and 
longer walking distance compared to males. Although gender was found to be a poor 
predictor of walking ability, females were found to have gained more psychologically 
from the intervention support and better disease management strategies, which may 
have influenced these results to show the significant differences between gender 
results. This is also supported by other studies suggesting gender differences in 
treatment response (Garrett et al., 2013; McCullagh et al., 2008). The results from 
this study indicate psychological benefit from the intervention and the support they 
provide, may lead to significant differences in physical outcomes, and that males and 
females may then respond differently because of this.  
The differences between males and females investigated in previous studies (Bailey 
et al., 2013; Granata et al., 2002b; Harbo et al., 2013; Kehoe et al., 2015) indicate the 
importance around the gender differences and how this affects their intervention 
response. Awareness of these differences could be essential depending on how 
tailored they are required to be for the individual and of this effect on results. Gender 
specific interventions may not be possible in every therapeutic scenario; however, 




2.4 Manual Therapeutic Interventions 
Manual therapy is often used for people with MS as a relief for symptoms connected 
with stiffness and pain, aiding symptom management. This type of physiotherapy 
involves use of manual touch in either a massage, manipulation, mobilisation or joint 
movement, in order to restore muscle and joint mobility to a more improved form of 
movement with less pain (Carnes et al., 2010; Olson, 2009).  This type of therapeutic 
has been used for many years due to its simple and effective results in terms of pain 
and stiffness release and is a well-known therapeutic in clinical practice (Millan et al., 
2012; Voogt et al., 2015). Although manual therapy is commonly used in clinical 
practice, there is limited understanding of the specific mechanisms responsible for 
the benefits seen (Goertz et al., 2016; Voogt et al., 2015). 
Manual therapies which target para-spinal muscles are suggested to act on various 
components of vertebrae, separating facet joints and passively allowing the para-
spinal muscles to be mechanically stretched (Maigne & Vautravers, 2003). Results 
from spinal therapy are both positive (Chiradejnant et al., 2003; George et al., 2006; 
Haas et al., 2014; Sterling et al., 2001) and conflicting (Assendelft et al., 2003; Childs 
et al., 2004; Goodsell et al., 2000; Stamos-Papastamos et al., 2011; Thomson et al., 
2009). There is therefore a robust rationale to establish the efficacy of such 
treatments given their low risk side effects (back pain, trigger of other pain, minor 
bruises) and potential economic savings. The National Institute for Health and Clinical 
Excellence (NICE) guidelines have recommended using manual therapy for these 
reasons (Carnes et al., 2010; Powers et al., 2008; Savigny et al., 2009; Shum et al., 
2013; Stamos-Papastamos et al., 2011; Wong et al., 2016).  
The unknown mechanisms of action of manual therapeutics means that deciphering 
whom they benefit, what type of intervention is most beneficial for a specific patient, 
and how long or often they should be receiving this treatment, is challenging. 
Investigations around spinal therapeutics and those most likely to respond positively 
have resulted in a clinical prediction rule (CPR) specifically for back pain sufferers 
(Childs et al., 2004; Fritz et al., 2005; Fritz et al., 2011). The results from these CPR 
studies indicate use of symptom severity, symptom location, symptom duration and 
symptom root cause to be predictors in therapy response, depending on type and 




patients, a third of people with MS claim that they use a form of manual therapy as 
an alleviation of these symptoms with success (Backus et al., 2016; Brouwer & 
Andrade, 2009). A similar predictive protocol based on symptom features may be an 
informative tool for manual therapy within MS physiotherapy.  
A systematic review by Zoogt et al. (2015), investigated 13 studies on the effects of 
spinal manual therapy on pain thresholds, with 10 of these studies revealing 
significantly improved immediate results. These results were for pressure pain 
thresholds (PPTs), with no studies showing any significant results for thermal pain 
thresholds. No conclusions were drawn for location or intensity of the manual 
therapeutic, therefore information on these aspects may help to draw conclusions 
around benefits for symptom type of the therapy receiver. Manual therapy is said to 
mechanically alter the neurophysiological triggers affecting the nociceptive pathways 
for pain, with many pieces of evidence showing that PPT can be altered with 
mechanical stimulation (Chaitow, 2015; Olson, 2009). However, the lack of results for 
thermal pain thresholds, could signify a different mechanism for these different types 
of pain. Zoogt et al. (2015) claim no conclusions were drawn from a central or spinal 
mechanism for manual therapy, therefore information about these specifics does not 
appear to be available.  Similar results were also seen in Lascurain-Agiurrebeña et al. 
(2016) in their systematic review of studies using spinal mobilisation treatment. This 
review revealed consistent results in studies with hypoalgesia, spinal stiffness 
reduction, improved muscle function, however no effect on thermal pain thresholds. 
Though they conclude very little about the lack of effect in thermal pain mechanisms, 
their review displays consistent results suggesting endogenous pain inhibition 
through mechanical stimulation.  
Schmid et al. (2008) found results based on 15 studies in a systematic review, 
revealing consistent results for hypoalgesia, activation of the SNS and changes to 
motor function, after receiving manual therapy. With their combined data, they 
concluded joint mobility improved by 20% along with reductions in pain or stiffness. 
The main outcome in results from these reviewed studies were outcomes for 
improved functional movements important in daily tasks, signifying its importance 




limited, due to their complex and multi-factorial nature. However, they offer similar 
suggestions as the Lascurain- Agiurrebeña et al. (2016) and Zoogt et al. (2015) reviews 
around release of pain modulating neurotransmitters due to mechanical stimulation.  
2.4.1 Lumbar Spine and Lower Back Pain 
The lumbar spine is the lower back region and consists of the 5 spinal vertebrae from 
L1 to L5. These are the largest of the vertebral column and help to provide support 
for the lumbar spine to bear the weight of that person. Large muscles that support 
the back also allow for movement of the trunk and the body as a whole and important 
in maintaining healthy lumbar vertebral movement (Balderston & Auerbach, 2005; 
Berry et al., 2018).  
Healthy spinal mobility is crucial in a general population for whole body movement. 
The importance of spinal cord health within MS has been demonstrated with 
significant results of spinal deterioration affecting disease status. Spinal cord function 
in MS patients is often used to define clinical disability. Spinal mobility can then be 
an issue for people with MS struggling with mobility, pain, and muscle stiffness. The 
manifestations of the disease in lower extremities, core strength and balance 
symptoms are often related to spinal cord atrophy and reduced spinal mobility 
emphasising the need for continued spinal mobility within the condition (Bernitsas et 
al., 2015; Evangelou et al., 2005).  
Reduced spinal mobility is often associated with an increase in lower back stiffness 
and pain, which can lead to longer-term lower back pain (LBP). This has shown to be 
common and become debilitating for daily life in various musculoskeletal conditions 
including the MS population (Compston & Coles, 2008; Hartvigsen et al., 2018; Hoy 
et al., 2010). This can however be as a result of different contributing factors, such as 
spasticity in some of the para-spinal muscles, and other physical symptoms that are 
affecting mobility, fatigue, mental health, kinesiophobia as well as symptoms directly 
causing pain to that area. Mobility related symptoms may also lead to an uneven 
distribution of weight that can subsequently put pressure on the lower back and 
contribute to pain in this area. LBP can cause a deviation from the normal posture in 
the static spine and often results in deviation of normal function of the spine (Maigne 




with altered loading patterns in the spine, an increase in spinal stiffness and spasticity 
and greater risk of injury (Powers et al., 2008; Shum et al., 2013). Patients often show 
limited flexibility and tenderness in lumbar muscles because of LBP, a possible 
connection between pain and stiffness. Para-spinal muscles can be the main limiting 
factor for movement when highly tense and stiff, particularly within the lumbar 
region (Maigne & Vautravers, 2003). Vertebral support from attaching muscles is also 
said to be important for prevention of spinal buckling during loading of the spine, by 
decreasing direct mechanical stress (Triano, 2001). Functionality of para-spinal 
muscles is crucial for mobility of the lumbar spine and consequently on the effect of 
someone’s whole body mobility and management of their condition.  
The severity of LBP is generally differentiated by the duration of symptoms, acute (0-
12 weeks) and chronic (over 12 weeks). However, further classifications can be made 
on the cause of pain (musculoskeletal, inflammatory, neuropathic)  (Hartvigsen et al., 
2018; Maigne & Vautravers, 2003). Furthermore, the factors influencing LBP can go 
beyond biomedical explanations, and developments have been in place to investigate 
these further including the psychological and social factors that can contribute to the 
LBP experience (Pincus et al., 2013). This can have a substantial effect on someone’s 
response to treatment and deciphering individual needs will therefore be beneficial.  
Treatment of the spine and para-spinal regions can have significant impact on 
mobility of the whole body due to its influence both structurally and physiologically 
on body movement initiated in the torso area (Bernitsas et al., 2015; Maigne & 
Vautravers, 2003). When muscles are highly tense and stiff, they lack the ability to 
respond to changes in shape that would allow contraction for movement. This can 
make voluntary movements more difficult and painful and create more likelihood for 
involuntary spasm reactions. Results from a systematic review suggested both 
manipulation and mobilisation as an effective therapeutic for LBP with many 
improvements in RoM, reductions in stiffness and relief of pain (Bronfort et al., 2004). 
Chronic back pain patients have shown a higher liklihood of response to spinal 
manual therapy compared to acute sufferers and could be an important element in 





2.4.2 Spinal Mobilisations 
Introduced in the 1960s by Geoffrey Maitland, mobilisations is a manual therapy 
technique still used today. It is particularly common for treatment of back pain, 
stiffness and to improve spinal RoM (Chansirinukor et al., 2003; Maitland et al., 2013; 
Piekarz & Perry, 2015). It consists of low-velocity and high amplitude oscillatory force, 
separating facet joints and stretching para-spinal muscles, differing from a 
manipulation thrusting and more forceful technique (Maigne & Vautravers, 2003; 
Pickar & Bolton, 2012; Stamos-Papastamos et al., 2011). The spine experiences 
movement by rotation of pelvis and thoracic cage, compression of skin and tissues, 
and movement of spinal joints (Chansirinukor et al., 2003; Lee & Evans, 2000; Powers 
et al., 2008; Shum et al., 2013). Mobilisation treatments can differ in level of force 
applied, rate of mobilisation oscillations, length of mobilisation treatment time and 
direction of the mobilisations. These are generally in the following categories: 
Anterior-Posterior (AP), Posterior-Anterior (PA), Longitudinal Caudad (towards the 
tail), Longitudinal Cephalad (towards the head), Medial Glide and Lateral Glide. 
Together the force, velocity, and direction of this manual treatment, dictate the way 
in which vertebrae and paraspinal muscles are influenced. The most used 
mobilisation technique is the PA (Chiradejnant et al., 2003; Snodgrass et al. 2005). 
Though objective research has been growing in recent years, more development is 
needed, particularly within spinal mobilisation efficacy to determine the specificities 
of what and how is most beneficial (Piekarz & Perry, 2016). Although a large body of 
research exists in mobilisations as a treatment for LBP, little exists on this treatment 
within MS rehabilitation. Advancements in this research area will contribute to the 
knowledge in MS therapeutics (Bronfort et al., 2004; Chiradejnant et al., 2003; Perry 
& Green, 2008; Piekarz & Perry, 2015, 2016; Stamos-Papastamos et al., 2011). 
The duration of mobilisations and number of repetitions can be used to regulate 
mobilisation treatment dose. The different dosages included in studies of spinal 
mobilisations often result in different findings as seen by differing methods within 
spinal mobilisation investigations. The 15 mobilisation studies reviewed in this 
section are summarised in table 2.2 and identified as regularly cited within spinal 




Also included were studies with high degree of relevance to the study design, despite 
having less impact through number of citations.  
The most common response seen in these spinal mobilisations studies is the 
reduction of pain (Ferreira et al., 2009; Goodsell et al., 2000; Lopez-Lopez et al., 2015; 
Powers et al., 2008; Shum et al., 2013; Sterling et al., 2001; Willett et al., 2010). This 
is suggested to be associated with reduction in stiffness in results from Shum et al. 
(2013) due to their potential similar mechanistic response as well as associations with 
improvements in RoM which known to be affected by both pain and stiffness (Lopez-
Lopez et al., 2015). Many study results also show results with increased activity from 
the SNS and is suggested to be an area of further development for the potential 
mechanistic influence of spinal mobilisation (Jowsey & Perry, 2010; Perry & Green, 
2008; Piekarz & Perry, 2016; Sterling et al., 2001). Though several studies investigate 
the optimal dose of mobilisations that are most beneficial in terms of these effects, 
there is no consensus on the number of sessions, length of time, or specific spinal 
location for the most beneficial outcomes (table 2.2).   
Table 2. 2 Results from previous spinal mobilisation investigations.  
Study Aim Mobilisation 
Method 
Findings  Reference 
















difference in pain 
and RoM measures 
compared to 
baseline or between 
groups.  
(Chiradejnant 
et al., 2003)  
Treatment of LBP 
investigating 
stiffness and pain. 
12 sessions in 8 







































applied to thoracic 
spine compared to 
a placebo. 
Significant difference 
between groups for 
skin conductance in 
the hand.  
(Jowsey & 
Perry, 2010) 
Treatment of neck 
pain investigating 
pain and RoM 













et al., 2015) 
Treatment of upper-
mid back pain 
investigating muscle 
activity and pain. 
Single 3-minute 
mobilisation 
applied to thoracic 















bouts of either 30 




30 or 60 second 
sessions for PPT 
compared to 
baseline. Significant 
improvement after 4 
sessions compared 










to placebo and 
control.  
Significant difference 
in skin conductance 
compared to control 




Treatment of LBP 
investigating SNS. 
3Hz and 2Hz 
mobilisation 
group compared 
to placebo and 
control, applied 
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in pain compared to 
baseline in both 
groups.  
 
(Powers et al., 
2008) 
 
Treatment of LBP 
investigating pain 
and stiffness.  
Single 3-minute 
session applied to 
lumbar spine.  
Significant 
immediate reduction 




pain and stiffness. 






stiffness and RoM. 
Single 3-minute 
mobilisation at 
2Hz and 3-minute 
manipulative 
thrust, both 
applied to lumbar 
spine. 
No significant results 
for stiffness or RoM.  
(Stamos-
Papastamos 
et al., 2011) 
Treatment of 
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2.5 Proposed Treatment Mechanisms  
2.5.1 Sympathetic Nervous System  
Reasons for the benefits of mobilisation therapy could lie at the neuro-physiological 
level with results showing an activation of the SNS and an increase in body alertness. 
Many studies have recorded some of these effects such as increased blood flow, 
increased heart rate, increased respiratory rate, pupil dilation, increased sweating, 
and increased skin temperature occurring as an outcome of mobilisation therapy 
(Kingston et al., 2014; Lascurain-Aguirrebena et al., 2016; Perry & Green, 2008; 
Piekarz & Perry, 2016; Sterling et al., 2001). However, these suggestions are mainly 
based on physical outcomes seen and could also be affected by other internal 
physiological systems (Lascurain-Aguirrebena et al., 2016; Schmid et al., 2008; Triano, 
2001). 
Skin conductance and skin temperature increase were seen in significant results from 
Sterling et al. (2001) after methodically applied mobilisations in participants with 
spinal pain. These SNS skin-based outcomes were also associated with pain 
reductions measured using Visual Analogue Scale (VAS) and PPTs when compared to 
a control intervention. Perry and Green (2008) also found significant changes in skin 
conductance and temperature in lower limbs after lumbar mobilisation treatment. 
The significant responses were specific to the side treated, indicating that mechanical 
stimulation in the lumbar spine, can elicit a neurophysiological response in the lower 
limbs. This investigation was continued by Piekarz and Perry (2016) to further analyse 
the rate of mobilisations used, and whether this affected the level of SNS response. 
Their results indicated mobilisations at 3Hz had significantly greater response 
compared to slower rate treatments. These results overall therefore imply that a 
faster rate of oscillatory movements, may have a greater effect on SNS activation. 
Therefore, faster mobilisations could be important for some of the more commonly 




A systematic review by Schmid et al. (2008) found results from several studies 
suggesting SNS activation with results in increased skin conductance, increased 
blood pressure, heart rate and respiratory rate. These results are over several 
different studies, and some of these effects extended beyond the body part that was 
being treated. Since the SNS is activated because of a stress trigger, the mechanical 
stimulation during mobilisation therapy could induce chemical release that initiate 
this stress trigger. A review by Kingston et al. (2014) similarly shows results from a 
range of studies demonstrating SNS-excitatory effects, irrespective of the location of 
the mobilisations on the spine. Along with other studies showing effects on body 
parts that were not manually treated, this suggests neural centralised influence. The 
main theory suggested for these effects is mediation by the mid brain (dorsal peri-
acqueductal grey area, dPAG). Mobilisation of a spinal segment stimulates receptors 
in joints, tendons and connective tissue that can directly or indirectly activate dPAG 
mechanisms in the mid brain. This subsequently affects neural descending pathways 
that can trigger the outcomes of the SNS such as increased heart and respiratory 
rate. This is also the primary control centre for descending pain mediation which may 
then be an interconnected stimulus response (Kingston et al., 2014; Schmid et al., 
2008; Vicenzino et al., 2001). Since SNS activity has been found at lower levels in 
people with MS, this could be a key area of benefit from mobilisation therapy and 
could be associated with the stiffness and pain reductions referred to from other 
people groups (Sternberg, 2012).  
2.5.2 Analgesia   
Analgesia or hypoalgesia are the terms referred to when the feeling of pain is reduced 
or absent, algesia meaning a sensitivity to pain. Several study results have referred 
to pain reduction after mobilisation treatment, along with results in SNS activation, 
with suggestions that their descending pathway regulation could be mediated in the 
same centralised location (Kingston et al., 2014; Schmid et al., 2008). The VAS is a 
standard and simple way of measuring pain, often before and after an intervention 
to analyse potential effects. It is a self-reported scale used regularly as standard 
practice for pain measurement (Lopez-Lopez et al., 2015; Shum et al., 2013). When 




a better overview of intervention effects and results, particularly with a clinical 
population (Rabey et al., 2017).  
The result of an experience of pain is a complex interaction of physiological and 
psychological interactions, and manual therapeutics have the potential to influence 
both (Voogt et al., 2015). The previously mentioned immediate results in improved 
PPTs suggest increased pain tolerance from mechanical stimulation (Millan et al., 
2012; Voogt et al., 2015). Neurophysiological theories are often used to explain the 
analgesic effects from manual therapies, such as peripheral nerve receptor 
stimulation that activates a centralised mechanism that mediate pain pathways. 
There is also said to be a psychosocial aspect of therapeutic exercises that induces 
relaxation (Lopez-Lopez et al., 2015; Voogt et al., 2015). 
George et al. (2006) found a hypoalgesic effect in lumbar areas where manual 
treatment was occurring, however, no correlations were found alongside 
psychological variables. Therefore, the suggestion of these results imply that 
physiological processes were responsible for the hypoalgesia effect. Though many 
claims of a placebo effect of manual therapeutics have been made (Goodsell et al., 
2000; Pecos-Martín et al., 2017; Ruddock et al., 2016) there is more to be investigated 
in neurophysiological mechanisms. However, Lopez-Lopez et al. (2015) demonstrated 
improvements in self-reported VAS pain levels with significant interactions between 
intervention type and anxiety traits, meaning that these elements may influence each 
other. This suggests that psychological factors, such as anxiety, depression, 
kinesiophobia, and catastrophizing can play an important role in some of the pain 
and RoM outcome measures. Goodsell et al. (2000) also investigated the effect of 
pain, stiffness and RoM, by testing a mobilisation treatment versus a control 
treatment. Their results did not show any significant changes in outcome measures 
for stiffness or RoM in either groups. However, significantly greater improvements 
for levels of pain on lumbar areas treated for mobilisations compared to controls was 
found (Goodsell et al., 2000). This potentially indicates greater effects on pain 
compared to stiffness and RoM are possible.  
Fritz et al (2011) also reported an immediate decrease in self-reported pain that was 




demonstrated that 12 sessions were necessary to see these kinds of effects. Although 
this study did not use a placebo or a control, therefore results could be less reliable. 
This implies long-term interventions are more likely to show significantly beneficial 
results than short-term immediate results. Pentelka et al. (2012) investigated in their 
study treatment time periods and number of treatment sets, to establish whether 
there is an optimum number of sets and time of treatment to achieve an analgesic 
effect. They showed no difference between 30 second and 60 second mobilisation 
sets but did however show that four sets were necessary to achieve the analgesic 
effect. These results could suggest that a certain number of sets is necessary in order 
for an analgesic effect to occur (Pentelka et al., 2012, table 2.2).  
The review by Lascurain-Agiurrebeña et al. (2016) collated some results for 
neurophysiological effects after spinal mobilisation treatments. They reported 
studies with results in mechanical algesia reduction along with improved muscle 
function. The relationship between these is unclear, though suggested to be 
associated with an excitation of the SNS inducing longer lasting effects, previously 
discussed due to activation of dPAG mechanisms in the mid brain. They also revealed 
results of an immediate increase in nociceptive flexion reflex (NFR) threshold. Used 
as a measure of spinal excitability, this is a spinal reflex elicited after activation of 
nociceptive A-delta afferent fibres. The magnitude of this reflex response is then 
related to the intensity of perceived pain. Therefore, mobilisation treatment may be 
affecting this pathway. Thermal pain threshold was unaffected by the treatment, like 
other study results. Pathways for this type of pain may be affected differently and 
less likely to be altered when mechanically stimulated.  
Other theories arose from an in-vivo experiment by Langevin et al. (2005) based on 
mechanically stretching fibroblasts, replicating what happens in-situ in a controlled 
cellular environment. Results showed a modification of interstitial osmotic pressure, 
increasing blood flow and reducing concentrations of pro-inflammatory cytokines, 
with the suggestion that this could cause a reduction in pain due to the reduction in 
cytokines (Langevin et al., 2005). Degenhardt et al. (2007) describe altered levels of 
pain biomarkers after manual treatment which was greater in people with chronic 




N-palmitoylethanolamide (PEA) and a decrease in anandamide (AEA) (Degenhardt et 
al., 2007). A similar decrease in AEA was also found by McPartland et al. (2005) after 
spinal therapy and found changes in AEA correlated with changes in experience of 
pain (McPartland et al., 2005). These theories are contributions to potential 
explanations as to what the underlying mechanisms are for the hypoalgesic 
responses that occur with countless reports in pain reduction post spinal manual 
therapy.  
The main summary of the biochemical theories of CNS-mediated pain pathways are 
based on the elicitation of primary afferent neurons, altering afferent inputs into the 
CNS. High frequency discharge from central neurons is associated with high levels of 
pain (Chaitow, 2015; Pickar, 2002; Reed et al., 2014). Though the specifics of these 
remain unclear, the concept of modifying proprioceptive afferent inputs to the CNS 
remains a common theme within literature (Chaitow, 2015; Pickar & Bolton, 2012; 
Pickar, 2002; Voogt et al., 2015). The regular reports of reduction in pain from 
mobilisation mean this is an important area to investigate. Though pain is an 
experience with physiological and psychological complexities, neurophysiological 
explanations for pain reductions, providing further physiological explanations for the 
hypoalgesic effect will be beneficial for the understanding of how to elicit this 
response through manual therapy.  
2.5.3 Stiffness Reduction  
Muscle stiffness is described as a stretch resistance in tissue, resulting in difficulty of 
change of length in muscle tissue and subsequently movement difficulties (Marusiak 
et al., 2012; Zinder & Padua, 2011). As previously described, this can be a result of an 
active forceful contraction creating the resistance to muscle change in length or 
shape, and can also be passive when no active force is being generated by the muscle 
and resistance to change of shape or length still occurs. The capacity of a muscle to 
resist deformation, either by contraction or external force can be measured to show 
stiffness, the opposite is termed compliance (Granata et al., 2002; Shum et al., 2013). 
Muscle stiffness is often referred to as a factor that affects localised movements, 
whole body movement and connected to pain and function of daily activities. The 
biomechanical characterisation of stiffness is a research area that is growing rapidly 




et al., 2014) though the reliability has been higher for stiffness and tone, and less for 
elasticity (Fröhlich-Zwahlen et al., 2014).  
Spinal stiffness values have previously been shown to have potential demographic 
characteristics based on age, sex, level of pain and lifestyle. With an element of active 
muscle stiffness required for the maintenance of stability in a joint, a heavier body 
mass is then likely to require a greater level of stiffness to maintain stability (Granata 
et al., 2002a; Granata et al., 2002b). Results from Granata et al. (2002a) revealed 
females have less than 57% active muscle stiffness compared to males in leg muscles 
and there was a significant difference in lumbar spinal stiffness between sexes in a 
study by Owens et al. (2007). This study also revealed L5 to have the highest values 
for stiffness (Owens et al., 2007). These results suggest that the lower lumbar regions 
are more likely to have greater stiffness and males tend to have higher stiffness 
values compared to females in both the lumbar spine and lower extremities. This 
could mean that males have a higher level of response to spinal therapy than females, 
supported by the proposal from Kehoe et al. (2015) that gender specific interventions 
are necessary for MS rehabilitation programmes.   
Studies have previously reported improvements in RoM, pain relief and stiffness 
however, the methods for measuring these improvements are often subjectively 
assessed and therefore can result in false positives due to the effects of bias 
(Chiradejnant et al., 2003; Edgecombe et al., 2013; Ferreira et al., 2009; George et al., 
2006; Lopez-Lopez et al., 2015). A significant relationship between pain and stiffness 
reductions has been previously reported by Shum et al. (2013), emphasising the 
importance of baseline symptom correlating with reduction levels. The implication of 
this relationship is that people with greater levels of stiffness and pain, may be more 
likely to show a reduction.   
Ferreira et al. (2009) did a thorough investigation with many lifestyles and 
performance-based outcome variables looking at the effects of a specific 
manipulation intervention. Their study showed a significant correlation between 
baseline stiffness and stiffness reduction levels. Pain measures were recorded using 
self-reported scales and showed a significant correlation with change in stiffness 




(2009) stiffness and pain are closely interlinked and can affect each other. Self-
reported functional status for daily activities also showed a change that was 
significantly correlated against change in stiffness. Stiffness reduction may also affect 
other areas associated with pain, muscle recruitment for mobility and therefore 
functional independence. Tissue stiffness therefore appears to be impactful, 
potentially affecting other areas within whole-body function. Consequently, a 
treatment that can successfully reduce stiffness, could potentially influence other 
areas also. This could impact whole body health and the physical activity needed for 
functional independence. 
Owens et al. (2007) demonstrated that subjects with a higher body mass index  (BMI) 
score tended to have lower stiffness and attributed this to a thicker level of overlying 
soft tissue at the contact point of stiffness measurement (Owens et al., 2007). High 
BMI levels could therefore create inaccuracies within the stiffness measurements and 
could be an area for further development in muscle stiffness measurement. Lee et al. 
(1998) determined a low average BMI for subjects in their study but did not find any 
correlation between BMI and stiffness values in their study (Lee et al., 1998). There 
could therefore be an association between BMI, levels of activity, level of stiffness 
and pain. Since previous studies have not found a pattern in this response for spinal 
therapy, there could be other anthropometric measures that could be better 
associated with spinal therapy and level of response.     
The notion of mechanical influence of spinal mobilisations encompasses altering 
receptors within para-spinal muscle tissue ultimately leading to a reduction in pain 
and stiffness. Mechanical manipulation of the tissue may have the potential to trigger 
primary afferent neurons, affecting muscle spindle response and the muscle fibre 
ability to change shape (Reed et al., 2013). This equates to the concept of 
mechanically stretching the muscle, allowing the muscle spindle (stretch receptors) 
to respond, which is the primary proprioceptor of the muscle, and allows adaptive 
signalling to reduce the resistance to the shape change (equating to muscle stiffness). 
The cascade of events in mechanical stretching may therefore assist in the reduction 
of stiffness (Pickar & Bolton, 2012; Reed et al., 2014; Reed et al., 2013). An element 




working within the sliding filament of the sarcomere structure, and acts as a muscle 
spring structure. This protein has the appropriate structural characteristics to allow 
plasticity within the skeletal muscle fibres to respond structurally and functionally 
according to the demands being placed on the muscle (Janecki et al., 2011; Lindstedt, 
2016; Viir et al., 2006). Therefore, passive stretching of the muscle during manual 
therapy can provide this adjustment, causing structural changes both in adaptive 
signalling in afferent nerve fibres and adaptive sarcomere structuring. The 
communication between peripheral sensory nerve fibres and the CNS is crucial for 
this process and the process of adaptive signalling may also be connected to altering 
pain biomarker concentration (Pickar & Bolton, 2012; Pickar, 2002; Piekarz & Perry, 
2015; Reed et al., 2015). 
2.6 Spinal Mobilisations as a Treatment for Multiple Sclerosis 
The literature around spinal mobilisations referred to within the literature review and 
found in literature searches (table 2.2), all referred to this treatment for people with 
LBP, neck pain, upper back pain, mid back pain and musculoskeletal pain; none were 
in the context of people with MS. However, many cross overs can be made in terms 
of symptoms experienced and ways in which these symptoms can be alleviated and 
therefore alter lifestyle factors. This also implies that research in this area has not 
been published and could therefore be novel within MS therapeutic literature.  
As previously discussed, many studies have shown effective results after spinal 
mobilisation treatment, with the main benefits consisting of reductions in pain and 
stiffness. Due to the symptoms experienced by MS patients, reductions in both could 
have large impacts on their daily life, as fatigue and walking difficulties are two of the 
most experienced symptoms. This can either directly or indirectly affect aspects such 
as muscle strength, muscle coordination, balance, stability, walking ability and daily 
functional activities. Direct influence would indicate that the mechanical stimulation 
affecting afferent pathways for pain, stiffness, and aspects of sympathetic excitation, 
could be counteracting the result of disrupted neural pathways resulting in these 
symptoms. Indirectly, reductions in pain and stiffness can subsequently affect 
symptoms such as fatigue, anxiety, depression, and daily functional activities, due to 
improved body movement. Previous mobilisation studies on developing a CPR and 




pain or stiffness, results in a greater level of response (Fritz et al., 2011; Shum et al., 
2013). Therefore, some of the people who benefit the most from mobilisation 
therapy, may be the people who have greater level of symptoms, and struggle with 
other forms of therapeutics such as exercise interventions.        
Exercise interventions have shown to be very helpful in MS therapeutics to aid 
improvement in body movement. However, movement limitations may be a barrier 
for some people to participate. Therefore, a manual intervention that involves 
passive work on muscles, with successful results from previous studies in people with 
similar symptoms, may contribute to MS therapeutic knowledge. Since MS is a 
chronic condition, and symptom management is a long-term feat, a sustainable 
management strategy incorporating therapeutics that are most helpful for 
individuals, will also be necessary to decipher in the long-term feasible plans for the 
individual.  
2.7 Biomechanical Measures 
2.7.1 Muscle Biomechanics 
There is value in the objective measurement in muscle changes due to methodology 
differences that arise when comparing intervention application and analysis. An 
objective form of measuring muscle tissue quality not only helps to remove some of 
these issues but can also aid diagnosis of conditions based on muscle tissue quality 
abnormalities, and help assess their progression (Bizzini & Mannion, 2003; Fröhlich-
Zwahlen et al., 2014).  
Developments in recent years have been made in the mechanical measurement of 
muscle stiffness, using biomechanical principles. Owens et al. (2007) developed a 
system measuring PA spinal stiffness where stiffness measurements were recorded 
over the lumbar spine using electronic sensors recording displacement and force. This 
is a measurement for bending stiffness, which is often referred to in stiffness 
measurement literature (Lee et al., 2005; Shum et al., 2013; Stamos-Papastamos et 
al., 2011). The spine is measured as a bending beam, that is fixed at two points: the 
pelvis, and the ribcage. A known level of force is applied to a third point on the beam, 
and the displacement recorded. There are differing methods that have been used in 




measure has been required (Lee et al., 2005; Owens et al., 2007; Shum et al., 2013; 
Stamos-Papastamos et al., 2011). Over time, the development of this method has led 
to a small hand-held indenter, for non-invasive stiffness measurement called 
myometry.  
A myometer is now a form of indenter and the main form of measuring viscoelastic 
properties of tissue. An indenter is placed above the desired tissue and produces a 
series of short force impulses from the electromagnetically activated device. This 
causes small deformations in the tissue for a predetermined period, to which the 
tissue responds with damped oscillations determined by the viscoelastic properties 
of the tissue. These oscillations are recorded by an accelerometer on the testing end 
of the indenter, recording the muscle deformation characteristics. Stiffness is then 
calculated as the ratio of resisting force response and the change in length of the 
tissue (mechanical stretch) (Bizzini & Mannion, 2003; Pruyn et al., 2015; Viir et al., 
2006). Studies that have been part of the development of these objective 
measurements with the use of a PA force-displacement indenter have become more 
prevalent in the past twenty years (Chansirinukor et al., 2003; Edgecombe et al., 
2013; Goodsell et al., 2000; Lee et al., 1998; Owens et al., 2007; Wong et al., 2015). 
This has become foundational work for biomechanically measuring muscle stiffness. 
The main way of working with these devices have remained broadly the same, with 
only changes in style and in size.  
A handheld myometer, MyotonPRO, has previously been validated with reliable 
results from investigations into stiffness, elasticity, and tone of soft tissue; 
characteristics said to be key elements of the biomechanical make up and 
functionality of muscles. The measurements from muscle mechanics can characterise 
muscle abnormality symptoms and monitor mobility and rehabilitation 
developments (Bizzini & Mannion, 2003; Schneider et al., 2014). Myometry has been 
used to assess results in interventions with Parkinson’s disease patients (Marusiak et 
al., 2012; Rätsep & Asser, 2011) that helped not only to assess the stage at which a 
patient was at in terms of stiffness and rigidity of muscles, but also the efficacy 




Alongside muscle stiffness, measuring the change in tone and elasticity can 
contribute towards knowledge of the effectiveness of an intervention and muscle 
quality (Kelly et al., 2018; Nair et al., 2016). Though muscle tone is necessary for 
background tension in resting state, hyper-tonality can cause high intramuscular 
pressure and have a harmful effect on muscle recovery. Elasticity of a muscle 
describes its ability to return to original shape after deformation and can be a used 
as a measure for mechanical stability and tissue changes (Kelly et al., 2018; Schneider 
et al., 2014). Investigation into tonality and elasticity of muscles can aid with 
diagnosis of musculoskeletal disorders as well helping to monitor the functional state 
of the muscle.  
2.7.2 Stability Measures 
The use of self-reporting scales and objective measures are both used within stability 
measures with differing benefits in terms of feasibility, accessibility, and performance 
outcomes (Bernardi et al., 2004; Cattaneo et al., 2006; Crenshaw et al., 2006; Kehoe 
et al., 2015). The measures that relate to daily activities, have a high value for QoL 
impact and used regularly within physiotherapy analysis (Rome et al., 2009; Shum et 
al., 2007). 
The use of force plates has previously been used to help evaluate stability, balance, 
and posture measures. Testing body sway variables is an aspect of mobility heavily 
associated with gait and daily activities. Measuring these variables can help to 
determine how they may be directly or indirectly influenced by an intervention. Body 
sway measures have previously been investigated with elderly population (Jonsson 
et al., 2004), LBP population (Goertz et al., 2016), rheumatoid arthritis (RA) 
population (Rome et al., 2009), investigating the effects of weightless environment 
(Treffel et al., 2016), determining balance disorders (Mancini & Horak, 2010) as well 
as MS patient rehabilitation (Kanekar et al., 2013; Ramdharry et al., 2006). This has 
helped to determine the influence of an intervention and improved outcomes have 
shown to have a high relation to improved functioning in daily activities. Other force 
plate measures allow analysis in force exertion as well as the level of body sway 
within movements associated with daily tasks and include movements from seated 
to standing, lunging, balancing, walking, and turning. These have been tested in 




Jonsson et al., 2004), stroke patients (Karlsson & Frykberg, 2000), musculoskeletal 
injuries (Alkjær et al., 2009), LBP (Reza et al., 2018) as well as MS (Bowser et al., 2015; 
Soyuer et al., 2006). These are all movements that are associated with functional 
independence and many of these mobility measures contribute to the basis of the 
EDSS scale (Mancini & Horak, 2010; Meyer-Moock et al., 2014).   
Assessment of balance and stability can help to process risk of falls and even 
determine some of the underlying causes for why balance disorders may occur. The 
suggestion has been made that this type of objective testing for balance could be 
useful for further investigation of potential sensorimotor mechanisms and how this 
could affect balance. However their use for investigating patient rehabilitation 
progression or the effects of an intervention are well warranted (Mancini & Horak, 
2010). 
2.8 Methodological Factors 
2.8.1 Spinal Mobilisation Measurement 
Investigations of spinal manual treatments often involve the subjective analysis of a 
practitioner, to decipher the range and force level of manual treatment. This will 
normally involve different grades (1-4) and techniques, and performed by an 
experienced practitioner (Chiradejnant et al., 2003; Jowsey & Perry, 2010). Objective 
measurement of treatment can help to standardise interventions and determine 
specific aspects of the treatment that may be beneficial to analyse. 
The specific information given from measuring the force of an intervention, helps to 
monitor its repeatability over different testing sessions. This can add an element of 
accuracy to an intervention that has a great deal of heterogeneity. The reliability 
studies based on these testing measures, help to determine a level of confidence in 
the repeatability of testing.  The mounting of a plinth onto force plates has been used 
successfully to decipher vertical ground reaction forces (GRF) elicited, particularly to 
decipher the force threshold reached (Goodsell et al., 2000; Pentelka et al., 2012; 
Stamos-Papastamos et al., 2011). Goodsell et al. (2000) used a custom-made 
treatment couch mounted on force plates for threshold assessment. They found the 
force loads to be between 60N and 230N, with a mean of 137N during mobilisation 




does not specify whether the force information was evaluated in real time or 
retrospectively. Similarly, Pentelka et al. (2012), Stamos-Papastamos et al. (2011), 
and Lee et al. (2005) used this method to measure force during mobilisation therapy, 
to decipher the threshold reached, as well as using a metronome to standardise the 
rate of mobilisations. Shum et al. (2013) appear to be the only study to display the 
force loads exerted in real time, with a maximum force of 250N exerted in their 
treatments, as is deemed to be the force tolerable for people with LBP.  
None of these studies specify any dampening effect from indirect measurement of 
force exertion, going through 2 systems before being recorded by the force plates. 
However, it seems to still be a very useful and valid description of force loads exerted 
during treatment assuming additional loads of plinth and participant remain 
consistent. Although none of these studies measure force loads over time and 
frequency of mobilisations, this is mainly monitored using a metronome. If recorded 
on force plates measures, this would indicate the total length of time someone is 
experiencing the force load for and not just the threshold or mean values. Therefore, 
methods to successfully determine forces applied during treatment are in 
development and could help to further research into specifics of who responds to 
what treatment and dosage response.  Overall, these studies seem to justify the 
feasibility of using a plinth mounted on force plates to measure vertical GRF, though 
different methods have been used to determine peak forces during the treatment.   
2.8.2 Participant Testing 
Testing with humans has many feasibility implications due to factors that cannot be 
controlled. Limitations for clinical studies with an MS population not only include 
time and funding restraints, previous studies have shown that lack of blinding, lack of 
follow-up evaluation, heterogeneity of the disease, medication variety as well as 
lifestyle differences that affect aspects of diet, activities and symptom management 
can create limitations (Gandolfi et al., 2015; Jagannath et al., 2010; Langdon et al., 
2012). Inclusion and exclusion criteria are essential to ensure the well-being of 
participants, while study design must also be developed to ensure scientific integrity 




Most MS rehabilitation studies involve people with an EDSS score of 6 and below due 
to the feasibility and ethical problems with testing more disabled people. Thus most 
of the results from these interventions are only applicable to people who still have a 
good degree of mobility (Benedetti et al., 1999; Bernitsas et al., 2015; Cruickshank et 
al., 2015; Rietberg et al., 2005). This is generally the relapse-remitting type and not 
the progressive type who also have far less pharmacological medication available to 
them (Kehoe et al., 2015). Even within this range of EDSS mobility, there is a vast 
spectrum of physical capabilities, and response to interventions could vary 
depending on certain types of strengths and weaknesses.  
Short-term investigations come under these restraints to a higher degree. In addition 
to this, the lack of spinal mobilisations literature on people with MS means that no 
criteria can be drawn for the participants for this intervention. Before testing a new 
intervention on an MS population ethically, the feasibility and efficacy of the 
intervention should be tested. The LBP population have symptoms that cross over 
with the MS population such as spasticity, pain, fatigue, depression, and movement 
difficulties. These are all symptoms that may be alleviated from spinal mobilisation 
treatment and could therefore provide useful pilot data where MS data are not 
available (Ahmad & Al-Sayed, 2018; Birkett & Day, 1994; Julious, 2005; Leon et al., 
2012). Since LBP is not only common in the general population but also within the MS 
population, pilot data with this population will be beneficial before recruiting for an 
MS clinical population.   
LBP as a musculoskeletal disorder is very common within the general population, with 
around 80% of people experiencing it at some point in their lives. It is one of the 
biggest costs for the national health service in the UK and often successfully treated 
with manual therapeutics. NICE have stated that manual therapy is recommended 
for LBP sufferers to help manage absences from work and mild disabilities 
(Chiradejnant et al., 2003; Maniadakis & Gray, 2000; Stamos-Papastamos et al., 
2011). There is therefore added value in investigating the effects of the intervention 





The development of research around MS, for diagnosis, cause and management has 
been rapidly growing for years, with still many areas to develop. The challenge with 
good quality research in MS rehabilitation and symptom management is both the 
individual nature of the condition and the heterogeneity of rehabilitative 
interventions. Though a lot of development has been done, conflicting results have 
also meant that there are many gaps still in literature and in clinical practice.  
Symptom management has huge importance for anyone suffering from MS, 
therefore good quality research appropriate for patients at all stages of disease is 
necessary. Objective forms of measuring manual therapeutics can assist in providing 
a comprehensive overview of intervention efficacy: an aspect crucial to assessing 
what is best for the symptom management of a patient. Manual therapeutics are 
often used in clinical settings for treatment of MS symptoms, therefore more 
knowledge about the effects they may be having will be beneficial to the 
development of MS and physiotherapy research.  
2.10 Project Aims and Research Questions  
The aim of this project was to provide a thorough investigation of a particular 
intervention, using spinal mobilisation techniques in a non—typical format. The 
project aimed to provide objective and novel data to characterise and analyse the 
intervention within the context of MS symptom management and rehabilitation. This 
is due to the observational and anecdotal success of the intervention along with the 
lack of spinal mobilisation investigations within MS literature. Given mobilisation 
therapy success in reduction of pain and stiffness in other rehabilitative contexts, 
there is good rationale for a scientific investigation of this within MS rehabilitation. 
There is a need for MS physiotherapy research development in deciphering the types 
of treatment and dosages most appropriate for individuals based on their symptoms 
experienced. This project aimed to provide a meaningful contribution to MS and 
physiotherapy research and provide rationale for future study.  
1. What data can be used to objectively characterise the spinal mobilisation 
using force produced by the therapist as well as the rate and timings of the 




2. How can the impact of the intervention be objectively measured on muscular 
response and whole-body movement patterns?  
3. How can a myometer device and force plate measurement provide objective 
data to analyse the impact of the intervention.  
4. Does the intervention have an immediate impact on a myometer measured 
muscle response in people with LBP? 
5. Does this intervention have an immediate impact on myometer measured 
muscle response and force plate measured movement patterns in people 
with MS? 
6. Does this intervention have a longer-term impact on myometer muscle 
response and force plate measured movement patterns in people with MS?  
7. Is there a gender-specific response?  
8. What is the importance in change of stiffness (myometry measured) to 
balance measures (force plate measured) and other lifestyle measures 







Study One: Intervention pilot study.  
Analysis of a spinal mobilisation intervention in 
people with lower back pain.   
 
3.0 Introduction 
The focus of this pilot study was to investigate and consider the feasibility and efficacy 
of a new spinal mobilisation intervention with no current scientific data or validation 
to support it. This together with the lack of MS data in mobilisation therapy and 
myometer muscle response data indicate that a pilot with MS participants was 
deemed unethical for new intervention feasibility testing. The intention of the pilot 
study was also to assess equipment usage and reliability within the testing situation, 
to pilot recruitment strategies, data collection, data management and scheduling of 
testing.   
Spinal mobilisation therapeutics are well documented with reports suggesting 
benefits from both single and multiple sessions (Ferreira et al., 2009; Goodsell et al., 
2000; Powers et al., 2008). Spinal mobilisation research for MS rehabilitation is 
lacking and therefore previous data cannot be used to forecast likely outcomes in this 
population. However, pilot data are still required for the intervention and myometer 
results which will support the development of an appropriate methodology for 
working with MS patients. This also helps to identify study design modifications that 
may be necessary (Hertzog, 2008; Leon et al., 2012).  
3.0.1 Study Aims  
The aim of this study was to provide data on the specifics of the intervention being 
investigated, given its novel status working at a specific rate, location, and pressure 
consistently over 30 minutes. Mobilisation treatments are generally given in smaller 
dosages, therefore data on longer mobilisation treatments does not exist. The study 
aims to gather data on muscle response values using a myometer as an objective 
form of analysis for treatment efficacy, as well as anthropometric data to investigate 




pilot data for the intervention feasibility and efficacy. Besides ethical requirements 
for testing new interventions with clinical populations, the feasibility of protocols 
often evolve and change according to the needs of the study and the participants. 
This is not only to retain adherence to the Declaration of Helsinki (Ahmad & Al-Sayed, 
2018) but to ensure that research integrity is maintained so that both vulnerable 
clinical populations receive the most benefit from the research outcome and the 
researcher does not use time and resources on issues that may arise during piloting 
that may negate some of the data collected.      
The study was also exploratory and aimed to investigate anthropometric measures 
and how they may influence results. The researcher hypothesised that there would 
be a reduction in para-spinal stiffness and tone due to the intervention compared to 
a control, and an increase in elasticity, and that these would be related to baseline 
values and gender as this has been previously seen in literature also. The null 
hypothesis stated that the intervention did not have any effect on these measures.     
3.0.2 Lower Back Pain Pilot Population  
The lack of scientific data for the intervention and mobilisations in an MS population 
led to the decision to recruit a population that share some symptoms with the MS 
population, and would potentially still benefit from a lumbar manual therapeutic. 
Many factors can contribute to LBP that are also experienced by people with MS such 
as muscle spasticity, pain, fatigue, depression, cognitive deficits, reduced mobility, 
reduced fitness, muscle weakness, ataxia; all known as risk factors for LBP and 
commonly experienced by people with MS also (Bishop & Rumrill, 2015; Dimitrov & 
Turner, 2014; Feinstein et al., 2015; Patti et al., 2002). It can appear as a direct 
consequence of a physical condition, however is most common as a side effect 
symptom of conditions affecting mobility (Hartvigsen et al., 2018). Although the two 
different conditions equate to two different populations, the cross over in symptoms, 
and treatment at a symptomatic level could result in benefits to both population 
groups.  
With several potential factors contributing to either acute or chronic LBP, the 
generator of pain can be difficult to identify. LBP pain can be derived from nerve 




pain, nerve pathway abnormal activities can also contribute to neuropathic pain. 
Psychological influences can contribute to pain with factors such as stress, depression 
and anxiety. These factors can contribute either directly or due to the side effects of 
these conditions and result in lower levels of back care. Psychosocial factors that can 
influence likelihood or levels of pain can include work conditions, economic status 
and family support and lifestyle factors such as smoking, hours of sitting and obesity. 
These are potential factors influencing pain as described in the biopsychosocial 
model previously described (Hartvigsen et al., 2018; Hoy et al., 2010; Naraoka et al., 
2017).  
As previously described, pain is a result of nociceptor mediation. Nociceptors are the 
sensory peripheral neurons and when triggered by a chemical, mechanical or thermal 
harmful stimulation is then transduced into an electrical signal that is communicated 
to higher brain centres. This signal is projected to the somatosensory cortex that 
processes this sensory information, subsequently signalling descending pathways 
resulting in a painful sensation. If this harmful stimulation persists, then these 
processes of peripheral and central sensitisation can occur. This stimulation can be 
fired off without a trigger, and can cause the pain to change from acute to chronic 
(Allegri et al., 2016; Pincus et al., 2013). This can result in people with MS more readily 
because of axonal degeneration and potentially damaged signalling process that 
characterises their condition. This can also occur in people with LBP due to abnormal 
signalling, though not necessarily due to an inflammation reaction of the nervous 
system. In both conditions pain can be as a result of spasticity contribution which can 
also occur due to disrupted descending motor pathways (Feinstein et al., 2015).  
Many people who have their mobility restricted by LBP are most likely to have 
recurring forms of LBP, making it more debilitating in many aspects of life (Hoy et al., 
2010). The likely consequences of lower levels of mobility for LBP sufferers are 
reduced function of the lumbar spine, reduced spine mobility, altered spine 
kinematics and increased stiffness (Ferreira et al., 2009; Goertz et al., 2016; Powers 
et al., 2008). This can have an impact on body movement capability, limited flexibility 
and lead to the development of chronic problems with posture, coordination and 




Since a high number of people in the UK experience back pain at some point in their 
lives, it’s a common problem for workplaces and disability management (Hartvigsen 
et al., 2018; Maniadakis & Gray, 2000). Therefore, with such a high number of people 
experiencing back pain, and many people incorporating management of LBP into 
their lifestyles, the availability of people within this group should be high to recruit 
for a pilot study.  
3.0.3 Spinal Mobilisations Summary 
Since spinal mobilisation treatments in MS studies are lacking, most literature 
reviewed for this treatment is based on LBP. Immediate reductions in pain have been 
found regardless of the type of mobilisation (pressure, rate and location differences) 
(Chiradejnant et al., 2003; Willett et al., 2010). Improvements in pain and RoM were 
found specifically after grade 3, 2Hz mobilisations on the spine by Lopez-Lopez et al. 
(2015), and their results revealed an association with anxiety level outcomes. Studies 
by Piekarz and Perry (2016) after investigating different rates of mobilisations, found 
that faster rates elicited a greater response in SNS activation. A collection of results 
have indicated that baseline symptomatic level of stiffness and pain has an effect on 
the level of response (Childs et al., 2004; Fritz et al., 2011; Shum et al., 2013). Results 
have also indicated that mobilisation treatment cannot be differentiated from other 
manual therapeutics in terms of these benefits (Stamos-Papastamos et al., 2011; 
Thomson et al., 2009). The range of results on spinal mobilisations are due to the 
different methods in studies investigating rate of application, location, time of 
mobilisation set, number of sets, and combination of other therapy types involved 
throughout treatment. Therefore, although there is a clear collation of results that 
demonstrate improvements in pain, stiffness and RoM from mobilisations, there is 
still no definitive specifications for what dosage is most beneficial for different 
population groups, depending on the symptoms they experience. Since these results 
differ in the benefit of their outcomes, analysing mobilisations with an MS population 
will be necessary to draw accurate conclusions for that separate population.  
While other mobilisation interventions have been scientifically tested, they have 
been generally tested in 1 to 6 minute bouts (Goodsell et al., 2000; Jowsey & Perry, 
2010; Krouwel et al., 2010; Pecos-Martín et al., 2017; Pentelka et al., 2012; Shum et 




form of treatment such as manipulation thrusts, stretches or exercises (Maitland et 
al., 2013). Therefore, to the author’s knowledge, this is the first intervention of its 
kind to use consistent mobilisations for a full 30 minutes in scientific testing. 
Knowledge around dosage, rate and timings of mobilisations will help to carry 
research in this area forward, particularly for types of responders. Since testing on 
mobilisations for this length of time has not previously been reported in scientific 
literature, this information can help develop mobilisation therapeutic research.  
The differences in these results may stem from methodological differences and the 
heterogeneity of participants. However, they still imply that further research around 
the specific benefits of mobilisations is necessary. Specifically investigating the 
benefit of spinal mobilisations either together with or in place of other types of 
therapies, can help in the management of LBP, affecting a large percent of the 
population.   
3.1 Methods  
3.1.1 Participants   
40 LBP participants were recruited for this study (male: n = 18, female: n = 22) in a 
repeated-measures cross-over study design. Inclusion criteria was based on testing 
with LBP participants to test the feasibility of the intervention. Therefore, participants 
were recruited with any level of LBP for recruitment to comply within timings of the 
study period. Exclusion criteria was based on safety of the participant to receive 
spinal treatment and retaining scientific integrity of the study.    
Inclusion criteria included: 
• suffering from LBP which could be acute, chronic, diagnosed, undiagnosed as 
long as pain has been experienced in the region between 12th rib and gluteal 
folds reaching the buttock within the time of recruitment and testing.    
• within the age range of 18 to 80.  
Exclusion criteria included, must not respond to any spinal therapy absolute 
contraindications including:  
• bone tumour  




• dysplasia  
• healing fractures/dislocations  
• spinal cord damage  
• cauda equine syndrome  
• aortic dysfunction 
• severe haemophilia   
• must not have a connection with Point One Clinic (previous name of Pacla 
Medical and practicing physiotherapy clinic collaborating on the project)  
• must not be taking any pain medication other than paracetamol 
Must not respond to any relative contra-indications including: 
• spinal disc prolapse  
• spondylosis  
• spondylolisthesis  
• inflammatory arthritides  
• osteoporosis  
• hypermobile syndrome  
• pregnancy  
• cancer  
• cardiovascular disease  
• respiratory disease  
• healing injury  
• adverse reaction to previous spinal treatment  
Ethical approval was obtained from the University Research and Integrity Committee, 
following the ethical guidelines stated by the Declaration of Helsinki (Appendix 1).  
3.1.2 Procedure 
Recruitment for the study was carried out via poster advertisement, social media 
(Facebook and Twitter) and word of mouth. The poster and information sheet were 
used either in hard copy or electronically when a participant showed interest in 
response to advertisement, no coercion was added when speaking face to face. 




questions regarding the study. Participants were involved in both a control and spinal 
therapy intervention session. All participants were informed about details of the 
study and all provided written informed consent to take part. Participants were 
randomly allocated into one of two groups via a random group generator on 
Microsoft Excel. All data collection took place in the same treatment room on the 
same standard physiotherapy plinth, and as close to the same time of day as possible 
to avoid additional environmental influences. Ambient room temperature was 
controlled (between 20 and 25° Celsius) for all sessions. 
All participants completed the Oswestry Disability Index (ODI) questionnaire and an 
ODI scoring sheet prior to their first session. The ODI was used to categorise level of 
LBP (Chou & Huffman, 2007; Fairbank & Pynsent, 2000; Fritz et al., 2011; Kamali & 
Shokri, 2012, Appendix 6). Anthropometric measures for height, mass, waist 
circumference and gender were also recorded.    
The chartered physiotherapist performing the treatment worked under their own 
liability. They had a Master of Science qualification in Physiotherapy, registration with 
the Health and Care Professions Council and 7 years of experience working as a 
physiotherapist in practice at the time of the study. The physiotherapist performed a 
30-minute session for the spinal mobilisation intervention, working at a specific rate 
(0.37 Hz) maintained by a metronome set to the equivalent 22 beats per minute in 
their view. The physiotherapist worked at a grade lower than grade 1 and at a specific 
location (L1-L5), using PA mobilisations, oscillating the lumbar vertebra, with both 
hands working on the lumbar spine. Contact remained consistent over the 30-minute 
period. This was a pre-set setting of the intervention based on what had been used 
by the physiotherapist themselves for several years. Although in practice the 
physiotherapist worked on parts of the upper spine also, for the study the 
intervention was performed only on the lumbar spine to focus on this area in testing. 
Force analysis of the intervention had not been set up at this stage of the project and 
was one of the elements that was taken forward as a feasibility factor for following 
studies. During the intervention treatment the physiotherapist’s manual contact was 




Outcome measures for muscle stiffness, tone and elasticity were taken before and 
after both sessions. The pre intervention stiffness measure determined which side 
the therapy was applied to, based on the greatest mean value for stiffness following 
3 repeated measures. The control session involved no physical touch. The participant 
lay either prone or supine on the same plinth, with no manual touch, and encouraged 
to relax for 30 minutes. These measures were taken by the researcher for the project 
who had research experience based on a Bachelor of Science in Biomechanics 
involving a research project and worked as a research assistant on two separate 
projects. All projects had involved working with participants and biomechanics-based 
equipment usage.   
3.1.3 Outcome Measures  
Measurements for para-spinal muscle stiffness, tone and elasticity were taken using 
a myometer palpation device (MyotonPRO, Myoton Ltd., London UK, fig. 3.1). This 
previously validated handheld device has been documented to give reliable results 
for muscle stiffness, tone and elasticity (Bizzini & Mannion, 2003; Marusiak et al., 
2012; Pruyn et al., 2014; Schneider et al., 2014; Sohirad et al., 2017; Viir et al., 2006; 
Zinder & Padua, 2011). The myometer uses a series of low force mechanical impulses 
(0.4N) registered as an oscillation in the form of an acceleration signal. The stiffness, 
tone and elasticity parameters are reported as a mean of these impulses along with 
the coefficient of variation (CV) (Andonian et al., 2015; Little et al., 2014; Schneider 
et al., 2014; Viir et al., 2006). The manufacturer recommends acceptance of values 
that have a CV of <3%, complying with the findings of Schneider et al. (2014).  
Measures were repeated 3 times on each side of the spine, to determine which side 
had higher levels of stiffness. The location for measurements were identified on both 
sides of the spine on erector spinae (longissimus). The myometer is held 
perpendicular to the identified spot and oscillations are sent through to the 
corresponding muscle. The participant was asked to lift their head and feet at the 
same time to contract their lower back muscles so the researcher could define the 
central belly of this muscle on either side of the spine. This spot was then marked to 
ensure pre and post measures were taken at the same location. The distance and 






Figure 3. 1 MyotonPRO device with active probe and calculations automatically used to produce 
variables for stiffness, tone and elasticity (image from myoton.com, acceleration graph image). 
3.1.4 Analysis  
Data were collected for outcome measures from MyotonPro (Desktop Software 
v5.0.0.177) and exported into Microsoft Excel spreadsheets for stiffness, tone, and 
elasticity pre and post each session. The mean was calculated for each variable and 
used in statistical analysis with SPSS (version 23), alpha level set at 0.05. Results from 
the ODI questionnaire and anthropometric measures were imported into an excel 
spreadsheet for covariate analysis. Analysis was carried out on each dependent 
variable (muscle stiffness, tone, and elasticity) in separate 2-way repeated measure 
within participant ANOVAs. This was to determine any significant differences that 
occurred due to the independent variables (condition and time). Covariates were also 
assessed in separate ANCOVAs to determine any significant factors contributing to 
their changes. Due to differences previously displayed in muscle characteristics 




al., 2007), gender was investigated further with independent t-tests and Pearson 
correlations, as well as within the ANCOVA analysis as a covariate.  
3.2 Results  
Results in this chapter are based on 40 LBP participants. 
Table 3. 1 Anthropometric and pain participant data collected before study testing. 
 Male Data 
Mean ± SEM 
(n=18) 
Female Data 
Mean ± SEM 
(n=22) 
All Data 




Height (m) 1.79 ± 0 1.66 ± 0 1.72 ± 0 1.6 – 1.9 
Mass (kg) 81.2 ± 1.6 69.3 ± 2.9 74.7 ± 1.9 52.5 – 
95.7 
BMI 22.3 ± 0.6 25.2 ± 0.9 25.2 ± 0.6 18.3 – 
33.7 




88.6 ± 8.3 82.8 ± 12.7 84.8 ± 1.6 71 - 113 
ODI score (%) 
Minimal 0 – 20% 
Moderate 20 – 
40% 
14.8 ± 10.8 
Minimal = 15 
Moderate = 3 
13.5 ± 9.5 
Minimal = 18 
Moderate = 4 
14 ± 1.5 
Minimal = 34 
Moderate = 6  
1 - 38 
 
3.2.1 Muscle Stiffness   
A 2-way repeated measures ANOVA revealed a significant interaction between 
condition and time, F(1, 39) = 12.411, p = 0.001, η2partial = 0.241. Pairwise comparisons 
were then used to determine where specific differences lie, showing a significant 
increase within the control from pre to post (p = 0.004, η2partial = 0.19) and a significant 
decrease within the intervention condition (p = 0.012, η2partial = 0.15, fig. 3.2). There 
was no significant difference between pre control and pre intervention values. 
Significance differences (p ˂  0.05) in the figures are denoted (*). Data variation shown 


























Figure 3. 2 Muscle stiffness change for mobilisation intervention from pre (281.24Nm ± 11.68) to post 
(270.28Nm ± 10.4) and control condition from pre (273.07Nm ± 10.22) to post (285.26Nm ± 11.45). 2-
way repeated measures ANOVA data presented with SEM error bars.  
 



























Figure 3. 3 Muscle stiffness significant bivariate correlation between pre-intervention stiffness and 
stiffness change.   
ANCOVA was performed using all covariates to explore their interaction with the 
change in stiffness post intervention. Change in stiffness was used as the dependent 
variable. Pre intervention stiffness, BMI, ODI, waist circumference, height and gender 
were added as covariates. A backward elimination was conducted based on highest 
p-value. The only covariate remaining with significant influence was pre-intervention 
stiffness (p = 0.002) with resultant model R2 = 0.22 (adjusted = 0.2). There was a 




stiffness (p = 0.002, r = -0.47, fig. 3.4, table 3.2). This results in a negative correlation 
due to the reduction in stiffness seen in figure 3.2.  
Table 3. 2 Muscle stiffness bivariate correlations between pre-intervention stiffness and stiffness 
change values.  
 p value r value 
Male 0.137 -0.37 
Female 0.057  -0.41  
All Data 0.002 * -0.47 * 
 
A significant difference was found between male and female stiffness change (p = 
0.032), however gender was not a significant contributor to the ANCOVA model. 
Bivariate correlations for pre-intervention stiffness and stiffness change carried out 
separately with male and female data showed a similar pattern (table 3.2) suggesting 
that initial stiffness rather than gender alone was the contributing factor. 
3.2.2 Muscle Tone   
A 2-way repeated measures ANOVA revealed a significant main difference for 
condition, F(1, 39) = 4.942, p = 0.034, η2partial = 0.11, and the interaction between 
condition and time, F(1, 39) = 20.908, p ˂  0.001, η2partial = 0.349. Pairwise comparisons 
were then used to determine where specific differences lie, showing a significant 
increase in tone within the control condition from pre to post (p = 0.006, η2partial = 
0.18) and a significant decrease within the intervention (p = 0.001, η2partial = 0.25, fig. 
3.4). There was no significant difference between pre-control and pre-intervention 
values.  
ANCOVA was performed using muscle tone as the dependent variable and in the 
same way as above. BMI (p = 0.048), waist circumference (p = 0.01) and gender (p = 
0.005) were found as significant contributors to tone change with resultant model R2 
= 0.253 (adjusted = 0.19). There was a significant bivariate correlation between pre 
intervention tone and change of tone (p = 0.044, r = -0.32, fig. 3.5, table 3.3). This 






















Figure 3. 4 Muscle tone change for mobilisation intervention from pre (15.06Hz ± 0.29) to post (14.74Hz 
± 0.28) and control condition from pre (15.1Hz ± 0.26) to post (15.39Hz ± 0.28). 2-way repeated ANOVA 
data presented with SEM error bars.  
 
























Figure 3. 5 Muscle tone significant bivariate correlation between pre-intervention tone and tone 
change.  
Table 3. 3 Muscle tone bivariate correlations between pre-intervention tone and tone change values. 
 p value r value 
Male 0.756 0.079 
Female 0.012 *  -0.528 *  





There was no significant difference between male and female tone change (p =0.052), 
however gender was a significant contributor to the ANCOVA model as a contributor 
to muscle tone change. Bivariate correlations for pre intervention tone and tone 
change conducted separately with male and female data show different patterns, 
accounting for the differences in male and females (fig. 3.5, table 3.3).  
3.2.3 Muscle Elasticity   
A 2-way repeated measures ANOVA revealed a significant main difference for time, 
F(1, 39) = 30.913, p = 0.000, η2partial = 0.442. Pairwise comparisons were then used to 
determine where specific differences lie, showing a significant increase in the post 
muscle decrement values within the control condition from pre to post (p = 0.000, 
η2partial = 0.3) and a significant increase in post muscle decrement values within the 
intervention (p = 0.001, η2partial = 0.24, fig. 3.6). There were no significant differences 






















Figure 3. 6 Muscle elasticity change for mobilisation intervention from pre (1.09 ± 0.04) to post (1.15 
± 0.04) and control condition from pre (1.05 ± 0.04) to post (1.1 ± 0.04). 2-way repeated measures 
ANOVA data presented with SEM error bars.  
ANCOVA was performed using changes in decrement as the dependent variable as 
above. There were no covariates with a significant influence on decrement change. 
Determination of change in decrement in elasticity is therefore likely linked to other 
variables not measured. A bivariate correlation between pre-intervention decrement 

































Figure 3. 7 Muscle elasticity non-significant bivariate correlation between pre-intervention elasticity 
and elasticity change. 
There was no significant difference between male and female elasticity change (p = 
0.162) and bivariate correlations for pre intervention decrement and decrement 
change conducted for male and female data showed no pattern (table 3.4).  
Table 3. 4 Muscle elasticity bivariate correlations between pre-intervention elasticity and elasticity 
change values. 
 p value r value 
Male 0.992 0.002 
Female 0.228 -0.268 
All Data 0.508 -0.108 
 
3.3 Discussion  
Though the premise of the study was a pilot investigation, the implications for 
objective results are relevant to the LBP population as well as other chronic 
conditions affecting mobility. Since reports of LBP as a common symptom have been 
increasing, addressing this in public health has potential for high impact in society 
including one the main reasons for work absence (Clark & Horton, 2018; Hartvigsen 
et al., 2018). Results for an intervention to improve aspects associated with LBP such 
as spinal stiffness, work towards not only benefiting this area of research but also 




3.3.1 Muscle Stiffness 
A significant reduction in para-spinal stiffness due to the intervention (fig. 3.2), signify 
that these results support the study hypothesis alongside other literature (Ferreira et 
al., 2009; Fritz et al., 2011; Shum et al., 2013; Wong et al., 2015). The results from this 
pilot study therefore imply that the spinal mobilisation intervention can have a 
significant effect on reduction of para-spinal stiffness. This provides an objective 
finding on reduction of muscular stiffness surrounding the spine after a 30-minute 
specific manual therapy treatment. Since stiffness characterises the muscle’s ability 
to resist change in shape, and is known to be associated with pain and reduced 
mobility (Fritz et al., 2011; Haas et al., 2014; Lopez-Lopez et al., 2015; Vicenzino et 
al., 2001), a reduction in stiffness of these muscles may allow greater compliance and 
agility, potentially allowing better fluidity of movement (Ferreira et al., 2009; Shum 
et al., 2013). The theory discussed in the previous chapter referred to mechanical 
stretching of the muscle, affecting the signalling for muscle spindles (the muscle 
stretch receptors) and adapting this signalling, in turn affecting the muscle fibre’s 
ability to respond to change in shape (Pickar & Bolton, 2012; Reed et al., 2014). This 
provides potential for further adaptations to take place with more sessions, which 
may lead to longer-term adaptations, and not just the immediate ones seen in this 
study.   
Where previous results have reported 12 as the optimum number of treatment 
sessions (Haas et al., 2014), this study demonstrates an immediate stiffness reduction 
similar to Fritz et al. (2011), Childs et al. (2004) and Flynn et al. (2004). These studies 
also demonstrated immediate stiffness reductions in their studies but did not state 
the force and time of the oscillations used, an important variable for deciphering 
optimum dosage and strength of the treatment. Therefore, this is an important 
element to analyse in current and future studies.  
The control condition resulted in a significant increase in stiffness after 30 minutes of 
lying still, showing stiffness levels can accumulate within a small period. Sedentary 
behaviour has been identified as one of the risk factors for developing LBP and 
stiffness (Hartvigsen et al., 2018; Naraoka et al., 2017) and this study shows the 




that movement, or avoidance of stationary positions, is beneficial for decreasing 
stiffness (Shum et al., 2013).  
The involvement of other factors influencing these levels of stiffness is partly 
explained in this study with significant correlations revealing baseline stiffness as a 
significant contributor (p = 0.002, r = -0.47, fig. 3.3, table 3.2). While this study 
demonstrates the benefit of a single mobilisation session in terms of stiffness 
reduction, it does not fully describe the influencing factors. More information on 
level, type, cause, and potential lifestyle contributors to pain could give more 
indication on potential contributors to stiffness also. While previous studies have 
found significant correlations with pain and stiffness (Ferreira et al., 2009; Fritz et al., 
2011; Shum et al., 2013), no significant connection was found in this study between 
pain and stiffness. This could indicate that either pain was not a factor involved in 
baseline stiffness or level of stiffness change. However, previous studies show a 
strong correlation for this (Shum et al., 2013, pre intervention correlation r = 0.89, 
post intervention stiffness r = 0.98), with similar significantly correlated findings from 
Fritz et al. (2011), suggesting an association. This supports the notion that back pain 
can contribute to muscular stiffness and is related to reduced mobility. Due to the 
lack of correlation found in our study between ODI pain score and baseline stiffness 
levels, it is likely that there was not enough variation in pain severity to show this. 
Most participants reported mild levels of LBP (no participants scored over 40%; 
minimally disabled: n = 34, moderately disabled: n = 6, table 3.1). This was expected 
due to the exclusion criteria for pain medication no other than paracetamol, included 
in the criteria as a safety measure. However, a recruitment strategy that allowed a 
larger variation of back pain sufferers to participate, may have revealed more 
informative results for the association between baseline stiffness and level of pain.  
This study did not collect pain data post intervention, which could have provided 
more data to investigate this association. The study aim was focussed on the muscle 
response aspect and therefore not the changes in levels of pain. The ODI was used as 
a measure of baseline levels of pain to investigate this as a potential influencing 
factor. The ODI categorises level of pain based on several lifestyle factors and to what 




questionnaire, would not have been suitable. However, the researcher acknowledges 
this information could have added benefit to the study given the previous reports on 
the relationship between pain and stiffness. This information could add a level of 
understanding on how stiffness is reduced and if pain is reduced in a related capacity. 
This was an aspect of the study design that was revised in the next study.   
Other literature suggests that the influence of pain is a significant factor on stiffness 
and on subsequent mobility factors involving many aspects of daily life and heavily 
involved in functional independence affecting QoL. Pain, BMI, waist circumference, 
height or gender were not found to be influencing factors in this study. These could 
therefore be investigated more with higher numbers of participants, or more 
effective ways of measuring these to get a better picture as to the influencing factors 
both of stiffness development and reduction.   
Given the subjective nature of pain, posture differences and daily environments, 
future research could consider additional measures that would affect initial levels of 
pain and stiffness. Aspects such as activity levels and sleep quality can affect either 
of these. Although the ODI questionnaire deals with these aspects in relation to pain, 
further information on these could reveal trends for baseline stiffness. Further insight 
into other influencing factors caused by daily activities that play a role in muscle 
stiffness could help to gain a more complete picture of the role stiffness plays in daily 
life. These could all be counted as prior environmental influences. As no significant 
differences were found between the control and intervention pre-stiffness levels, it 
was concluded that the protocol design had been successful in controlling for prior 
environmental influences. The study found that baseline stiffness is related to level 
of stiffness change, which corresponds with previous study findings also. This not only 
determines that higher levels of stiffness are more likely to show a change with 
regards to mobilisation therapy, but is also indicative of a relationship, changing one 
can alter the other. This correlation would indicate that an increase in sedentary time, 
could also increase muscle stiffness and increase the level of stiffness reduction in 
response to manual therapy, and vice versa.  
With the comparison to a control condition, the results indicate that the intervention 




specifically the benefits of the intervention, the intervention should be tested against 
a placebo therapy, investigating the effects of the consistency of the pressure, 
location, and rate of the mobilisations, compared to a placebo treatment. This will 
help to determine if any type of manual therapy is best or if these mobilisations 
specifically are most efficient. Differences in pain, stiffness and RoM can often be 
attributed to placebo effects regularly referred to in manual therapeutics. The 
concept of receiving a therapeutic, and a therapist manually treating an area of pain 
or stiffness, being encouraged to relax, can all influence psychological well-being. The 
benefit of therapy sessions often encourage recipients to feel and move better 
regardless of the mechanisms behind manual therapy (Goodsell et al., 2000; Shum et 
al., 2013). However, since this study was investigating objective muscle response 
values, this effect should have been reduced, though would be more robust with a 
placebo trial comparator.  
Although the ANCOVA results showed that initial stiffness was a significant 
contributor to stiffness response (also supported by a significant correlation, fig. 3.3), 
results for gender as a covariate were more complex. Gender did not account for the 
variance in stiffness within the ANCOVA model, however a significant difference in 
the ANOVA suggests that stiffness response have pooled results that can be 
attributed to their levels of pre intervention stiffness. This result would mean that 
male and female correlations separately were expected to show a similar pattern, 
which was the case (fig. 3.3). Therefore, the difference in baseline levels of stiffness 
accounted for differences in their level of response, however the relationship 
between baseline and reduction, appears to be the same. Specifically, males 
displayed greater levels of baseline stiffness compared to females, and significantly 
greater stiffness reduction (p = 0.032). This indicates males are more likely to show a 
stiffness reduction after treatment due to a higher likelihood of greater baseline 
levels. The lack of significant contribution from ODI, BMI, waist or height 
measurements suggest that if these factors were to contribute to stiffness response, 





Previous studies also describe baseline stiffness correlation with response levels but 
did not find a connection with clinically important outcomes. Therefore, relating 
these results to functional daily activities and QoL is still important to investigate 
(Ferreira et al., 2009; Shum et al., 2013). The development of a CPR by Childs et al. 
(2004) indicated that symptom severity was an important predictor for therapy 
response, however, this is in relation to pain rather than stiffness. Combining these 
findings with baseline stiffness measurements in further investigation, and the use of 
further biomechanical factors as diagnostic tools can help to determine the likelihood 
of responders to this type of therapy.  
Knowledge around muscle health and how to measure this can help to monitor 
changes within neurophysiological conditions and prevention of further injury for risk 
populations. Stiffness specifically is referred to in literature as one of these important 
factors to learn about (Bailey et al., 2013; Kelly et al., 2018). From first thing in the 
morning to last thing before sleeping, efficient use of muscles, whole body 
movements, and refined movements are crucial for daily activities. This helps to 
retain not only good QoL, but also aspects of good mental health due to the 
association of mobility with functional independence. Better knowledge on these 
specific factors such as muscle stiffness and how they affect whole body mobility, as 
well as psychosocial factors on QoL will work towards better care to people most in 
need.  
3.3.2 Muscle Tone  
Results for muscle tone (fig. 3.4) were similar to results for muscle stiffness (fig. 3.2) 
which has also been seen in previous studies (Fröhlich-Zwahlen et al., 2014; 
Schneider et al., 2014; Wang et al., 2016). This indicates a potential similarity 
between stiffness and tone response to manual therapeutics. Although stiffness and 
tone are muscle characteristics used within a similar context, they describe different 
aspects of muscle quality. The myometry form of muscle tone is describing resting 
muscle tension and is described mechanically by the acceleration frequency of the 
oscillations induced and recorded. This is based on intrinsic skeletal electrical activity 
of the muscle cells (Bizzini & Mannion, 2003; Viir et al., 2006). Whereas stiffness is 
based on the resistance to the change of shape induced, it is a responding value 




value and tone is describing a resting value, knowledge on both these characteristics 
is useful.  
Similar results for muscle tone and stiffness indicate that both variables respond to 
the intervention in a similar way. Pre-intervention tone values for the control and 
intervention groups were very similar, and although pre intervention stiffness 
(between control and intervention) was not significantly different, they showed more 
variation than baseline tone. Since tone is an intrinsic muscle cell characteristic 
required for resting muscle tension, this may be a reason as to why there is less 
variation in baseline values. Tone revealed a similar response to stiffness 
measurements, only with less variation (smaller SEM values) and less difference 
between baseline values for the 2 different groups. Therefore, the difference in their 
intrinsic and responding nature, may be a factor in terms of their level of variation.  
Factors contributing to the response were different in the ANCOVA results. This 
showed BMI, waist circumference and gender to have a significant influence, with no 
contribution from baseline tone. Though similarity in stiffness and tone results are 
shown in previous studies (Gervasi et al., 2017; Kelly et al., 2018; Schneider et al., 
2014; Wang et al., 2016), the difference in contributing factors may indicate some 
potentially key underlying differences in the mechanism of response. Since tone 
relates to the underlying electrical activity, these electrical signals may be 
mechanically altered, in a similar manner described in analgesia effects and stiffness 
reduction produced in previous studies. These outcomes seem to be connected, 
however underlying differences in electrical signalling may be responsible for the 
slight differences in pain, stiffness, and tone results.   
The contributors influencing results for change in tone showed different results 
compared to those seen with stiffness. Where baseline stiffness was the only 
contributor to change in stiffness, tone showed to have differences, gender being a 
significant factor for this. Again, possibly the difference between these is the ways in 
which the concepts are described. Since tone is based on an intrinsic value, male and 
female differences could be more prominent and therefore show more of a 
significant difference between them. Males and females showed different trend lines 




factor for tone also shown by the ANCOVA model. Fröhlich-Zwahlen et al. (2014) 
showed gender to be a significant contributor to tone values in their study, but also 
for stiffness which was not the case in this study (Fröhlich-Zwahlen et al., 2014).   
The ANCOVA model also described other contributors including BMI and waist 
circumference. Both these measures are associated with body weight and health 
measures. Both BMI and waist circumference give indication of body weight and fat 
distribution, however adipose tissue was not directly measured in this study, which 
is a known limiting factor for the MyotonPRO, despite having excellent reliability 
(Fröhlich-Zwahlen et al., 2014). There could therefore be a connection between the 
intrinsic tone value and health measures such as BMI and waist circumference, and 
how they may affect changes in tone.  
Though differences are seen between the changes in tone and stiffness, they seem 
to be affected by different factors, and dependent on different aspects within the 
body. Baseline level of stiffness is the main important factor to show that level of 
change of stiffness is affected by. However, baseline stiffness tends to differentiate 
between males and females, with males showing higher levels than females and 
therefore showing more likelihood of response. Tone however, showed to be 
influenced by both gender, and health measures such as BMI and waist 
circumference from the ANCOVA results (fig. 3.4), which may represent a greater 
dependence on intrinsic health factors.  
Although an aspect of background resting muscle tension is necessary (Rätsep & 
Asser, 2011), high muscle tone has been associated with pain and discomfort during 
injury rehabilitation studies (Ortega-Cebrian et al., 2016). Hypertonia is also 
associated with conditions known to have symptoms in rigidity and muscle spasms, 
restricting movement such as stroke and Parkinson’s disease (Fröhlich-Zwahlen et al., 
2014; Schneider et al., 2014). Monitoring levels of hypertonia and when they are 
related to pain and discomfort of these conditions, will be useful knowledge for 





3.3.3 Muscle Elasticity   
Elasticity results show a higher degree of variance compared to stiffness and tone 
(fig. 3.6) also shown previously (Gervasi et al., 2017). An increase in decrement 
relates to a higher dissipation of mechanical energy, and a lower level of elasticity 
(Schneider et al., 2014), therefore the results show that both control and intervention 
conditions resulted in decreased elasticity due to an increase in dissipated energy. 
This suggests that both relaxing in the same position and manual therapy affected 
the elasticity of para-spinal muscles in a similar way. Schneider et al. (2014) and 
Rätsep and Asser (2011) reported a decrease in stiffness and tone and an increase in 
decrement and Viir et al. (2006) showed elasticity to have wide variation in their 
results (Rätsep & Asser, 2011; Viir et al., 2006). Whereas the study by Gordon et al. 
(2015) saw a decrease in stiffness and increase in elasticity due to a manual therapy 
intervention (Gordon et al., 2015). The reason for this is unclear and was suggested 
by Schneider et al. (2014) to be the result of the muscle relaxed state. The passive 
nature of the therapy may have resulted in an elasticity decrease because of the 
participant lying still with no active movements. Consequently, muscles may require 
active movements to have any effect on elasticity. With no covariates showing to be 
significant contributor to the level of change this supports that a higher level of 
variation seen in these results.  
Muscle elasticity seems to clearly be an area worth investigating more as results from 
studies so far show a varied response, but the implications of what the benefits to 
increased elasticity are include many areas within muscle health that will 
undoubtedly include muscle recovery (Gordon et al., 2015; Schneider et al., 2014). 
Since elasticity describes a muscle’s ability to return to original shape after 
deformation, a high value of elasticity therefore indicates a lower level of dampening 
and release of mechanical energy, this could also be a crucial element to muscle fibres 
recovering from injury.   
3.3.4 Gender Differences and Potential Explanations  
Gender differences described in this study have arisen in both stiffness and tone but 
not with elasticity. Though differences in stiffness results were due to initial levels, 
gender was found to be a significant contributor to differences in tone. These gender 




and females are likely to have in terms of muscles. This then affects how they respond 
to treatments, both to isolated muscles and the whole body, and can influence 
chosen treatments. Similar results were found by Zinder and Pauda (2011) and Nair 
et al. (2016) with significant differences found between gender and stiffness. 
Therefore, further confirmation of gender differences in muscle response 
characteristics could add knowledge to differences in treatment responses (Nair et 
al., 2016; Zinder & Padua, 2011). 
Knowledge of gender differences is important because of the difference in response 
to treatment, different dosages, timings or pressure may be necessary and also shows 
a difference in their risk of injury (Granata et al., 2002a; Granata et al., 2002b). With 
gender differences in neuromuscular affected conditions such as MS, the suggestion 
for gender-specific physiotherapy has been made due to its influence as a significant 
contributor (Kehoe et al., 2015). Gender assumptions should however be avoided, as 
it is one of the factors involved in muscle response, there may still be other 
influencing factors other than the ones this study has identified. Therefore, despite 
results in gender differences, treatment should have an individual assessment 
regardless of gender, and use these findings to enhance treatment plans.  
3.3.5 Study Limitations   
MyotonPRO manufacturers state that measurements beyond 20mm of subcutaneous 
fat limit results; a variable not measured in this study. BMI and subcutaneous fat layer 
have also been factors in previous studies. Owens et al. (2007) showed that subjects 
with a higher BMI tended to have lower stiffness, attributing this to a thicker layer of 
adipose tissue at the point of stiffness measurement. BMI itself as a measurement of 
a person’s physical condition does not consider muscle to fat ratio and may therefore 
not be an accurate description. This could mean that high levels of adipose tissue can 
affect measurements, and this is difficult to determine with BMI. The cross-over 
design and within participant analysis will to some degree reduce this effect. 
The lack of myometer data in MS investigations means that these results cannot be 
compared to data with MS participants, and therefore only act as data for 
intervention feasibility and efficacy. The intervention was also tested against a 




signifies that any benefits seen from the intervention could be due to any form of 
passive treatment or any form of activity since the comparison level was sedentary 
stillness. More meaningful comparisons would allow for specific information about 
treatment to be analysed. As LBP data analysis was not the main focus of this project 
and due to time constraints on the project, further analysis on these comparisons 
were not completed.     
The inclusion criteria for LBP participants indicated any level of LBP as well as only 
taking paracetamol as a form of medication. This resulted in many participants with 
mild levels of LBP and a large degree of heterogeneity between participants and 
lifestyle factors. A specification of chronic diagnosed LBP and even restricting to 
specific type of LBP or related side effect symptoms would potentially allow for 
further analysis contributing factors. Post-intervention measurement for pain would 
have allowed for stiffness and pain change comparisons, and analysis into their 
interaction with each other and how they can potentially influence each other.  
However, as described above, this was not the main aim of this study. 
Participants were all recruited from a University working environment and time of 
day for each condition were consistent to reduce the chances of variance in pre-
assessment activity levels. Physical activity levels were not controlled and could be a 
factor in baseline levels of stiffness, tone and elasticity.  
3.4 Study Conclusions  
The 30-minute spinal mobilisation intervention had a significant immediate effect on 
muscle quality showing a stiffness and tone reduction in sufferers of LBP when 
compared to a control. Initial levels of stiffness contributed to reduction levels post 
intervention and there was more variance in contributing factors for tone. Although 
significant differences exist between male and female stiffness results, gender was 
not a significant contributor and was likely due to initial baseline levels. Gender was 
however a significant contributor to reduction levels of tone.  
Results show the intervention had an immediate effect and improved stiffness and 
tone outcomes. Further study will need to investigate the use of the intervention 
against a placebo therapy rather than a control to find if there are specific benefits 




feasibility and efficacy of the intervention and may need more investigation time to 





Study Two: Multiple sclerosis immediate effect 
study. 
Analysis of a spinal mobilisation intervention in 
people with multiple sclerosis.  
 
4.0 Introduction  
The aim of the PhD project is to contribute to physiotherapy research for MS patients. 
Therefore, the results from study one with LBP participants demonstrate that it is 
feasible and safe and testing can continue to ethically test with an MS population. 
The shared symptoms between the LBP and MS population means that the level of 
response may show similarities. The implication of para-spinal stiffness reduction 
could be connected to reduced spinal pain and improve whole-body mobility (Barnes 
et al., 2010; Donzé, 2015; Stevens et al., 2013). However, the complications of the 
MS condition and how it is manifested in individuals may introduce differences in 
their response. 
4.0.1 Introducing Multiple Sclerosis as a Population Group 
As previously discussed, MS is the most common non-traumatic neurological disease 
in young adults affecting millions of people around the globe (Giovannoni et al., 
2016). There is a high social cost for the individual because of the duration of the 
disease and also a high cost of health care necessities, correlating with the disease 
severity (Mackenzie et al., 2014; Pugliatti et al., 2006). There is great humanistic 
benefit to investigating MS with results that are relevant for the MS individual, family 
members and carers making decisions for this people group.  
Though substantial progress has been made in MS research including diagnosis, 
treatment and symptom management, there are still many unknown elements of the 
condition. There is difficulty in diagnosis of MS phenotype and monitoring symptoms 
due to the large array in clinical presentation of the disease. The development of the 




with MRI development can provide an improved representation of the condition. This 
helped to categorise patients into MS phenotypes as well as distinguishing it from 
other neurological conditions (Dimitrov & Turner, 2014; Gafson et al., 2012; 
Giovannoni et al., 2016). A patient centred approach is an important element to 
retain while developing study design and managing feasibility, particularly with the 
complex nature of this condition. Re-evaluation of interventions and rehabilitation 
programmes are also said to be crucial for both the recipient patient, and the efficacy 
of the intervention (Khan et al., 2007).  
This systematic categorisation of patients with the EDSS has highlighted areas of 
research to enable analysis that can put MS patients on a rating system, helping with 
grading level of disability in interventional studies. As well as categorising overall 
degree of disability, it also categorises symptoms into functional system groups, in 
order to distinguish between the different types of symptoms experienced. The scale 
has helped to progress MS research and has since been used in countless research 
studies with MS patients (Barnes et al., 2010; Benedetti et al., 1999; Bernitsas et al., 
2015; Crenshaw et al., 2006; Freeman et al., 1997; Khan et al., 2007; Kobelt et al., 
2017; Patti et al., 2002). It is used widely in MS physiotherapy studies as a categorical 
tool, but not an outcome that is likely to change as an outcome measure (Freeman 
et al., 1997; Khan et al., 2007; Patti et al., 2002).  
Symptom management can involve both pharmacological and non-invasive 
treatments. Although steroids can provide relief in some symptom areas and help to 
improve QoL, they can also be the source of negative side effects (Dimitrov & Turner, 
2014; Jagannath et al., 2010). The benefit of investigating non-invasive 
physiotherapy-based interventions is the lack of potential side effects compared to 
drug treatments. However, there is a lack of evidence and understanding of their 
efficacy and scientific basis for their effectiveness. Further investigation into the 
objective analysis of their effects on the musculoskeletal system may help to bridge 
this gap (Campbell et al., 2016; Etoom et al., 2018a; Garrett et al., 2013). 
4.0.2 Multiple Sclerosis and Physiotherapy  
Physiotherapy interventions have been previously reported as having beneficial 




with MS (Bellanti et al., 2018; Donzé, 2015; Patti et al., 2002). The progressive and 
debilitating nature of MS means emphasis on retaining functional movement is 
important. Physiotherapy can be adaptable to individual needs of the patient 
depending on their specific symptomatic areas, while maintaining whole body 
movement as an overall focus. They can also involve treatments including manual 
therapies, exercise treatments and stretches, which all aim to improve efficiency of 
musculoskeletal movements (Campbell et al., 2016).   
The pilot study in the previous chapter reported that a single session of spinal 
treatment had a significant effect on an LBP population in terms of muscle response. 
Better efficiency of muscle tissue function is also likely to improve movement 
patterns and whole-body mobility (Pickar & Bolton, 2012). Stevens et al. (2013) 
reported that nerve dysfunction in MS patients is greatest over the longest pathways 
due to the accumulation of lesion impact on the CNS. This results in nerve dysfunction 
between the cortex and lumbo-sacral roots, leading to dysfunction in nerve pathways 
that affect muscle recruitment in the lower extremities. Gait impairments often 
experienced by MS patients could be due to lesions in these long nerve pathways, 
leading to weakened muscle recruitment and coordination, numbness, muscle 
spasticity and fatigue, all contributing to gait abnormalities. As well as gait 
disturbance, other symptoms commonly reported that can affect mobility and 
functional independence are depression, osteoporosis, falls, spasticity, pain and 
sleep disorders, all highly associated with QoL and have been influenced by 
physiotherapy interventions previously (Dimitrov & Turner, 2014; Kehoe et al., 2015; 
Stevens et al., 2013; Yamout et al., 2013).  
It has been reported that around 33% of surveyed MS patients use massage therapy 
as a form of treatment for their MS symptoms with significant improvements in 
fatigue, pain and health perception (Backus et al., 2016). Their results revealed a 
significant correlation between fatigue and pain, and between perception of health 
and QoL, showing how these outcomes can influence each other. The significant 
correlation between spinal atrophy and clinical disability also signifies the importance 
of spinal health for both RRMS and progressive MS (Bernitsas et al., 2015). The 




clinical disability. This can significantly impact the disability outcome of patients 
(Losseff et al., 1996; Shum et al., 2013). Therefore, physiotherapy interventions 
facilitating spinal mobility and function, can play a positive influential role in 
maintaining whole body mobility and clinical disability status in the long term for MS 
patients.    
The lack of consistency in testing manual therapeutics has led to conflicting results in 
objective measures. However, similarities exist in outcomes directly related to more 
subjective measures of QoL with improvements in self-esteem, self-perception, 
fatigue, anxiety, depressed mood, body image and social participation (Finch & 
Bessonnette, 2014; Hernandez-Reif et al., 1998; Porcari et al., 2019). Therefore, these 
appear to be common outcomes for manual therapy interventions and important to 
recognise as elements of the treatment. A review by Namjooyen et al. (2014) around 
complementary and alternative medicine in MS found the management of functional 
independence and fatigue to be a key factor in symptom management-based 
therapeutics (Namjooyan et al., 2014). Several studies have reported improvements 
in pain reduction. Though difficulties around the measurement of pain has meant 
that the clinical significance of some study results is low (Backus et al., 2016; Bronfort 
et al., 2004; Reid et al., 2014; Shum et al., 2013; Thomson et al., 2009; Voogt et al., 
2015).  
Better understanding of biomechanical and biochemical changes induced by spinal 
therapeutics would add to the knowledge around pain and stiffness reductions found 
in investigations. Theories around pain mediation stem in altering primary afferent 
neurons through chemicals triggered by the mechanical manipulation as described in 
the literature review (Pickar & Bolton, 2012; Voogt et al., 2015). Manipulating the 
para-spinal tissues by mechanical stretching, would then lead to a response from 
muscle spindles as the stretch receptors for the muscle fibres. By detecting the 
change in length of the muscle and conveying this information to the CNS by afferent 
nerve fibres allows adaptive signalling in descending pathways contributing to 
chemical signals involved in the experience of pain and stiffness in muscle tissue 
(Pickar & Bolton, 2012; Reed et al., 2014). The adaptable nature of the protein titin 




to the original muscle shape, and could be a key element in this signal adaptation 
during mechanical stretching of muscles (Janecki et al., 2011; Lindstedt, 2016). 
Spinal mobilisations have been reported to be helpful for other chronically ill 
populations suffering from back pain, dizziness and stroke recovery, with immediate 
effects seen in short-term intervention (Bronfort et al., 2004). The common theme 
around these interventional studies is the improvement of symptoms such as pain, 
stiffness, and RoM, which are often shared symptoms for people with MS. This bears 
impact on the quality of movement on not only daily tasks, but participation in other 
forms of physical activity that are potentially beneficial for the individual also.   
In addition to pain symptoms, spasticity is commonly seen in MS patients, and is a 
disorder as well as a symptom for many other conditions. This motor disorder is 
caused by an imbalance of signals in the CNS and characterised by sporadic increased 
levels of tone and stiffness. This leads to exaggerated tendon jerks due to 
hyperexcitability from the stretch reflex. It is associated with higher levels of 
disability, causing issues in whole-body mobility, and contributes to muscle spasms 
and weakness. It is experienced by approximately 60% of people with MS (Barnes et 
al., 2010; Etoom et al., 2018a; Shakespeare et al., 2010). A study by Barnes et al. 
(2010) found that 97% of their MS study participants showed spasticity and out of 
those, 47% had spasticity at a clinically significant level. The individuals with spasticity 
had significantly higher levels of disability than those without spasticity in this study. 
With its high prevalence, the authors of this study recommended treatment of 
spasticity as a priority for a large proportion of the MS population. 
The spinal mobilisation intervention introduced in the last chapter uses an oscillatory 
force, at a low force and velocity. Spinal mobilisations have been used within 
physiotherapy for a number of years often as a treatment for back pain (Maitland et 
al., 2013; Perry & Green, 2008; Piekarz & Perry, 2016; Shum et al., 2013). Immediate 
benefits have been demonstrated in reduced levels of pain, stiffness and RoM 
(Chiradejnant et al., 2003; Pecos-Martín et al., 2017; Willett et al., 2010) similar to 
the results reported in study one of this thesis. Researchers have previously 
investigated the effect of different forces and rates of mobilisation with equivocal 




specific differences seen between these study results lie in whether location, force, 
oscillation rate or number of sets make a difference as to the magnitude of pain relief, 
with no clear answers for any of these factors (Chiradejnant et al., 2003; Pecos-Martín 
et al., 2017; Shum et al., 2013; Willett et al., 2010).  
4.0.3 Multiple Sclerosis and Myometry  
The development of myometry now allows objective analysis of interventions and 
their effect on superficial muscles. As mentioned in chapter two (section 2.7.1), 
myometry has been used to analyse muscle quality in conditions that have similar 
neuromuscular issues as MS. Marusiak et al. (2012) revealed a significant reduction 
in resting muscle stiffness when on medication compared to the medication off-
phase for Parkinson’s patients. This information has then helped to inform 
medication prescription for Parkinson’s patients with rigidity through an objective 
and reliable assessment. Frölich-Zwahlen et al. (2014) investigated bilateral 
differences in muscle characteristics for stroke patients. Using objective analysis, 
these muscle response results gave good test-retest reliability. Since myometry is a 
relatively new way of measuring muscle quality, studies in this area with MS patients 
are limited, but those involving other neurological conditions such as Parkinson’s and 
Stroke indicate reliable results that have informed treatment of the condition.  
MyotonPro has some limitations including detecting deep layer muscles under other 
tissue structures, analysis of muscle groups rather than a single muscle and detecting 
muscles that aren’t palpable. However, the feasibility and reliability has been tested 
and approved in previous literature and study one of this project. Schneider et al. 
(2014) reported positive results for feasibility, ease of use, non-invasive assessment 
and for real-time assessment. The MyotonPRO reliability has been shown in several 
studies, with moderate to high test-retest reliability and good validity (Bailey et al., 
2013; Fröhlich-Zwahlen et al., 2014; Kelly et al., 2018; Pruyn et al., 2014; Viir et al., 
2006). The method for establishing the side of the lumbar back with a higher 
magnitude of stiffness and use of palpation to determine measurement location had 
good feasibility in the pilot study with LBP participants and was not anticipated to 




4.0.4 Multiple Sclerosis and Balance Measures 
The use of balance measures with MS patients can be particularly useful to identify 
differences in balance and gait, which are seen in a large percentage of patients. 
Information gathered can help monitor movement patterns and establish how they 
may or be not be improving, particularly with balance and stability as main outcomes, 
and how they relate to QoL (Mancini & Horak, 2010; Panuccio et al., 2015; Stevens et 
al., 2013). 
Mobility issues related to balance and stability can affect many aspects of gait with 
patients experiencing balance problems, a higher number of falls and altered step 
cadence. These can lead to reduced endurance and increased metabolic cost, 
affecting many areas of mobility and functional independence. Even in people with 
minimal disability, analysis has shown them to still walk slower, with fewer, shorter, 
wider and increased variability between steps when compared to healthy controls 
(Sosnoff et al., 2012; Stevens et al., 2013). If muscles pertaining to gait are not 
functioning to full potential, they can impact limb movements, impairments such as 
foot drop, hyperextension, hyperflexion around the knees, leaning towards anterior, 
posterior, or either lateral side, and hip drop (Crenshaw et al., 2006; Sosnoff et al., 
2012; Stevens et al., 2013). Balance requires integration from all sensory systems; 
visual, somatosensory and vestibular to inform the brain and the body of its position 
in the environment, and elements of this can be measured by the force and pressure 
exerted by the body in some of these movements (Cameron & Wagner, 2011; Stevens 
et al., 2013). Analysis of these balance and stability issues can help determine some 
of the underlying causes of why falls occur, how to help develop exercises to prevent 
them, and improve the endurance and metabolic cost of walking and daily activities 
(Mancini & Horak, 2010; Panuccio et al., 2015). 
Analysis of some of these movement patterns may help to stabilise some basic 
everyday movements, in particular walking gait (Cameron & Wagner, 2011; Sosnoff 
et al., 2012; Stevens et al., 2013). The overall muscle activity generated by MS 
patients is a lower level of contraction compared to healthy controls due to a reduced 
central motor drive and reduced muscle recruitment. Muscle atrophy can then result 




Static balance is an aspect of human balance characterising the ability to maintain 
certain postures requiring neuromuscular control and refined movement to stay in a 
stable position. Lack of refined movements can often lead to increased levels of body 
sway which can be magnified in neuromuscular disorders, including MS. 
Measurements of body sway characteristics can be influenced by many factors 
including levels of concentration, proprioception, and neuromuscular activity (Borg 
& Laxaback, 2010; Karlsson & Frykberg, 2000; Mancini & Horak, 2010).  
The use of force plates as balance measures also has numerous reliability studies 
within literature, including MS rehabilitation (Bowser et al., 2015; Kanekar et al., 
2013; Ramdharry et al., 2006). Le Clair and Riach (1996) analysed the use of force 
plates as a means of investigating postural stability, finding that centre of pressure 
(CoP) measures and GRFs had good reliability for differentiating between mechanical 
and sensory conditions, and can detect postural differences, either between 
conditions or between interventions (Le Clair & Riach, 1996).  
CoP measurements give a summary of the forces exerted on a force plate, the 
position of this will change as the body on the force plate moves. CoP measures the 
pressure below the participant’s feet, and the resultant force on the force plates. 
Though centre of gravity (CoG) represents the point within the body where all forces 
are equally dispersed, this point within the body will change as the body moves. 
However, this may not be the same as the resultant force that is applied to the 
supporting surface. Though both measures are related to body balance and represent 
body movement to maintain an equilibrium of forces, CoP can be measured directly 
with force plates as the supporting structure and used as an analysis for how these 
movements represent balance and stability. Several parameters can be assessed 
from this including direction of body sway, determining whether sway is more 
common in one direction compared to another (Karlsson & Frykberg, 2000). Rome et 
al. (2009) investigated its use with an RA population in an eyes open and eyes closed 
task for body sway CoP measures, finding that AP body sway was significantly 
different to healthy controls, but not for mediolateral (ML) body sway. This result 
meant that the RA group had more CoP excursions within the AP direction (Rome et 




population, looking at displacement velocity range of movement along both ML and 
AP planes. Displacement velocity was found to be the most consistent difference 
between all their testing situations of elderly compared to young healthy controls 
(Raymakers et al., 2005). 
Although body sway is commonly investigated for both MS patients and other 
populations, there are multiple activities that are part of a daily routine are essential 
for functional independence. For example, DeBolt and McCubbin (2004) 
incorporated forward lunges, leg curls and step ups as part of an exercise intervention 
with MS patients. They found significant benefits for leg extensor power, however 
not for mobility and balance measures (DeBolt & McCubbin, 2004). These are 
activities that can also be measured objectively on force plates and analysed for body 
sway and efficiency of movement. It may be that the exercise intervention helped to 
improve strength, but to apply that strength into activities requires its incorporation 
into the intervention. 
Forward lunge is not generally used as a daily task in isolation, however used as part 
of other activities. The stepping forward motion involves control and pushing off from 
the back leg to the returning position and requiring strength, balance, and control. 
Although strength benefits have been seen from the use of forward lunge as an 
intervention (Alkjær et al., 2009; DeBolt & McCubbin, 2004; Rietberg et al., 2005) 
there is limited evidence for interventions and balance improvements with the MS 
population. The objective analysis from force and body sway measures using force 
plates will help to contribute to this area of knowledge.   
While these tests have the potential to give useful information for MS patients and 
symptom management, it does require participants with reasonable walking ability 
in order to obtain valid measures. These measures were not piloted with the LBP 
population in study one and must therefore be chosen carefully to be appropriate 
and beneficial to the MS population. Therefore, these tests are not beneficial for 
patients who are EDSS at 6 or above with higher levels of disability.  
4.0.5 Pilot Study Result Implications  
The improved muscle stiffness and tone results from study one support the notion it 




intervention has been tested and although some aspects of this second study have 
not been piloted, a large part of the protocol has been successfully carried out. 
Ethically, the researcher has a better understanding of what testing sessions will look 
like for the participants.  
The gender-based differences in the muscle response results led to the recruitment 
decision of a single gender. With a higher prevalence for females compared to males 
with MS as previously described, it was deemed appropriate to recruit female 
participants only for this study to control for gender as a possible factor, to contribute 
to potential gender specific intervention and remain relevant to current MS 
prevalence.  
To allow analysis on differentiation or otherwise because of the nature of the manual 
therapy intervention and to avoid worsening symptoms, this study will use an 
alternative manual therapy treatment session to compare to the intervention rather 
than a controlled environment.  This is anticipated to increase the internal validity of 
the findings and improve ethical integrity of the study. 
4.0.6 Study Aims 
The aim of this study was to investigate the efficacy of the intervention on acute 
muscle response and movement patterns within the MS population. The study design 
was informed by results from the pilot. The study therefore recruited females with 
MS for a repeated-measures cross-over, single intervention study, where all 
participants received both the mobilisation intervention and an alternative therapy 
session. The study was investigating the intervention treatment in comparison to a 
general manual therapy session to investigate the specificities that may be beneficial 
in terms of the forces, oscillation rate and consistency used. Though this cannot be 
used as a placebo comparison due to the therapeutic elements involved, the 
comparison will be more beneficial than a control session of sedentary lying still.   
The researcher hypothesised that there would be a reduction in muscle stiffness, 
tone, body sway and pain measures because of the intervention compared to the 
general massage. The null hypothesis stated that the intervention would have no 




4.1 Methods  
4.1.1 Participants 
20 female participants were recruited for this study. The recommended number of 
participants for repeated measures, within factors ANOVA was 24. This was 
established from a G-power calculation with a large effect size using partial eta 
squared (0.25) from the pilot study results, a power of 0.95 and an alpha significance 
level of 0.05. There was no MS mobilisation data available for estimation of a clinically 
meaningful effect size, therefore this was based on study 1 results with LBP data. Due 
to time constraints and participant availability, recruitment was completed with 20 
participants.   
Inclusion criteria included:  
• must be female  
• must have an MS diagnosis, must be able to walk independently with an EDSS 
of 6 or below  
• must be within the ages of 18-80 
Exclusion criteria included that participants must not respond positive to spinal 
therapy absolute contraindications including:  
• bone tumour  
• inflammatory/infectious/metabolic disease affecting the spine  
• dysplasia  
• healing fractures/dislocations  
• spinal cord damage  
• cauda equine syndrome  
• aortic dysfunction 
• severe haemophilia   
• must not have a connection with Point One Clinic  
In addition, participants must not respond to any relative contra-indications 
including: 




• spondylosis  
• spondylolisthesis  
• inflammatory arthritides  
• osteoporosis  
• hypermobile syndrome  
• pregnancy  
• cancer  
• cardiovascular disease  
• respiratory disease  
• healing injury  
• adverse reaction to previous spinal treatment  
Participants who responded positively to any relative contraindications were 
excluded based on severity and GP recommendation. If participants responded 
positively to relative contraindications, they were asked to request permission from 
their GP for their opinion as to whether it was safe for them to take part.  
The physiotherapist was made aware of all relative contraindications before any 
treatment and all treatments were considered gentle and low grade. Participants 
were told to inform the therapist or researcher if they felt in pain or discomfort at 
any point during the treatment.   
Ethical approval was obtained from the University Research and Integrity Committee, 
following the ethical guidelines stated by the Declaration of Helsinki (Appendix 9).  
4.1.2 Procedure 
Recruitment for the study was carried out via poster advertisement, social media 
(Facebook and Twitter) and word of mouth. Contacts were made to private or charity-
based physiotherapy centres and MS therapy centres. Initial contact was made in 
accordance with ethical approval and information days were organised with two MS 
therapy centres in Edinburgh and Glasgow.  
The poster and information sheet were used either in hard copy or electronically 
when a participant showed interest in response to advertisement and no coercion 




the information sheet and ask questions regarding the study. Participants were 
offered to be accompanied by a friend or family member to make them more 
comfortable during the testing if they wished.  
Once participants had shown interest in taking part, they were sent a link to a Novi 
Survey (Appendix 11). This was created to collect basic information about their MS 
condition and ask about any contraindications they may respond positively to. They 
were given a participant number to fill this out, so all information was pseudonymised 
to maintain security of their personal and medical information. This also ensured that 
the information was received before the participant began the protocol, meaning 
knowledge of their eligibility was received beforehand and avoiding any unnecessary 
journeys for someone who was not eligible. Only the researcher had access to this 
information on the Novi Survey. One password protected document was kept with 
the participant name and number code, to which only the researcher had access to, 
and which will be destroyed after completion of the PhD, as per General Data 
Protection Regulation guidelines. All other information was then pseudonymised 
according to their participant number. If the participant was eligible, they were 
randomly allocated to group A or group B by a random group generator on Microsoft 
ExcelTM, to organise suitable times for their sessions. Group A received the placebo 
massage first and then the intervention treatment, and vice versa for group B.  
Participants were required to attend on two separate occasions for the intervention 
treatment and general massage. These sessions were requested to be one week apart 
and at the same time of day for both their sessions, however this was not possible 
for a small number of participants. The order of the treatments they received were 
based on their randomly allocated group. The participants were blind to which 
treatment they were receiving. Though they were aware that one session was a 
general treatment and one was a specific intervention treatment and were therefore 
likely to be able to decipher which was which. All testing took place at the Edinburgh 
Napier University Sighthill campus Engage building with the room maintained at 
standard room temperature (20-25°).  
Participants again had the opportunity to read through the information sheet and the 




Participants were invited to ask any questions about the study before consent forms 
were given and encouraged to ask throughout the sessions if they wanted. They were 
also informed they could withdraw from the study at any point and it would not affect 
their treatment. Their data could be removed up until the point of dissemination of 
summarised results. Once written informed consent was given, anthropometric 
measures were taken for age, weight and height. Information was also taken 
regarding their most prominent symptoms and location of symptoms. Results from 
their Novi Survey were reviewed to go through their MS condition and EDSS.  
The same chartered physiotherapist who performed the intervention in the previous 
study performed the same intervention for participants in this study (same details 
from chapter three, section 3.1.2). The physiotherapist was involved in the rationale 
development for the study. However, all data collection and analysis were done by 
the researcher guided by academic supervisors without input from the 
physiotherapist. During the intervention treatment the physiotherapist’s manual 
contact was constant and not removed from the participant’s spine. The massage 
therapy was conducted by a different qualified massage therapist also working under 
their own liability and performed a 30-minute general massage applied on mid-lower 
back, with no specificities or consistencies; physical contact, rate and force 
magnitude was not constant. This treatment acted as an alternative therapy, allowing 
comparison of the specificities of the intervention. The use of a non-consistent 
massage therapy ethically allowed MS participants to still receive a form of treatment 
that may be beneficial to them on their alternate session. The use of objective criteria 
for force, rate and location, allowed for the differentiation between the treatment 
protocols. This is similar to placebo therapeutics from previous studies testing 
mobilisations (Haas et al., 2014; Perry and Green, 2008). The use of different 
therapists for the two treatments was due to practicality issues and allowed for the 
analysis of two different therapy treatments and their comparison. However, this 
results in different therapists who may already have different techniques and 
therefore result in differences due to this factor alone and is a study limitation to be 





Figure 4. 1 Plinth mounted onto 2 portable force plates to record vertical GRF.  
The force of both the intervention and the massage treatment was measured by 
monitoring vertical GRF profiles using two force plates (Kistler Instruments Ltd., 
Hampshire, UK, Force Plate Type 2875A) placed underneath the plinth. These were 
placed securely on the ground ensuring the floor surface was even and the force plate 
did not wobble. The plinth legs were placed on top of each force plate and secured 
with the breaks (example is demonstrated in figure 4.1). Only vertical GRF was 
measured. To ensure standardisation between participants of differing mass, a zero 
force was generated once each participant was lying supine and still on the plinth and 
recordings were taken during treatment every 3 minutes in 30-second samples 
periods (Kistler Ltd., BioWare). The summation of the vertical GRFs from the force 
plates were graphed and monitored during the treatment sessions to check the 
consistency of the force. The same process was carried out for the massage session 
(sample graphs in Appendix 16).   
The researcher conducted myometer tests for muscle quality, balance tests with the 
force plates and VAS tests with lumbar movements before and after the treatment 
sessions, completing a total of 4 separate set of tests. The participants could practice 
each of the balance tests on the force plates before testing began, however no 
separate familiarisation session took place. Once both testing sessions were 
complete, participants were thanked for their contribution and given a debrief sheet 




4.1.3 Outcome Measures 
Participants started with VAS tests measuring lumbar movements during flexion, 
extension, lateral flexion and rotation. They rated their pain during these movements 
on a scale of 0 to 10, 0 equating to no pain and 10 equating to worst pain felt. The 
researcher also completed the lumbar movements to provide a demonstration and 
instruction continued through the measurement process. Visual images for each 
lumbar movement and the pain scale were given to the participants (Appendix 15).  
Myometer tests were completed with participants lying in a prone position on a 
plinth and using a myometer digital palpation device (MyotonPRO, Myoton Ltd., 
London, UK). This is the same device used in study one, and collected the 
measurements in the same way, for the same muscle. The measurement collection 
was the same protocol as study one (section 3.1.3), collecting values on both sides of 
erector spinae muscle and using the higher mean value to determine the stiffer side 
of the spine. The same location was then palpated using the measurements from the 
base of the spine recorded from the first session and remarked.  
The participants then performed two balance tests positioned on the force plates. 
These were performed on force plates (Kistler Instruments Ltd., Force Plate Type 
2875A) using MARS performance analysis software which allows for body sway data 
extraction, including directional body sway. The first test involved the single leg 
stance where the participant was asked to balance on a single leg for 10 seconds. This 
test was performed with the leg corresponding to the side of the body with higher 
stiffness results. For example, if a participant showed the left side of their lower back 
had higher levels of stiffness compared to their right, the balance tests were 
performed on the left leg, and vice versa (fig. 4.2). The participant was asked to place 
their balancing leg in the middle of the force plate, with the front of their foot facing 
the anterior direction of the force plate. The test lasted for 10 seconds and they were 
instructed when this started and finished. The participant was asked to stand on their 
single leg with their other leg lifted while holding onto a chair placed beside them. 
They were counted into the test before letting go of the chair and visually focussing 




the test automatically stopped and was not counted. The chair placed beside them 
was an aid to help them re-stabilise if necessary and stop them from falling.   
The full 10-second period was used for analysis using the CoP measurements 
produced by the MARS software (fig. 4.3). The variables extracted for analysis were 
total path length, AP path length, ML path length and path length velocity 
automatically produced by the software. The participant repeated this test 5 times if 
they were able. Any tests where the participant stepped off the force plate was 
deleted, and the test re-started.   
The second test used was the forward lunge test which required normalisation to the 
participant’s body weight. The force plate was set to zero and the participant then 
instructed to step on and stand still. The plate was then calibrated by the researcher 
and the participant could step off. Participants were asked to lunge forward on the 
same leg that performed the single stance test. They stepped forward until they 
reached approximately a 90° angle with their front leg, as directed by the researcher, 
and then step back to normal position (fig. 4.4). The distance at which the participant 
was stepping onto the force plate from their back leg was marked on the floor, to 
allow the test to be repeated from the same distance in the post therapy protocol. 
This was determined in a practice test based on where the participant felt most 
comfortable to step forward. A chair was placed beside them again to assist 
stabilisation if needed and recorded if used. The participant was asked to have their 
arms by their side while lunging forward onto the force plate and the test recording 
was initiated automatically when their foot was placed on the force plate. Therefore, 
they were not counted into this test and could lunge forward when they felt ready to 
do so and the researcher affirmed the test was ready. 
The researcher was available to help at any time if participants felt uncomfortable or 
unstable during the tests or therapy session. Participants were encouraged to rest 
between the balance tests and at any time they felt tired. Once the participant 
stepped onto the plate the test automatically recorded all phases of the test 
(stepping forward, bending to a 90° angle, stepping up and stepping off the plate). 
The variables extracted for analysis were CoP ML displacement, impact force 




participant repeated this test 5 times if they were able. All tests were repeated after 
the treatment session to collect pre and post data for both conditions.  
 
Figure 4. 2 The single leg stance test, on either left or right foot placed in the centre of the plate with 
normal upright position (image from Kistler MARS Software v2.1 Manual). 
 
Figure 4. 3 The CoP path length result from which body sway measures were analysed (image from 





Figure 4. 4 The forward lunge test with participant stepping forward onto the force plate and stepping 
back to same position (image from Kistler MARS Software v2.1 Manual).    
 
Figure 4. 5 The force result measurements from which impact force and contact time were analysed 





Figure 4. 6 The CoP result measurements from which CoP ML displacement was analysed from (image 
from Kistler MARS Software v2.1 Manual).  
4.1.4 Analysis 
Data were collected for outcome measures from MyotonPro (Desktop Software 
v5.0.0.177) and Kistler MARS Software (v2.1) and exported into Microsoft Excel 
spreadsheets. Both MyotonPro and MARS software produced the variables used for 
analysis from the recorded tests. The mean was calculated for each variable of viable 
tests for pre and post in both testing sessions of each participant. VAS score was 
recorded as a number for pre and post in both testing sessions. Each participant then 
had a mean value for each variable pre and post for both testing sessions. Patient’s 
data were kept on their own file and then the mean values were brought together 
for each variable and each participant into a summary data file. Statistical analysis 
was then carried out on these mean values for all dependent variables on SPSS 
(version 23). The mean for all tests were gathered with standard error dispersion 
values. 2-way repeated measures ANOVAs were used to determine differences pre 
and post treatment, and between the intervention and massage trials with an alpha 
level set ˂ 0.05.  
4.2 Results  





Table 4. 1 Patient anthropometric data displayed with mean and SEM and range values. Data gathered 
in Novi survey and in their first session.  
 Mean ± SEM Range 
Height (m) 1.66 ± 0 1.55 – 1.7 
Mass (kg) 76.7 ± 5.4 52 – 140.4 
BMI 27.7 ± 1.9 19.7 – 46.9 
Age (years) 46.5 ± 3 23 - 70 
EDSS 3.3 ± 0.4 1 – 6 
 
Table 4. 2 Patient MS information with regards to their condition. Data gathered in Novi survey and in 
their first session.  
MS Type 
 
RRMS = 16 
PPMS = 1 
SPMS = 3 
Most Symptomatic Functional System  Pyramidal = 8 
Sensory = 7 
Bowel and Bladder = 3 
Cerebral = 2 
Most Symptomatic Side 
 
Right = 10 
Left = 8 
Both = 2 
Dominant Side 
 
Right = 17 
Left = 1 
Both = 2 
4.2.1 Muscle Stiffness 
All three tests on muscle quality data had Shapiro Wilk normality violations due to 
outliers within the data. These data were not removed as they did not seem to be 
inaccurate and represented the level of variation within the population muscle 
quality data. These values could have been represented as percentage change to 
minimise the variation and would also change the normality violations. However, this 




absolute values. To best represent the data and test for an effect between pre and 
post, parametric tests were chosen due to the ability to detect an effect if there is 
one. If non-parametric tests are used, a larger sample size is required to test for this 
effect. 
A 2-way repeated measures ANOVA revealed no significant main effect for time (F(1, 
19) = 0.397, p = 0.536), condition (F(1, 19) = 0.047, p = 0.83) or their interaction (F(1, 
19) = 0.176, p = 0.680) for either treatments in stiffness. There was no significant 
difference between the mobilisation intervention and the massage baseline values 
pre-treatment. Both conditions revealed an increase in stiffness after treatment. The 
increase after the intervention treatment was less than the increase for the massage 




















Figure 4. 7 Muscle Stiffness change for intervention from pre (292.05Nm ± 23.69) to post (298.17Nm ± 
21.32) and massage from pre (286.68Nm  ± 23.38) to post (297.82Nm ± 25.78) in a  2-way repeated 
measures ANOVA data presented with SEM error bars. 
A bivariate correlation was carried out on the stiffness data comparing baseline 
stiffness with the degree of stiffness change. With data from both treatments 
together, this was a non-significant correlation with a similar pattern to study one 
data and a p-value close to the alpha level (r = -0.31, p = 0.05, fig. 4.8). Separately the 
treatments had non-significant correlations (massage: r = -0.23, p = 0.34, 

































Figure 4. 8 Muscle stiffness non-significant bivariate correlation between pre-treatment stiffness and 
stiffness change.  



















Figure 4. 9 Muscle tone change for intervention from pre (15.47Hz ± 0.82) to post (15.64Hz ± 0.75) and 
massage from pre (15.09Hz ± 0.79) to post (15.46Hz ± 0.88) in a 2-way repeated measures ANOVA 
data presented with SEM error bars.  
A 2-way repeated measures ANOVA revealed no significant main effect for time (F(1, 
19) = 0.44, p = 0.515), condition (F(1, 19) = 0.328, p = 0.573) or their interaction (F(1, 
19) = 0.368, p = 0.551) for either treatments in tone. There was no significant 
difference between the massage and intervention baseline values pre-treatment. 




after the intervention treatment was less than the increase for the massage 
treatment, however not significantly. A bivariate correlation was carried out on the 
tone data comparing baseline tone with the degree of tone change. With data from 
both treatments together the correlation was non-significant (p = 0.12, r = -0.25, fig. 
4.10) and non-significant correlations for treatment data separately (massage: p = 
0.66, r= -0.11, mobilisation: p = 0.07, r = -0.41) however with a similar pattern to 
study one.   























Figure 4. 10 Muscle tone non-significant bivariate correlation between pre-treatment tone and tone 
change.  
4.2.3 Muscle Elasticity 
A 2-way repeated measures ANOVA revealed no significant main effect for time (F(1, 
19) = 0.001, p = 0.98), condition (F(1, 19) = 0.125, p = 0.727, or their interaction (F(1, 
19) = 2.404, p = 0.138) in elasticity. There was no significant difference between the 
intervention and massage baseline values pre-treatment. A decrease in the 
decrement equates to an increase in elasticity. Therefore, figure 4.11 demonstrates 
the intervention treatment resulting in an increase in elasticity and the massage in a 


























Figure 4. 11 Muscle elasticity change for intervention from pre (1.62 ± 0.15) to post (1.57 ± 0.15) and 
massage from pre (1.59 ± 0.14) to post (1.64 ± 0.17) in a 2-way repeated measures ANOVA data 
presented with SEM error bars.  
























Figure 4. 12 Muscle elasticity non-significant bivariate correlation between pre-treatment elasticity 
and elasticity change.  
A bivariate correlation was carried out on the elasticity data comparing baseline 
elasticity with the degree of elasticity change. With data from both treatments 
together the correlation was non-significant (p = 0.99, r = -0.02, fig. 4.12) and 





4.2.4 Single Stance Test Results  
A 2-way repeated measures ANOVA revealed no significant main effect for time (F(1, 
19) = 4.318, p = 0.05), condition (F(1, 19) = 0.149, p = 0.703) or their interaction (F(1, 
19) = 1.37, p = 0.256) for either treatment in body sway total path length. Both 
treatments showed a decrease and the mobilisation decrease was greater than the 
massage decrease (fig. 4.13). Significance differences (p ˂ 0.05) in the figures are 
denoted (*). Effect sizes are reported as partial eta squared values (0.01 = small, 0.09 
= medium, 0.25 = large). 
The same analysis displayed for AP path length revealed a main significant difference 
for time (F(1, 19) = 5.823, p = 0.026, n2 partial = 0.235) and no significant difference for 
condition (F(1, 19) = 0.384, p = 0.543) and no significant interaction (F(1, 19) = 0.657, 
p = 0.428, fig. 4.14) in AP body sway path length. Pairwise comparisons with a 
Bonferroni adjustment were then used to determine where specific differences lie, 
revealing a significant reduction in the massage treatment between pre and post and 
large partial eta squared effect size (p = 0.0015, ƞ²partial = 0.273). The same analysis 
for ML body sway path length did not show any significant main effect for time (F(1, 
19) = 1.173, p = 0.292), condition (F(1, 19) = 0.11, p = 0.744) or their interaction (F(1, 
19) = 0.7, p = 0.413) (fig 4.15). The same analysis displayed for velocity of body sway 
movements had no significant main effect for time (F1, 19) = 4.398, p = 0.052), 
condition (F(1, 19) = 1.814, p = 0.194), or their interaction (F(1, 19) = 1.453, p = 0.243) 
(fig. 4.16). 
All 4 variables analysed for this test had Shapiro Wilk normality violations due to 
outliers within the data. If the outliers are removed, normality was not violated, and 
some reductions become significant. However, outliers were not removed as they did 
not seem to be inaccurate and represented the level of variation within the 
























Figure 4. 13 Body sway, total path length change for intervention from pre (451.54mm ± 38.55) to post 
(410.66mm ± 38.72) and massage from pre (430.54mm ± 36.84) to post (418.06mm ± 42.63) in a 2-


























Figure 4. 14 Body sway, AP path length change for intervention from pre (287.65mm ± 26.9) to post 
(271.06mm ± 28.68) and massage from pre (302.69mm ± 28.93) to post (272.14mm ± 27.2) in a 2-way 



























Figure 4. 15 Body sway, ML path length for intervention from pre (265.93mm ± 24.46) to post 
(245.55mm ± 24.93) and massage from pre (262.63mm ± 25.32) to post (257.01mm ± 27.8) in a 2-way 




















Figure 4. 16 Body sway velocity change for intervention from pre (44.78mm/s ± 3.82) to post 
(40.67mm/s ± 3.83)  and massage from pre (42.71mm/s ± 3.65) to post (41.49mm/s ± 4.21) in a 2-way 
repeated measures ANOVA data presented with SEM error bars.  
4.2.5 Forward Lunge Test Results  
A 2-way repeated measures ANOVA revealed no significant main effect for time F(1, 
19) = 0.934, p = 0.346), condition (F(1, 19) = 1.814, p = 0.194) or their interaction (F(1, 
19) = 0.625, p = 0.439) in CoP ML displacement during the forward lunge (fig. 4.17). 
The same analysis was conducted on impact force of the forward lunge (percentage 
of body weight used when leaning into the forward lunge). This also revealed no 




p = 0.35) or their interaction (F(1, 19) = 0.771, p = 0.391, fig. 4.18). The same analysis 
on contact time, representing the time the participants took on the forward lunge, 
revealed no significant main effect for time (F(1, 19) = 1.102, p = 0.307), condition 























Figure 4. 17 Forward lunge body sway, ML displacement for intervention from pre (20.84mm ± 1.87) 
to post (21.15mm ± 1.15) and massage from pre (21.72mm ± 1.33) to post (23.52mm ± 1.37) in a 2-
























Figure 4. 18 Forward lunge relative impact force change for intervention from pre (74.94%BW ± 2.1) 
to post (75.88%BW ± 2.41) and massage from pre (76.05%BW ± 2.1) to post (78.21%BW ± 2.42) in a 2-































Figure 4. 19 Forward lunge contact time change for intervention from pre (4.05sec ± 0.5) to post 
(3.98sec ± 0.59) and massage from pre (3.31sec ± 0.29) to post (3.05sec ± 0.3) in a 2-way repeated 
measures ANOVA data presented with SEM error bars. 
All three variables analysed for this test had Shapiro Wilk normality violations due to 
outliers within the data. However, outliers were not removed as they did not seem 
to be inaccurate and represent the level of variation within the population balance 
data. If the outliers were removed, normality was still violated, and these differences 
are still non-significant.  
4.2.6 Visual Analogue Scale Results 
A 2-way repeated measures ANOVA revealed a significant main effect for time (F(1, 
19) = 5.817, p = 0.026, n2partial = 0.234), no significant main effect for condition (F(1, 
19) = 0.597, p = 0.449)  and no significant interaction (F(1, 19) = 0.318, p = 0.58). 
Pairwise comparisons with a Bonferroni adjustment were then used to determine 
where specific differences were, revealing a significant difference in the intervention 
condition from pre to post with a large partial eta squared effect size (p = 0.008, n2 
partial = 0.333, fig. 4. 20). Both conditions revealed reductions for this self-reported 
measure. However, these results violated Shapiro Wilk’s normality with several 
outliers due to a large variation in pain scores. Since there was no indication that 
these pain scores were a poor representation of the participant’s level of pain, these 





















Figure 4. 20 Self-perceived pain change for intervention from pre (1.63 ± 0.44) to post (1.15 ± 0.39) and 
massage from pre (1.35 ± 0.45) to post (1.05 ± 0.37) in a 2-way repeated measures data presented 
with SEM error bars.  
4.3 Discussion 
4.3.1 Myometer Results 
Muscle stiffness immediately increased following treatment for both conditions (fig. 
4.7). This was an unexpected result due to stiffness reductions in previous studies 
within literature (Ferreira et al., 2009; Fritz et al., 2011; Shum et al., 2013; Stamos-
Papastamos et al., 2011; Wong et al., 2015) as well as the results from study one 
within this project (chapter 3, fig. 3.2). However, all but one of these stiffness 
reductions listed in the literature above (Shum et al., 2013), are from interventions 
with more than 1 session. Less evidence exists for an immediate effect on stiffness 
with manual therapeutics on the lumbar spine. These findings could therefore be 
important in determining how many sessions are necessary to elicit a muscular 
stiffness response, since no immediate response was found for this outcome. Other 
studies within this area of muscle dosage response, investigate the optimal number 
of sets with results ranging from 4 to 12 (Haas et al., 2014; Pentelka et al., 2012; Xia 
et al., 2014).  
Both conditions resulted in an increase of stiffness post treatment, which was also 
found post the control sessions in study one (chapter 3, fig. 3.2). This could be an 
important finding in terms of the formation of stiffness in muscles during inactivity. 
The increase post intervention (2.1%) was less than the massage increase in stiffness 




in stiffness that may occur while stationary (Ferreira et al., 2009; Janecki et al., 2011, 
chapter 3, fig. 3.2). However, due to no significant changes in these results, both 
treatments were found to have no effect on muscle stiffness and therefore 
ineffective as an immediate form of treatment for muscle stiffness within this MS 
group. 
The proposed theory of mechanical stretching, creating a cascade of events that 
ultimately lead to a physiological reduction in pain and stiffness may not happen 
immediately. Since an immediate stiffness reduction was seen in the LBP pilot 
population, this could in fact be due to physiological differences between the two 
groups. Afferent neurons respond to a sensory stimulus and alter signalling to the 
CNS and the brain (Pickar & Bolton, 2012; Reed et al., 2013). The muscle spindle that 
controls the muscle’s ability to change shape due to adaptive signalling from afferent 
neurons, may have a delayed response because of inflammatory damage. These 
muscles would therefore not respond to this immediate stimulus in the same way 
that someone from the general population would. Due to potential altering of this 
sensory response in MS patients, they are likely to require more than a single session 
for this stiffness reduction to be mechanically shown. This is supported by the high 
level of sensory symptoms in the study participants (table 4.2), likely a representation 
of CNS sensory disruption. The individualisation of inflammatory attacks on the CNS 
in MS patients may also result in a greater variability in response depending on CNS 
pathways affected and therefore require more numbers to show this response if it is 
occurring.     
A significant association in change of stiffness relative to baseline stiffness has been 
previously found in literature (Ferreira et al., 2009) as well as the previous study 
result (chapter 3, fig. 3.3). A similar pattern in the correlation was found in this study 
results, however without significance (fig. 4.8, r = -0.31, p = 0.05). These results along 
with study one imply that baseline level of stiffness is an important factor. The higher 
someone presents with muscle stiffness, the more likely they are to respond to 
treatment, regardless of the type of treatment. This suggests that someone struggling 
with movement due to a build-up of muscle stiffness, is more likely to respond with 




stiffness can ultimately mean better movement and improve QoL, particularly due to 
its association with reductions in pain, implying that these are connected within 
muscle and movement pathways (Shum et al., 2013) and particularly with MS 
patients (Backus et al., 2016; Compston & Coles, 2008; McCullagh et al., 2008; 
Stevens et al., 2013).  
The results for tone (fig. 4.9) had a very similar pattern to stiffness which was 
expected due to previous results (Bailey et al., 2013; Fröhlich-Zwahlen et al., 2014; 
Ortega-Cebrian et al., 2016; Schneider et al., 2014) and the results from study one 
(chapter three, section 3.2). This consistency in their pattern of response again shows 
how they are related in function and can show similarity in results despite their 
differences in function description (Bailey et al., 2013). Some studies record only 
stiffness and elasticity with myometry, due to the relatedness in results for stiffness 
and tone (Kelly et al., 2018; Rätsep & Asser, 2011). Though a level of tone is required 
for muscle and body stability, hypertonality is seen in neuromuscular conditions, and 
can contribute to some symptoms such as spasticity, pain and fatigue (Fröhlich-
Zwahlen et al., 2014; Marusiak et al., 2012). A reduction in tone may help to ease 
some of these symptoms in MS patients, and improve the efficiency of movement. 
Similar to the stiffness results for this study, since there were no significant changes 
after either treatment, both were ineffective as an immediate form of treatment for 
muscle tone.       
The results for elasticity (fig. 4.11) had a higher level of variability, similar to previous 
studies (Schneider et al., 2014). As previously discussed in the biomechanical 
description of muscle elasticity, it may require active movement rather than passive 
to make a consistent difference. There have also been reports of elasticity decrease 
while in relaxed state, and could be result of periodic tremors in patients with 
neuromuscular disorders (Rätsep & Asser, 2011). This again implies that active 
movement may be required for improvements in elasticity. This would mean that 
mechanical energy is released more efficiently also allowing for more efficiency in 
plastic change of the muscle shape. Again, due to non-significant changes, both 




Neither treatments therefore had a significant impact on the muscle quality 
measured by the myometer, which articulates an element of the MS condition and 
the variation they are likely to show in terms of their muscle response data. MS 
patients report a high degree of spasticity, pain, fatigue and sensorimotor symptoms, 
depending on the location of lesions within the CNS, which can be a large factor in 
how their muscles respond to manual therapy (Backus et al., 2016; Stevens et al., 
2013). The difference in location of lesions may be a factor in the variation seen 
within the data, highlighted by the difference in study one results. Although there 
was a difference in sample size, this emphasizes the likely element of variability seen 
in the MS data, and is therefore likely to require multiple sessions to see any longer-
term effect in the muscle data.       
4.3.2 Force Plate and Body Sway Results 
Analysis of body sway parameters help to characterise body stability and ability to 
keep control of muscle function. Body sway parameters represent body movement 
to recover body balance equilibrium. Objective measurements to represent these 
movements can aid the analysis of sensorimotor mechanisms that manage postural 
control. A reduction in body sway parameters has been reported to signify an 
improvement in stability and control of the movement performance (Karlsson & 
Frykberg, 2000; Mancini & Horak, 2010; Raymakers et al., 2005). Reductions in all 
body sway variables were displayed in this study, however most were not a significant 
level of change. Therefore, with more data or more consistent sessions continuing to 
have the same effect (like the myometer results), these results would possibly 
become significant.  
Within the body sway path length data, total path length reduced three times more 
in the mobilisation intervention with a 9.1% decrease compared to the massage 
intervention with a 2.9% decrease (fig. 4.13). However, when split into the path 
directions, the massage intervention shows a larger significant decrease in the AP 
direction (fig. 4.14, 10.1% decrease) and the mobilisation intervention trial showed a 
larger decrease in the ML direction (fig. 4.15, 7.7% decrease), though not significant. 
This potentially implies that stabilising movements could originate from the AP plane 




with MS patients in both AP and ML planes in their study. Due to a similar trend in 
the reductions for all path length variables in this study (fig. 4.13 - 4.15), 
proprioceptive improvements for both planes of movement may still be occurring 
and would therefore show improvements in both planes of motion. However, the 
previous results from Rome et al. (2009) suggest that improvements are more likely 
in the AP plane because of higher initial body sway movements in this direction and 
more falls in this direction. Improvement in this plane may therefore have an 
important implication on likelihood of falls.     
Similarly, Raymakers et al. (2005) reported that ML sway showed more variation than 
AP in body sway measurements when comparing young and elderly patients. 
Karlsson and Frykberg, (2000) suggested two different strategies for maintaining 
posture in those two planes, with ML controlled by a load-unload strategy, and AP by 
an ankle stabilising strategy. These results suggest that the ankle stabilising strategy 
proposed by Karlsson and Frykberg (2000) may be responsible for improvements in 
AP directional body sway. Therefore, body sway may be more common and more 
variable in the ML direction, and easier to stabilise in the AP direction. Potential 
influences from the intervention could be multivariate. There could be better 
efficiency from muscles working to stabilise the body, these could be concentrated 
on ankle muscles according to the theory suggested by Karlsson and Frykberg (2000). 
These could also be improved from higher levels of concentration and a learned 
effect in performance (Büla et al., 2011; Mancini & Horak, 2010).  
Balance tests can often show a conditioning effect, meaning that stability 
performance improves with practice, and therefore body sway measures would be 
improving due to practice rather than a stabilising effect from the intervention. This 
is an aspect of neural reorganisation, beneficial for motor learning in many conditions 
with mobility difficulties, such as stroke patients (Arya et al., 2011). A separate 
familiarisation session with the stability exercises, could have reduced this effect to 
an extent. The participant would have learned the stability movements required in 
the initial session and therefore this learned effect may not carry over into the testing 
sessions. However, improvements in neural organisation and muscles required for 




included in this study to reduce unnecessary travel for the participants and was 
therefore a practical consideration.  
If reductions in stiffness and tone were seen, a degree of assumption could be made 
that this reduction contributes to improved stability, due to the complex nature of 
balance coordination, combining functional skills, and muscle quality contributing to 
posture and stability (Mancini & Horak, 2010). However, since this synergy of 
symptom improvements was not seen in the results, our data results cannot 
contribute to the association of reduced stiffness and improved stability.  
Evidence exists on improved balance confidence after practice for better posture and 
less likelihood of falling (Büla et al., 2011). This may have been useful data in a self-
reported confidence interview to see if this influenced their performance 
improvement. These balance data with improvements for a single stance movements 
can have positive implications for many aspects of daily living (Jonsson et al., 2004; 
Karlsson & Frykberg, 2000; Mancini & Horak, 2010). However, they cannot be 
attributed to reduced stiffness in this study, though both treatment conditions may 
have still influenced this.  
The forward lunge body sway results did not show reductions, indicating improved 
stability. In fact, both conditions revealed an increase, with the intervention 
treatment showing less of an increase than the massage treatment (fig. 4.17). Better 
efficiency in this movement would lead to less body sway, and less impact force in 
the front leg, which also revealed an increase (fig. 4.18). Therefore, this movement 
did not show noticeable improvement through body sway reduction in this study, 
whereas the single stance balance movement did. To improve forward lunge as a 
movement is likely to require a combination of postural control, balance and stability 
and may therefore require more work to improve. This could be both through 
practice and a manual intervention (Alkjær et al., 2009).  
The contact time for forward lunge decreased non-significantly for both treatments 
(fig. 4.19). However, the participants were not directed to try and perform the 
forward lunge in a quick time, therefore this decrease in time used appears to be self-
motivated from the participants. This decrease in contact time could also be 




utilised for faster movement (Raymakers et al., 2005). Due to the body sway stability 
increasing and increased impact force in these sessions, the reduced contact time for 
the forward lunge could therefore also be an indicator of reduced stability due to the 
faster movement.  
4.3.3 Visual Analogue Scale Results 
To help get an overview of the experience from the patient, a self-reported 
measurement of pain was taken, specifically after and during spinal stretches as part 
of the session. This is regular practice within manual therapy research (Kamali & 
Shokri, 2012; Owens et al., 2007; Powers et al., 2008; Xia et al., 2014) as well as 
allowing the participant to respond themselves. Previous literature has also shown a 
large number of studies resulting in a hypoalgesic effect from manual therapy 
interventions (George et al., 2006; Pentelka et al., 2012; Thomson et al., 2009; 
Vicenzino et al., 2001; Willett et al., 2010; Yeo & Wright, 2011). Due to the association 
between stiffness and pain (Fritz et al., 2011; Wong et al., 2016) a reduction in 
stiffness would be expected to also show a reduction in pain. The VAS was used as it 
complied well with feasibility and ethical considerations, though it added an element 
of a subjective pain measure. Pain was unofficially, anecdotally reported through the 
researchers initial PhD interviews with patients that helped to gather the rationale 
for the project.  
This measurement showed a significant difference in the mobilisation intervention 
treatment, with a reduction in self-reported pain (29.5%) and a large effect size. The 
massage intervention also revealed a similar reduction with 22.2% decrease however 
this was not significant (fig. 4.20). The intervention may have a larger effect on pain 
relief in comparison to other more general manual treatments. This could be to do 
with the specifics of the mobilisations and location and consistent movement 
resulting in pain relief. However, although the reduction in pain is statistically 
significant, the initial levels of pain in participants was already low and therefore this 
difference is still marginal. Kelly (2001) studied different groups in pain severity and 
their difference in levels of pain dependent on their initial pain. They found that to 




the VAS regardless of the initial levels of pain (Kelly, 2001). Therefore, the differences 
in the levels of pain in fig. 4.20 do not reach this degree of clinical significance.  
This could also be one of the indicators that more than one session is necessary to 
show objective difference in results, but self-perceived pain can still be reduced after 
a single session. A reduction in perceived pain, even if based around a psychological 
effect can influence movement confidence, which has previously shown to improve 
balance and reduce falls in other populations such as the elderly (Büla et al., 2011) as 
well as MS (Cattaneo et al., 2006; Donzé, 2015; Negahban et al., 2018). Therefore, 
reduced perception of pain could possibly influence balance measures, but would be 
unable to influence the muscle response measures unless there is also a physiological 
effect occurring.   
4.3.4 General Discussion 
The lack of significance in the study results is likely to be due to the variability seen in 
the MS population and the complex nature of the condition. The difference in 
outcome measure results in relation to each other highlights the difficulty in defining 
the beneficial mechanisms of manual therapeutics. Finding a significant result in a 
subjective measure could be more common than objective measures such as self-
reported pain, due to the benefits already associated with manual therapy. This 
therefore provides a possible confirmation bias in the participants, encouraging the 
results of a placebo effect. This highlights some of the importance of why the 
objective measures are necessary alongside the subjective. Since most participants 
in the study reported pyramidal and sensory based symptoms as their most common, 
improvements in pain and stability are likely to be of great benefit to their functional 
living. Therefore, investigating the degree to which these can be affected is valuable 
for this population.    
Outliers were not removed from the results as it did not change any significance level 
for the measures and there was no indication of any of the data being a poor 
representation of that movement or response. Given the level of variability seen 
within the MS patient data in these results as well as other studies (Boes et al., 2012; 
Crenshaw et al., 2006), outlier data seems to be a crucial element for the full picture 




quantitative representation of less consistent response, showing greater degrees of 
fluctuation when compared to the response of a healthy population.   
The combined results for this study informed us that there was a significant 
improvement in participant’s experience of pain because of the intervention. 
However, this is unlikely to be clinically significant and there is not enough evidence 
to discount a placebo effect. Therefore, further investigation, with repeated sessions 
and data to help determine the specifics of this, is the next step within the research.  
4.3.4 Study Limitations 
The design for this study controlled for gender as a factor that could contribute to a 
difference in responses between participants, and therefore the study only recruited 
females due to the higher prevalence of the condition. The result of this meant that 
there was a cofounding factor removed, but that recruitment was reduced. However, 
higher number of participants is likely to be more beneficial for insight into measure 
outcomes. Much higher number of participants is likely needed to show gender 
differences in response to manual therapy. Therefore, recruitment was limited with 
a female only study, as well as limited in time and resources for large scale 
recruitment. This then had bearing on decisions made for the next study, whether 
reducing recruitment to a single sex is best for the outcomes of the study with the 
limited time-periods of these studies.  
The study was also based on pilot data from the LBP study in the previous chapter 
due to the lack of myometer data for the MS population. Although the sample size 
recommended for this study was 24, it is likely for an MS population to experience an 
immediate effect this would be much higher.  
Although the intervention and the myometer tests had been piloted in the previous 
study, the balance tests had not, and five repeated successful trials of each exercise 
could become strenuous for some participants. Therefore, the combination of the 
single leg stance and forward lunge tests may not be suitable for all MS participants. 
The forward lunge did not show to be improving in the same way as the single stance 




The use of two different therapist for the two treatments means that any differences 
found, could already be attributed to inter-therapist differences. The intervention 
was compared to a general massage manual therapy session to investigate potential 
benefits from the intervention specificities. This was based on previous study designs 
with similar type placebo trials. However, since this was still a form of therapy, the 
analysis could not provide a placebo type comparison. This meant that when 
attending both trials, participants were still receiving a type of therapy and could 
explore themselves if they found benefit in either one.  
4.4 Study Conclusions 
In conclusion, the main aim of this study was to investigate the effects of the 
intervention with an MS population. Results revealed no significant differences in any 
of the muscle quality measurements, with stiffness and tone even reporting increases 
for both conditions. Movement pattern results for balance and stability did show 
reductions, with a significant reduction in the AP direction, indicating that both 
treatments may influence balance that reduces body sway. However, without similar 
results in muscle response, this can still be attributed to a learned or placebo effect. 
The MS population is therefore likely not to show an immediate effect and need more 
sessions to show or have an effect for muscle quality response. 
Due to lack of significant results between the two treatments, the specificities of the 
intervention and their potential benefits could not be determined. This leads to the 
next step in the project in collecting more data with a longer testing time, to see if 
there is a cumulative effect occurring. Repeated sessions could be more likely to be 
beneficial for the participants, creating a cumulative effect. Therefore, the next study 
will aim to analyse similar outcome measures, only testing people for more sessions, 






Study Three: Multiple sclerosis cumulative effect 
study. 
Analysis of a spinal mobilisation intervention in 
people with multiple sclerosis – continued.  
 
5.0 Introduction   
The lack of significant results from study two demonstrate that the intervention did 
not have an immediate effect with an MS population, despite some reductions in 
body sway measures and pain measures. Results also revealed an abnormal 
distribution and large variance. Therefore, with inconclusive results for a single 
session, investigating a cumulative effect after repeated sessions may have greater 
value, based on results from some previous studies with MS and other conditions 
(Backus et al., 2016; Bronfort et al., 2004; Naraoka et al., 2017).  
To make the most use of the remaining time for data collection on the PhD, this study 
was developed to test for a longer-term intervention, rather than the continuation of 
data collection for a single session response. This is also more likely to be beneficial 
for the participants taking part in the study, receiving multiple treatment sessions 
and potentially having a longer-term effect, since it is a long-term condition (Etoom 
et al., 2018b).  
5.0.1 Multiple Sclerosis and Long-Term Interventions  
There is evidence to suggest that long-term therapeutics can have cumulative effects 
that last longer than a short-term intervention (Backus et al., 2016). Short-term 
interventions are beneficial due to a lower cost and resources required to carry them 
out. Therefore, if a beneficial result is seen in a short-term intervention, this is 
resource efficient. Short-term interventions can be useful for short-term relief of 
symptoms, such as pain and muscle spasms shown in some previous studies 




However, since MS is a chronic condition, incorporating interventions that help to 
manage symptoms in the long-term is critical.  
A physiotherapy intervention aims to restore function and well-being of the whole-
body while concentrating on areas where function has been disrupted and focussing 
on mechanical properties of the musculoskeletal system (Etoom et al., 2018b; 
Pentelka et al., 2012). For MS patients this will be due to symptoms that arise from 
their condition, which can result in sensory and motor dysfunction such as pain, 
muscle weakness, spasticity, poor balance leading to secondary symptoms such as 
depression and fatigue. The management of these symptoms can then have knock-
on effects including areas such as cardiovascular health, mental health, sleep quality, 
fatigue and functional independence, all affecting QoL (Kobelt et al., 2017). Given the 
previously discussed importance of symptom management for MS patients, a long-
term intervention that can address these will benefit the patient in their routine 
management. Additionally, information on the specific areas of symptom 
improvement will be beneficial. Long-term follow up analysis will ultimately help to 
determine how the intervention is helping to sustain elements of their symptom 
management as a long-term lifestyle.   
Objective results, and aspects around biomechanical methods for measurement help 
to give added information in terms of physiotherapy intervention efficacy. By 
monitoring different areas within functional independence and aspects of daily life, 
the areas that would benefit from physiotherapy can be distinguished. This can also 
contribute towards creating individualised rehabilitation based on specific needs and 
symptoms. Exercise has shown particularly to improve symptoms for MS patients 
when it comes to aerobic endurance, balance and stretching as treatment of MS 
related fatigue (Dimitrov & Turner, 2014; Garrett et al., 2013; Rietberg et al., 2005). 
Many studies state the importance of exercise, movement, and healthy living as long-
term therapeutics for management of MS symptoms (Campbell et al., 2016; DeBolt 
& McCubbin, 2004; Garrett et al., 2013; Rietberg et al., 2005). However, long-term 
manual therapeutics for MS symptom management is less prevalent within current 
literature. This is a simple form of treatment, with little need for equipment and is 




with objective information will help to further not only MS therapeutics, but also 
physiotherapy research.  
The individual nature of MS often requires re-evaluation of disease progression and 
therefore how it is symptomatically affecting the patient. In a systematic review by 
Khan et al. (2007), studies were reviewed which investigated multidisciplinary 
rehabilitation for the management of MS symptoms. The overall outcome from their 
review suggested that levels of impairment were unchanged, however experience of 
the condition and functionality of daily activities improved, including social 
participation and activities. This multidisciplinary technique was found to adapt well 
to the specific and individual needs of the patients, however required a lot of re-
evaluation and assessment. They also found that studies of low intensity over a 
longer period had a greater impact on QoL than high intensity programmes over a 
short period. This was attributed to better self-efficacy and health promoting 
behaviours in a sustainable manner (Khan et al., 2007).   
5.0.2 Quality of Life Measures  
Side effects experienced due to reduced mobility can affect various elements of daily 
life. MS patients are known to have more difficulties with mobility leading to physical 
deconditioning, greater likelihood of fatigue, depression, and poor health. These can 
lead to long-term consequences in other areas of general health with potential risk 
of cardiovascular disease, obesity, osteoporosis, diabetes and hypertension 
(McCullagh et al., 2008). The goal of a physiotherapy-based intervention is to 
enhance movements, return them to functionality, with an end goal that relates to 
improved QoL. However, there are many aspects encompassed into QoL, as it is a 
multifaceted concept. Physically it involves movement, as well as psychological and 
emotional factors. These can be a secondary consequence of certain MS symptoms, 
and can be improved through aspects within an intervention such as pain reduction 
and positive emotional affects that improved movement capability can have. There 
are also social factors involved in QoL that encompass areas such as employment and 
social participation, which influence QoL (Kobelt et al., 2017; Yamout et al., 2013). It 
is therefore appropriate to measure an aspect of this to give a more complete view 




Forms of measuring QoL can be quite complex. Many scales and questionnaires exist, 
some of which have been listed in chapter two (section 2.3.3, table 2.1). These can 
span a wide range of areas that contribute to QoL, and some of these are specifically 
used for an MS population. Examples of these are; Multiple Sclerosis Quality of Life-
54, EDSS, Multiple Sclerosis Impact Scale-29, Functional Assessment of Multiple 
Sclerosis (McCullagh et al., 2008; Patti et al., 2002; Porcari et al., 2019; Yamout et al., 
2013). All these scales can be time consuming for patients and for medical staff 
interpreting these data. Since the main aspect of this project does not revolve around 
these concepts, but recognises the importance of QoL measurement, a more concise 
version is appropriate for this study. Pain and fatigue measurements are elements 
that influence a QoL score, and used in previous studies (Backus et al., 2016; Heine 
et al., 1996; Kamali & Shokri, 2012; Kobelt et al., 2017; Reid et al., 2014; van den Akker 
et al., 2016). These measures can therefore be incorporated into study outcomes, 
without it being the focus. QoL is a complex concept to measure, however literature 
and the results previously from studies one and two would indicate that this is an 
important concept to acknowledge and incorporate.  
Rehabilitation programmes can consider many aspects of people’s lives. This may 
consider care received from family and friends, socialising outside of home, ability to 
get outside and employment ability. It may also consider aspects in overall care for 
oneself such as the ability to dress themselves, to wash themselves, to cook and to 
feed themselves (Caminero & Bartolomé, 2011; Kesselring & Beer, 2005; van den 
Akker et al., 2016; Vucic et al., 2010). Knowledge of these aspects influencing QoL, 
can help with the management of symptoms within rehabilition and develop a full 
picture that individual measures would not be enough to decipher (Kobelt et al., 
2017).  
The reduction of pain and fatigue has a large implication on overall QoL (Yamout et 
al., 2013). Collecting measures for this is not only common practice within these 
studies, but allows the participant to feedback on this aspect of their experience 
(Kamali & Shokri, 2012; Owens et al., 2007; Powers et al., 2008; Xia et al., 2014). It 
can help identify the important aspects of the patient’s experience for improvment, 




whether they feel better (Ontaneda et al., 2017; Patti et al., 2002). With some of the 
previous results revealing improvements in pain and stability, this could indirectly 
influence aspects that contribute to fatigue that can be measured in a long-term 
intervention. Many aspects can contribute to fatigue in both a physical and mental 
capacity and reduction in muscle pain, stiffness and improved movement efficiency 
are all aspects that may help to reduce this symptom (Backus et al., 2016). Since this 
is a variable that is highly linked to QoL and highly experienced by people with MS, 
results in this area will help to inform the overall effect of the intervention.  
A mixed method design would allow both these elements to be investigated fully. 
This would allow both quantitative and qualitative measures based on interviews to 
be analysed and would help to cover all potential areas of effect. However, study 
design must encompass all aspects of feasibility, and qualitative based interview data 
were not possible for this study. Therefore, these aspects can be recognised and 
brought into the analysis using a quick and easy to use self-reported measure, for 
pain and fatigue, the two most likely aspects to affect parts of QoL (Yamout et al., 
2013).  
5.0.3 Studies One and Two Results  
Aspects learned from the previous study were incorporated into this study design to 
aid the continuity of the studies.  
The likelihood of difference between sexes in their response to treatment has been 
established in previous studies and supported in study one results. This could be due 
to differences in muscle composition, level of stiffness, hormonal differences and 
other physiological traits (Granata et al., 2002; Houtchens & Bove, 2018). However, 
large numbers of the same sex would be necessary to show this. Due to time 
constraints on the PhD project and findings in study two, it was deemed most 
appropriate to recruit both male and females to have larger number of participants.  
Non-significant reductions in body sway for balance tests are worth investigating 
further, as these reductions may increase with the accumulation of treatment 
sessions. Without improvements in the forward lunge tests, it was important to make 
best use of the participants’ time and therefore use a functional stability test that 




incorporated into the study. This is a test that can apply to many aspects of daily 
movement, such as getting out of bed, standing up from a chair, and getting up off a 
toilet; all largely associated with movements and QoL (Agrawal et al., 2011; Reza et 
al., 2018; Vosoughi & Freedman, 2010). This is an important movement to maintain 
function in and could therefore have informative value to as an outcome measure. 
This test has been used in previous literature with chronically ill populations using 
force plate data (Bernardi et al., 2004; Bowser et al., 2015).  
Pain measures are important to gather patient feedback on their experience, as well 
as information with regards to a possible hypoalgesic effect from manual 
therapeutics (Chiradejnant et al., 2003; Krouwel et al., 2010; Lopez-Lopez et al., 2015; 
Millan et al., 2012; Sterling et al., 2001). The VAS worked well in the previous study 
in terms of feasibility and resulted in a significant decrease after the mobilisation 
intervention, albeit small. This study will therefore continue to utilise these measures 
and investigate further if there is abnormal distribution of results. The previous study 
collected the VAS with lumbar movements as this was generated in previous similar 
studies or with functional movements on the area treated (Appendix 15, 
Chiradejnant et al., 2003; Goodsell et al., 2000; Pecos-Martín et al., 2017; Yeo & 
Wright, 2011). However, previous studies have also recorded VAS without lumbar 
movements (Freddolini et al., 2014; Kobelt et al., 2017; Naraoka et al., 2017). To use 
time efficiently in the testing sessions and to reduce the risk of excessive fatigue, 
resting lower back VAS was deemed most appropriate. 
Fatigue measures have shown to be useful indictor and integral to overall QoL given 
its reported as one of the most commonly experienced symptoms and can affect so 
many elements of movement and activity (Heine et al., 2015; McCullagh et al., 2008; 
Vucic et al., 2010). The fatigue measure Modified Fatigue Impact Scale (MFIS) is well 
known for work within the MS population (Farinotti et al., 2007; Garrett et al., 2013; 
Kehoe et al., 2015). However, this scale uses a total of 21 questions and categorises 
them for analysis. This could again make sessions very long for participants. While 
being an interesting element to assess, is not the focus of the study. Therefore, to 




used with 5 questions, also validated in previous studies (Backus et al., 2016; D’Souza, 
2016). 
5.0.5 Study Aims 
The aim of this study was to investigate the effectiveness of the intervention with an 
MS population in a repeated session approach with both earlier studies informing 
methods and design.  
The intervention treatment was compared to the same massage treatment used in 
study two; however, participants were randomly allocated to either an intervention 
or a massage treatment group. Time constraints on the project meant that all 
participants could not receive both treatments for repeated sessions and compare 
them to each other. Therefore, treatment groups were assessed as independent 
groups, and allowed for a randomised controlled trial analysis. The study tested 
objectively for muscle quality and stability measures, as well as self-reported 
measures for pain and fatigue, to investigate a well-rounded picture of the effects. 
The researcher hypothesised that there would be a reduction in muscle stiffness, 
tone, body sway, pain, and fatigue measures because of the intervention compared 
to the massage treatment. The null hypothesis stated that the intervention would 
have no different effect on these measures compared to the massage treatment.  
5.1 Methods 
5.1.1 Participants 
20 participants were recruited for this study in a mixed factor study design (between-
subject, repeated measures). The recommended number of participants for repeated 
measures, between factors ANOVA is 36 (18 participants in each group). This was 
shown from a G-power calculation with a large effect size (0.4), a power of 0.8 and a 
significance level of 0.05. The previous study used the effect size from the pilot study 
results (0.25) and did not show significant results apart from VAS measures (p = 0.008, 
n2 partial = 0.333). It was recommended by the Research Integrity Ethics Committee to 
estimate a larger effect size than the previous study since this did not reveal 
significant results. Due to time constraints, participant availability and feasibility, 




unfortunate and has an impact on the validity of the results, it was out with the 
researcher’s control to continue recruitment beyond that time point. 
Participants who took part in study two could take part in study three as long as they 
met the inclusion and exclusion criteria. As this study has a different protocol with 
the aim of looking at effects over the 4-session period, previous participation was 
deemed to have no effect on their response in the new intervention. Inclusion and 
exclusion criteria remained the same as study two (chapter 4, section 4.1.1), except 
both males and females were included in recruitment. A total of seven participants 
who took part in study two also took part in study three. Given these participants had 
already experienced both treatments, they would know which type of treatment they 
were receiving for their four sessions. This could add to their learned effect in the 
balance tests and could alter their bias depending on their treatment preference in 
the pain and fatigue measures.  
Participants responding positively to absolute contraindications were unable to take 
part. Participants responding positively to any relative contraindications were 
excluded based on severity and GP recommendation. They were asked to request 
permission from their GP for their opinion as to whether it was safe for them to take 
part. The therapist was made aware of all relative contraindications before any 
treatment and all treatments were gentle and low grade. Participants were asked to 
inform the therapist or researcher if they felt in pain or discomfort at any point during 
the treatment.  
5.1.2 Procedure 
Recruitment strategy was the same as study two (chapter 4, section 4.1.2). Contacts 
already made from study two were re-contacted to inform them of the study without 
coercion.   
Once participants had shown interest in taking part, they were sent a link to the same 
Novi Survey used for study two (Appendix 11) to gather information about their MS 
condition and contraindications. Only the researcher had access to this information 
on the Novi Survey. All participant information was pseudonymised according to their 
participant number. If the participant was eligible, they were randomly allocated to 




suitable times for their sessions. Group A received the massage for four sessions and 
group B received the mobilisation intervention for four sessions.  
Participants were required to attend on four separate occasions, receiving the same 
treatment for each session. Though previous studies have recommended more 
sessions from their results, the remaining time on the project did not allow for more 
than four sessions per participant, given time for recruitment, testing and analysis for 
the study. Four sessions would still allow analysis for a cumulative effect, however 
previous research would indicate that 8-12 sessions is more likely to show benefit 
from a manual therapeutic intervention. This was a single-blind trial, so participants 
were blind as to which treatment they were receiving. All testing took place at the 
Edinburgh Napier University Sighthill campus Engage building in a physiotherapy 
room which was maintained at standard room temperature (20-25°). The participants 
were asked to attend sessions at the same time on four consecutive weeks, to have 
a consistent gap between sessions. This was possible for the majority of participant 
sessions apart from a small number of sessions. 
Upon arrival, participants had the opportunity to read through the information sheet 
again and the researcher ran through the protocol with each participant. Participants 
were invited to ask any questions about the study before consent forms were given 
and encouraged to ask throughout the sessions if they wanted. They were also 
informed they could withdraw from the study at any point and it would not affect 
their treatment. Their data could be removed up until the point of dissemination of 
summarised results. Once written consent was given, anthropometric measures were 
taken for age, weight, and height. Information was also taken regarding their most 
prominent symptoms and location of symptoms. Results from their Novi Survey were 
reviewed to go through their MS condition and EDSS.  
The licensed massage therapist worked under their own liability and performed both 
treatments on all participants for this study. The therapist received training from the 
physiotherapist who worked on studies one and two to perform the spinal 
mobilisation intervention. This training was monitored with force plate 
measurements (Kistler Instruments Ltd., Force Plate Type 2875A, Hampshire, UK) 




the intervention treatment sessions to retain the same treatment as much as 
possible, however differences between therapists will still occur therefore this 
creates a limitation in the comparison between studies two and three.  
For the spinal mobilisation intervention, the therapist performed the same 30-minute 
spinal mobilisation intervention as the other two studies (rate = 0.37Hz, 22 beats per 
minute, force = less than grade 1, threshold of 80N, location = L1-L5, further detail in 
chapter 3, section 3.1.2). This allowed analysis on the cumulative impact of the 
mobilisation intervention on an MS population group for MS-based symptoms. This 
has not been tested on an MS population group before and can therefore be assessed 
for MS based symptoms on this populations group. The force for both the 
intervention and the massage treatment were controlled using force plate data 
collection, using the same method as study two (chapter 4, section 4.1.2). The 
massage therapy involved a 30-minute general massage, with no specificities or 
consistencies. Manual contact was applied on mid-lower back; rate and force 
magnitude of touch was not constant. This treatment acted as an alternative therapy, 
allowing comparison of the specificities of the intervention, and blinding of 
treatment.  
During the first session, the participant carried out all myometer, balance, pain, and 
fatigue tests pre their first session for both massage and intervention sessions. The 
myometer, balance and pain tests were then tested post the first session. During the 
subsequent three sessions, the participants completed the myometer, balance and 
pain tests post treatment and the final fatigue test following their last session. 
Participants therefore completed five sets of tests for the myometer, balance and 
pain, to test the cumulative effect rather than a pre and post analysis of each 
treatment session. The fatigue test was only completed pre and post all treatment 
sessions due to the set-up of the questionnaire. Once all testing sessions were 
complete, participants were thanked for their contribution and given a debrief sheet 
with further information and contact details to give to their GP or carer as 




5.1.3 Outcome Measures 
Participants self-reported pain using a visual analogue scale (VAS). This was the same 
scale used in study two (chapter four, section 4.1.3), only without the lumbar 
movements to use time more efficiently. The VAS uses a pain rating scale from 0-10, 
0 represented no pain and 10 represented worst pain felt. Participants were given a 
visual scale to rate their resting lower back pain in each of the testing sessions 
(Appendix 15).  
Participants completed a shortened version of the Modified Fatigue Impact Scale 
(MFIS) consisting of five questions on the impact of fatigue in their lives over the past 
4 weeks. There was a total possible score of 20 (Appendix 22). This was completed at 
the start of the first session and at the end of the fourth session.   
Myometer tests were completed using the same method as study one (chapter three, 
section 3.1.3) collecting measurements for stiffness, tone, and elasticity. The 
measurement collection was the same protocol as studies one and two, collecting 
values on both sides of erector spinae muscle and using the higher mean value to 
determine the stiffer side of the spine for treatment 
The participants then performed two balance tests positioned on the force plates. 
Test one involved a single leg stance test, the same protocol used in study two 
(chapter four, section 4.1.3) collecting measurements for body sway total path length 
AP path length, ML path length and velocity. The second test used was a sit-to-stand 
test. This required a calibration of force plates to the participant’s body weight and 
used the same protocol as the forward lunge test calibration described in chapter 
four (section 4.1.3). Participants were seated on a chair directly in front of the force 
plate, with their feet resting on the force plate. They were asked to move from a sit 
to stand position, using only their leg strength (fig. 5.1). This was repeated five times. 
The researcher was available to help at any time if participants felt uncomfortable or 
unstable during the tests or therapy session. Participants were encouraged to rest 
between the balance tests or at any time they felt tired.  
The software used to collect the force data (Kistler, MARS) gave an automatic output 




rising index (the percentage of body weight applied to the force plates during the 
standing movement) and weight transfer (the time taken to stand).     
 
Figure 5. 1 The sit-to-stand test with participant moving from a seated to a standing position on the 
force plate (image from Kistler MARS Software v2.1 Manual).    
 
Figure 5. 2 The force result measurement from which rising index and weight transfer were analysed 





Figure 5. 3 The CoP result from which CoP body sway velocity was analysed from (image from Kistler 
MARS Software v2.1 Manual).    
A total of five testing sessions were completed for each participant, pre and post 
session 1, and post sessions 2, 3 and 4.  
5.1.4 Analysis 
Data were collected and reduced in the same manner as study two (chapter 4, section 
4.1.4). The sit-to-stand test results were collected using Kistler MARS Software (v2.1) 
and extracted onto Microsoft Excel spreadsheets. The mean value of the 5 trials for 
each variable in each testing session was calculated, resulting in 5 values for each 
variable (except fatigue) and each participant used for statistical analysis. The fatigue 
scores were a numerical value between 0-20 and only collected twice, pre and post 
all sessions, resulting in 2 values for each participant. Data collected from their Novi 
Survey and in their first session were collated and summarised into mean, range and 




SPSS (version 23) using mean values with standard error dispersion values. All 
dependent variables for muscle response, single stance balance, sit-to-stand stability, 
pain, and fatigue scores were analysed each in a between-subjects repeated 
measures ANOVA. This was to determine differences between the two treatment 
groups and between the different time points. Pearson correlations were carried out 
on the myometer variables, comparing baseline measures to the level of change after 
the final session, since these have revealed significant correlations in the previous 
studies.  
5.2 Results 
Results in this chapter based on 20 participants with diagnosed MS. 
Table 5. 1 Patient anthropometric data displayed with mean and SEM and range values. Data gathered 
in Novi survey and in their first session. 
 Male Data 
Mean ± SEM (n 
= 8) 
Female Data 
Mean ± SEM (n 
= 12) 
All Data 
Mean ± SEM 
(n = 20)  
All Data 
Range (n = 
20) 
Height (m) 1.8 ± 0 1.67 ± 0 1.72 ± 0 1.5 – 1.9 
Mass (kg) 93.8 ± 11.4 71.8 ± 6.1 80.6 ± 6.2 56 – 158.5 
BMI 29.3 ± 3.2 25.6 ± 1.8 27.1 ± 1.7 22.2 – 47.8 
Age (years) 43 ± 1.9 41.5 ± 3.9 42.1 ± 2.4 24 - 71 
EDSS 2.3 ± 0.2 2.3 ± 0.2 2.3 ± 0.2 1.5 - 4 
 
Table 5. 2 Patient MS information with regards to their condition. Data gathered in Novi survey and in 
their first session. 
MS Type 
 
RRMS = 17 
PPMS = 2  
SPMS = 1 
Most Symptomatic Functional System  Pyramidal = 8  
Sensory = 8   
Cerebral = 3 




Most Symptomatic Side 
 
Right = 9  
Left = 5  
Both = 6  
Dominant Side 
 
Right = 17  
Left = 2  
Both = 1  
 
All variables were assessed for normal distribution using the Shapiro-Wilk test, if 
abnormal distribution was found, group baseline data were tested for differences 
using a t-test for each group. This was only calculated on the baseline data to check 
if an abnormal distribution affected initial values between the two treatment groups 
since these were separate groups of people. If normality violations were found, these 
data were transposed into percentage change, relative to their baseline score, 
reducing the level of inter-participant variation and allow these data to be analysed 
on one scale. To transpose into percentage change values, the means for the variable 
in each testing session were still used. The mean values for each testing session were 
calculated relative to the baseline mean value for that variable.   
5.2.1 Muscle Stiffness 
Stiffness values were analysed as a percentage change, to normalise group variances. 
A between-subjects repeated measures ANOVA revealed no significant main effect 
for time (F(1, 19) = 1.132, p = 0.379), condition (F(1, 19) = 0.055, p = 0.817) or their 
interaction (F(1, 19) = 0.661, p = 0.628, (fig. 5.4). Correlations run between baseline 
stiffness and stiffness change after four sessions was non-significant for all data 
together, however the mobilisation intervention group correlation was significant 































Figure 5. 4 Muscle stiffness change for intervention and massage treatments. Between-subjects 
repeated measures ANOVA data presented as percentage change with SEM error bars.  

































Figure 5. 5 Muscle stiffness significant bivariate correlation for mobilisation intervention between 
baseline stiffness and stiffness change after four sessions. 
5.2.2 Muscle Tone 
Tone values were also analysed as a percentage change, to normalise group 
variances. A between-subjects repeated measures ANOVA revealed no significant 
main effect for time (F(1, 19) = 2.345, p = 0.102), condition (F(1, 19) = 0.001, p = 0.972 
or their interaction (F(1, 19) = 0.339, p = 0.847, fig. 5.6). Correlations run between 




treatment groups run separately, however when run with the data combined 
together this correlation is significant (fig. 5.7, p = 0.03, r = -0.48).  






















Figure 5. 6 Muscle tone change for intervention and massage treatments. Between-subjects repeated 
measures ANOVA data presented as percentage change values with SEM error bars.  






























Figure 5. 7 Muscle tone significant bivariate correlation between baseline tone and tone change after 
four sessions. 
5.2.3 Muscle Elasticity 
No significant differences were found between the treatment groups for muscle 
elasticity and no normality violations, therefore the values given by the myometer 




ANOVA revealed no significant main effect for time (F(1, 19) = 1.119, p = 0.384), 
condition (F(1, 19) = 0.097, p = 0.759) or their interaction (F(1, 19) = 0.846, p = 0.518, 
fig. 5.8). All correlations run between baseline elasticity and elasticity change after 
four sessions were non-significant (fig. 5.9).  





















Figure 5. 8 Muscle elasticity change for intervention and massage treatments. Between-subjects 
repeated measures ANOVA data presented for log(decrement) values with SEM error bars.  






















Figure 5. 9 Muscle elasticity non-significant bivariate correlation between baseline elasticity and 
elasticity change after four sessions. 
5.2.4 Single Stance Results  
A significant main effect for time was revealed for body sway total path length (F(1, 




19) = 2.378, p = 0.14) and no significant interaction (F(1, 19) = 0.576, p = 0.685). 
Pairwise comparisons were then used with a Bonferroni adjustment to determine 
where specific differences lie, revealing significant reductions between time points 
for both intervention mobilisation and massage treatments with large effect sizes 
(massage: p = 0.002, n2 partial = 0.677, intervention: p = 0.034, n2 partial = 0.408, fig. 5.10). 
There were no significant differences revealed between treatment groups. 
Significance differences (p ˂ 0.05) in the figures are denoted (*).  Effect sizes are 
reported as partial eta squared values (0.01 = small, 0.09 = medium, 0.25 = large). 
A significant main effect for time was revealed for body sway AP path length (F(1, 19) 
=4.265, p = 0.017, n2 partial = 0.532, fig. 5.11), no significant main effect for condition 
(F(1, 19) = 2.776, p = 0.113) and no significant interaction (F(1, 19) = 0.655, p = 0.633). 
However, pairwise comparisons with a Bonferroni adjustment revealed no 
differences between time points for either treatments. There were no significant 
differences between treatment groups.  
A significant main effect for time was revealed for body sway ML path length (F(1, 19) 
=6.7, p = 0.003, n2 partial = 0.641, fig. 5.12), no significant main effect for condition (F(1, 
19) = 1.053, p = 0.318) and no significant interaction (F(1, 19) = 0.461, p = 0.763). 
Pairwise comparisons with a Bonferroni adjustment revealed a significant difference 
in the intervention mobilisation treatment between time points with a large effect 
size (p = 0.016, n2 partial = 0.535) and no significant difference for the massage. There 
were no significant differences revealed between treatment groups.  
The same analysis for body sway velocity changes revealed a significant main effect 
for time (F(1,19) = 5.531, p = 0.006, n2 partial = 0.596, fig. 5.13, no significant main effect 
for condition (F(1, 19) = 2.557, p = 0.127) and no significant interactions (F(1, 19) = 
0.604, p = 0.665). Pairwise comparisons with a Bonferroni adjustment revealed a 
significant difference in the massage treatment between time points with a large 
effect size (p = 0.047, n2 partial = 0.453) and no significant difference in the intervention 





























Figure 5. 10 Body sway total path length change for mobilisation and massage treatments. Between-
subjects repeated measures ANOVA data presented with SEM error bars.  






















Figure 5. 11 Body sway AP path length change for mobilisation and massage treatments. Between-





























Figure 5. 12 Body sway ML path length change for mobilisation and massage treatments. Between-
subjects repeated measures ANOVA data presented with SEM error bars. 






















Figure 5. 13 Body sway velocity changes for mobilisation and massage treatments. Between-subjects 
repeated measures ANOVA data presented with SEM error bars.  
5.2.5 Sit-to-Stand Results  
The CoP body sway velocity was analysed as a percentage change to normalise group 
variances. A between-subjects repeated measures ANOVA revealed no significant 
main effect for time (F(1, 19) = 2.63, p = 0.12), condition (F(1, 19) = 1.961, p = 0.178) 
or their interaction (F(1, 19) = 0.634, p = 0.646, fig. 5.14). There were no significant 
differences between treatment groups. A between-subjects repeated measures 




= 0.2), condition (F(1, 19) = 0.323, p = 0.577) or their interaction (F(1, 19) = 0.04, p = 
0.997, fig. 5.15).  
The weight transfer variable was also analysed as a percentage change to normalise 
group variances. A between-subjects repeated measures ANOVA revealed a 
significant main effect for time (F(1, 19) = 9.829, p ˂ 0.001, n2 partial = 0.724, fig. 5.16), 
no significant main effect for condition (F(1, 19) = 1.63, p = 0.218) and no significant 
interaction (F(1, 19) = 2.232, p = 0.104). Pairwise comparisons with a Bonferroni 
adjustment revealed both treatment groups to have significant differences between 
time points with large effect sizes (massage: p = 0.017, n2 partial = 0.532, intervention: 
p = 0.001, n2 partial = 0.678). No significant different between treatment groups were 
revealed.  


























Figure 5. 14 Body sway velocity changes for intervention and massage treatments. Between-subjects 





























Figure 5. 15 Rising index changes for intervention and massage treatments. Between-subjects 
repeated measures ANOVA data presented with SEM error bars.  






























Figure 5. 16 Weight transfer changes for intervention and massage treatments. Between-subjects 
repeated measures ANOVA data presented with SEM error bars.  
5.2.6 Visual Analogue Scale Results 
VAS score resulted in normality violations with the Shapiro-Wilk test, however data 
could not be transposed to relative percentage changes as some participants scored 
0 on their baseline levels. Therefore, the absolute values for these data have been 
presented. A between-subjects repeated measures ANOVA revealed no significant 
main effect for time (F(1, 19) = 0.655, p = 0.632), condition (F(1, 19) = 0.193, p = 0.665) 




















Figure 5. 17 VAS change for intervention and massage treatments. Between-subjects repeated 
measures ANOVA data presented with SEM error bars.  
5.2.7 Fatigue Results  
A between-subjects repeated measures ANOVA revealed a significant main effect for 
time (F(1, 19) = 7.416, p = 0.023, n2 partial = 0.452), no significant main effect for 
condition (F(1, 19) = 0.032, p = 0.862) and no significant interaction (F(1, 19) = 1.691, 
p = 0.226). Pairwise comparisons were then used with a Bonferroni adjustment to 
determine where specific differences lie, revealing a significant reduction for the 
intervention mobilisation treatment between time points with a large effect size (p = 
0.041, n2 partial = 0.386). A non-significant reduction was revealed for the massage 
























Figure 5. 18 Fatigue score change for intervention and massage treatments. Between-subjects 
repeated measures ANOVA data presented with SEM error bars.  
5.3 Discussion 
5.3.1 Myometer Results 
High levels of stiffness in MS patients can reduce QoL due to the resulting effects of 
limited mobility. These can consequently lead to greater levels of fatigue, pain, 
anxiety, posture deficits, higher risk of falls and muscle spasticity (Freddolini et al., 
2014; Little et al., 2014; Shum et al., 2013; Xia et al., 2014). Therefore, reductions in 
the level of para-spinal stiffness has potential to improve QoL, improve body 
awareness and efficiency of muscle and joint movement. If symptom management 
programmes were able to achieve a stiffness reduction effectively and consistently 
through therapeutics, there would likely be important positive associations for the 
QoL of people with MS (Etoom et al., 2018a; Stevens et al., 2013).  
The results for muscle stiffness for both treatments in this study revealed a decrease 
over time within the four sessions (four weeks with a weekly session, fig. 5.4). 
However, these reductions were non-significant for both groups, and equivalent to 
approximately a 5% reduction. Statistical analysis did not reveal a cumulative effect 
of four sessions on stiffness and indeed these results reveal stiffness does not follow 
a linear increase or decrease, but rather fluctuations between sessions. The 




same result is mirrored in the results for tone (fig. 5.6). Though these could be 
random fluctuations appearing by chance, this could also be representative of part of 
a pattern that would emerge if treatment and testing continued for longer. For both 
tone and stiffness measures, a linear decreasing trend is displayed until the third 
session when an increased spike occurs and then decreases again after. This may give 
an indication as to the cumulative effect on these measures. There may be two or 
three treatment sessions that cause a decrease in stiffness and tone, and then 
occasional sessions where there is a spiked increase, and then start to decrease again 
with further sessions. This could be investigated further with a longer study for both 
stiffness and tone values in an MS population.  
It is not possible to determine whether the stiffness levels measured at each session 
were maintained for the week between sessions however, there does appear to be a 
trend towards a decrease in stiffness over time in both treatment groups. With 
further opportunity to intervene and larger participant numbers, it is possible that a 
stiffness reduction pattern would have emerged. No significant differences were 
revealed between the two treatment groups. Therefore, if more sessions revealed a 
significant reduction, it would be important to determine whether the mobilisation 
intervention distinctively improves stiffness more than another form of manual 
touch, or whether this occurs with any form of manual therapy.  
Manual therapy studies testing stiffness have revealed significant stiffness reductions 
with varying lengths of times and number of sessions. Lack of consistency within 
manual therapy methodology means that specific results associated with stiffness 
benefits are difficult to determine. A large population of people with MS suffer from 
spasticity as a main disabling symptom of their condition and has a severe and direct 
effect on QoL. The movement disorder caused by nerve disruption and characterised 
by sporadic increases in stiffness and tone, results in exaggerated and uncontrolled 
muscle spasms. This can be painful, can cause large disruptions to movement control, 
can directly relate to onset of fatigue, and often related to high levels of stiffness also. 
The treatments for reducing stiffness are often shared with treatments for reduced 




Negahban et al. (2013) reported significant spasticity improvements after 15 massage 
sessions over 3 months. Giovanelli et al. (2007) found significant spasticity 
improvements with MS patients after 15 manual therapy and stretch sessions in 15 
days, however, with a vague description of the therapeutic protocol (Gafson et al., 
2012; Negahban et al., 2018). These studies both measured spasticity using the 
Modified Ashworth Scale rather than an objective analysis, allowing more room for 
human error, and possible inter-rater discrepancies depending on training of the 
individual recording results from the scale. This can make comparisons between 
studies more difficult due to discrepancies in inter-rater reliability (Blackburn et al., 
2002; Craven & Morris, 2010; Mutlu et al., 2008). 
A range of results exist in the literature to determine the optimal number of sessions 
required to induce a significant stiffness reduction. Previous results from spinal 
manual therapy on stiffness reduction have shown significant stiffness reductions in 
as many as 12 and as little as 1 session. However, differences in assessment methods 
again create limitations in these comparisons (Ferreira et al., 2009; Fritz et al., 2011; 
Shum et al., 2013). The lack of significant results from this study and the lack of 
previous results in MS spinal therapy on stiffness to compare these results to would 
signify that 4 sessions was not enough to elicit a significant stiffness response if there 
is one. If the specifics of the required manual intervention dose and treatment type 
are defined, this can be harnessed to its most effective use to the people who require 
it most.   
As already discussed, the results for tone (fig. 5.6) in this study mirror the results for 
stiffness (similar for study one, fig. 3.5 and study two, fig. 4.9), showing their 
similarities in functionality. The similarities of stiffness and tone mean that they often 
have a similar pattern of response, as seen previously also (Fröhlich-Zwahlen et al., 
2014; Schneider et al., 2014). Hypertonality is associated with musculoskeletal 
disorders (Parkinson’s, Stroke, MS) and its reduction has many similar implications to 
a reduction in stiffness. The reductions seen in figure 5.6 are likely to represent a 





In a study investigating the effect of an exercise therapy with progressive MS 
patients, reduced levels of tone were found to be associated with improved 
endurance and improved QoL score (Giesser et al., 2007). The participants in our 
investigation were mainly relapse-remitting and likely to be in a less severe stage of 
the disease, and therefore less likely to show these differences. The participants in 
this study also had average low EDSS scores with males and females in the study both 
showing an average of 2.25, and the highest EDSS only reaching 4, displaying minimal 
levels of disability (table 5.2). This is supported by the correlations found in all three 
studies, between baseline tone and stiffness and subsequent levels of change (fig 5.5 
& 5.7). Progressive patients appear to be more likely to have higher levels of tone and 
stiffness and therefore more likely to show a reduction in these. However, 
investigations with progressive patients are limited due to the symptom difficulties 
experienced at this stage and the participant’s ability to take part (Campbell et al., 
2016). Therefore, developments in testing measures for the more disabled group 
within the MS population is both lacking and likely to have beneficial outcomes.  
Muscle elasticity, based on the inverse of the log(decrement) presented, did not 
show any significant differences between time points for either treatment group (fig. 
5.8). Similar to previous studies (Rätsep & Asser, 2011; Schneider et al., 2014), the 
values result in a different pattern of response compared to stiffness and tone. A 
decrease in the muscle decrement (the loss of mechanical energy) equates to an 
increase in elasticity, the pliability of the muscle (Rätsep & Asser, 2011). Since neither 
treatment resulted in a decrease of decrement, neither treatment showed to be 
beneficial for elasticity.  
Limited literature exists on elasticity change in people with MS and could therefore 
warrant further investigation with larger numbers to try and decipher how this 
characteristic may respond during mobilisations. The lack of significant results for 
elasticity in all three studies in this investigation could imply this is a more variable 
measure to calculate, and a less consistent way of responding within the muscle. 
Other studies however have found associations between elasticity and stiffness and 
may therefore have a more vigorous testing method that warrants further 




increased, elasticity also increased, contrary to belief that elasticity should increase 
with stiffness decrease. This is however based on concepts stated in previous studies 
and not the findings of this study. Therefore, the nature of elasticity, its modifications, 
and the application of this in muscle control and movement requires further 
investigation.    
Veldi et al. (2004) also found a decrease in muscle elasticity in Parkinson’s patients 
who struggle with sleeping. This could be associated with subconscious tremors 
during sleep, affecting the muscle’s ability to relax (Veldi et al., 2004). Therefore, 
these findings may indicate that an increase in elasticity could arise from 
subconscious activity or tremors in the muscle, and an increased level of variability in 
this recorded measure, which may be more apparent in an MS population compared 
to a general population.          
5.3.2 Force Plate Results 
Total path length body sway resulted in significant reductions with a large effect size 
after the four sessions, (fig. 5.10), a different result from the previous study, which 
showed a non-significant reduction after a single session (chapter four, fig 4.13). Body 
sway velocity had a similar pattern but with a significant reduction in the massage 
treatment (fig. 5.13). These reductions also have less fluctuation, and therefore may 
be more likely to continue decreasing. Where study two results revealed that a single 
session was not enough to significantly reduce total path body sway, four sessions 
does appear to have this significant effect. Body sway velocity can give added 
information than the path length depending on the stabilising strategy used by the 
participant. Postural control is based on a person’s ability to return the body close to 
the equilibrium point when exposed to a perturbation (Karlsson & Frykberg, 2000). 
An increase in path length may then represent an increase in stabilising movements, 
where previously they may have stepped out to avoid falling and not necessarily 
represent a decrease in performance. However, a decrease in body sway velocity, 
would indicate an increased level of control in these stabilising movements 
(Ramdharry et al., 2006). Path length and velocity appear to have maintained the 




between them. Therefore, a reduction in path length was likely to have coincided 
with a reduction in velocity.  
The results for directional path length, however, reveal differing significance for the 
treatment groups. Previous results from study two displayed AP direction significant 
improvements where ML direction did not (chapter four, section 4.2.4), and 
therefore relating to ankle stabilisation strategies that help to improve body sway in 
this direction (Karlsson & Frykberg, 2000). Study three results reveal improvements 
in both AP and ML directions with specific improvement in the ML direction for the 
intervention group (fig. 5.11, 5.12). The difference between these results is unlikely 
to be a central component, as similar reduction patterns are displayed and both 
treatments displayed significant reduction in total path length with no significant 
differences arising between treatment groups. These results therefore suggest that 
improvements in single leg balance can be because of stabilisation in either plane. 
This coincides with findings from Kanekar et al. (2013) who found improvements in 
both planes of motion in MS patients because of an increased proprioceptive 
stimulus. The previous findings from Rome et al. (2009) suggested that greater initial 
levels of AP sway led to greater levels of improvement, also coinciding with the 
findings from Karlsson and Frykberg (2000) suggesting this is due to an ankle 
stabilising strategy. This is an element of body sway balance that could be further 
investigated, with important implication on the lives of MS patients due to reduced 
risk of falls.   
Neural re-organisation to enable motor learning is particularly important for people 
with MS due to the demyelination effects of their condition (Sumowski et al., 2018). 
Depending on what pathways within the CNS are affected by this may depend how 
well they are able to adjust to improve movements and balance. Certain individuals 
may require more practice and muscle relief compared to others affected in different 
pathways (Arya et al., 2011). However, a release of stiffness and tension in the 
muscles, particularly para-spinal muscles important for postural control, can improve 
the muscle quality and efficiency. Balance coordination is a complex combination of 
muscle quality as well as functional skill, therefore allowing both of these to improve 




incorporate into every-day activities and overall mobility (Stevens et al., 2013). 
Although significant balance improvements were found after both treatment groups, 
the lack of significance in muscle response data signify this improvement cannot be 
attributed to improved muscle efficiency.   
As discussed in the previous chapter, these reductions may be attributed to a learned 
effect from having better practice over the different sessions. Similarly, the lack of 
significant reduction in stiffness and tone from this study means that the balance 
improvements cannot be explained by mechanical influence on muscles enabling 
better muscle efficiency. There is thus reason to suggest that practicing single leg 
balance, has a better outcome for improving balance than because of manual 
therapy, whether specific mobilisations or general massage.  
Self-reported confidence interviews may have added a useful element in the results 
to decipher if the improvements in body sway could be attributed to improved 
confidence. This would suggest a learned effect and the creation of a positive 
environment for participants to feel they had space to practice and improve balance 
movements. However, this would have added an extra element to the testing 
sessions and could be subjected to bias from the participants and the researcher. 
Previous studies have however reported improved balance due to confidence (Büla 
et al., 2011; Mancini & Horak, 2010) and if it allows the participants to improve 
elements of the balance and take it into their every-day routine, their QoL should 
improve.   
The sit-to-stand test was chosen rather than the forward lunge test due to its use in 
previous studies with informative results. It also encompasses a crucial part of daily 
movement that is critical for functional independence (Agrawal et al., 2011; Bernardi 
et al., 2004; Bowser et al., 2015; Fröhlich-Zwahlen et al., 2014; Reza et al., 2018). For 
people with MS particularly, weakness in the lower limbs may occur due to leg 
weakness because of pain, stiffness and disuse and can then result in a greater trunk 
flexion during this sit-to-stand movement. This was shown by Bowser et al. (2015) in 
their results with MS patients displaying significantly different aspects of the sit-to-
stand movement compared to a general population. These aspects included 




knee extensor power and slower rising time. Therefore, many elements can lead to a 
less efficient technique for rising to standing up position. These are said to be mainly 
derived from decreased leg extensor strength, which can be a common symptom for 
people with MS (Bernardi et al., 2004; Lambert et al., 2001; Van der heijden et al., 
2009). This has then led to the trunk-flexion theory, which states that if leg weakness 
is shown, people take longer to stand up and use a greater trunk flexion to 
compensate for decreased leg strength requiring more energy.  
This study did not examine kinematic measures and therefore cannot consider trunk 
flexion in its analysis. Although a reduction in body sway velocity would represent a 
more efficient movement, as this requires less energy to stand up (Bernardi et al., 
2004). The results for both treatments in this study reveal no significant differences 
and no consistent pattern (fig. 5.14). They also showed a high level of variability and 
have been presented as a relative percentage change value to compensate for this.  
Similarly, results for rising index has fluctuations and even displaying a gradual 
increase in both treatments over the four sessions (fig. 5.15). This measure describes 
the percentage of force used to stand up in relation to body weight. Therefore, an 
increase in this measure would signify a greater level of energy required. Faster 
movement will cause the percentage of body weight used in movement to increase 
(Agrawal et al., 2011; Bowser et al., 2015; Cheng et al., 1998), also demonstrated in 
the forward lunge results in study two (chapter four, section 4.2.5). In accordance 
with this, the results for weight transfer (representing the time taken to rise to 
standing) significantly decreased in both treatment groups (fig. 5.16). The cumulative 
increase in rising index and decrease in weight transfer both correspond with a faster 
movement from sitting to standing, but not a more controlled movement. Therefore, 
the stabilisation method of this movement could be investigated further whether by 
a learned or training effect or muscular therapeutic.  
In a similar manner to single leg balance, improvement in stability for a sit-to-stand 
movement requires both elements of neuromuscular activity as well as concentration 
and proprioception. More perturbations are likely to occur in a single leg balance 
activity than a movement activity and may have more room for these to improve as 




previously found in MS patients consisted of both early and late recruitment in leg 
muscles and suggested to be caused by impaired reflex system due to delayed 
transmission in certain pathways (Benedetti et al., 1999). This can be improved 
through neural re-organisation, however likely to be different for an MS population 
compared to a healthy population depending on demyelinated pathways in the CNS 
(Arya et al., 2011; Sumowski et al., 2018).   
The sit-to-stand movement has been previously found to improve with improvement 
in leg extensor strength with MS participants (Bernardi et al., 2004; Bowser et al., 
2015). Therefore, the neuromuscular recruitment of these leg extensor muscles may 
also influence the muscle’s contraction ability. Given the leg strength deficits found 
in the MS population as well as other neurological disorders, this appears to be an 
important element to be aware of in relation to movement stability (Büla et al., 2011; 
Cruickshank et al., 2015). A leg strengthening protocol is likely to be beneficial for 
improvement in this measure. Again, interview data on self-reported improvement 
for this test may have been interesting to see if people reported any self-perceived 
improvements, or if this movement improved in their daily lifestyle and activities.         
5.3.3 Visual Analogue Scale Results 
Figure 5.17 displaying the pain results based on VAS indicates the low levels of pain 
reported by participants from baseline. Therefore, any reductions seen here are likely 
to be non-significant which was indeed the case. These results again revealed the 
same for both treatment groups and no distinction between the two treatments can 
be made based on these. A larger sample of participants with more variations in 
baseline pain may be a better representation of potential decreases in pain occurring 
during manual therapy.  
Previous studies have indicated a relationship between stiffness and pain values and 
their levels of change (Shum et al., 2013). However, the lack of any findings regarding 
pain difference in this study means this association cannot be analysed. There was a 
greater likelihood of volunteers for the study from people who suffer less from pain. 
This was attempted to be managed in the methods with providing transport for 




elements were still likely to influence the range of baseline pain scores and EDSS 
scores.  
The study was designed around the concept of mobility and how to measure 
improvements in this. Pain is seen to interact to a high degree with mobility and 
factors into many symptoms experienced by MS patients and so was an important 
aspect to evaluate. Since the values collected for pain were insufficient for analysis, 
this association was not investigated, however future work could examine this 
further. Given the number of studies that report a hypoalgesic effect after manual 
therapy, investigations regarding pain pathway mechanisms and how they might be 
altered would be valuable for this research area (Millan et al., 2012; Moutzouri et al., 
2012; Pecos-Martín et al., 2017; Perry & Green, 2008; Shum et al., 2013; Sterling et 
al., 2001).  
5.3.4 Fatigue Results 
Fatigue score was a new measurement assessed for this study to add a variable 
affecting QoL into the analysis. A short 5-question version of the MFIS was used 
asking participants to rate their fatigue from 1-4 in five different areas over the past 
four weeks. They were given this at the start of the first session and at the end of the 
last session and the highest possible score was 20. The limitations of the 
questionnaire are based around the possibility that the participants may remember 
their previous score form the start when completing at the end. They were however 
encouraged to complete the questions based on the effect of fatigue in the past four 
weeks rather than fatigue they felt before they started the study.  
Results for these scores indicate a significant reduction in fatigue for the mobilisation 
intervention, and a non-significant reduction for the massage, though no significant 
differences between the groups were revealed and no significant interaction (5.18). 
Reduced  fatigue has many implications for someone with MS given fatigue is one of 
the most commonly reported symptoms and one of the most debilitating (Backus et 
al., 2016; Yamout et al., 2013). It is also very difficult to explain and determine specific 
causes for. Therefore, an effective treatment to reduce these effects would be highly 
beneficial for MS research, since MS sufferers are known to deal with the effects of 




findings with associations in stability and fatigue improvements due to the significant 
results in body sway and fatigue (Crenshaw et al., 2006). This is an area for potential 
research development in terms of how these measures may be associated with each 
other and the potential direct or indirect influence of mobilisation therapy. 
The intervention group appears to have benefited more than the massage group for 
this measure. Therefore, an element of the specifics and consistent nature of the 
intervention, could have a greater effect than other manual therapies for this 
measure, like the VAS results reported in study two (chapter four, section 4.3.3). The 
specificities of the intervention compared to a generalised massage, may also have a 
placebo type effect where patients feel like are improving, because of the medicinal 
nature of this treatment. However, the results of a placebo effect cannot be negated 
due to the lack of placebo in the trial. The lack of a placebo comparator means that 
the reduction in self-reported fatigue could result due to the feeling of a beneficial 
experience, rather than as a direct result of the treatment. Further investigation in 
this area could do more in-depth analysis to focus on fatigue reductions and if certain 
types of manual therapeutics have a greater effect on this.  
5.3.5 General Discussion 
The only measure to display a significant improvement after the intervention 
compared to the massage was self-reported fatigue. Study two in a similar manner, 
revealed self-reported pain significantly reduced compared to the massage also. The 
objective measures (myometer and force plate tests) had more variability and 
fluctuations compared to the subjective measures, potentially due to less scope for 
variation in the scales used. This supports the rationale of using a full analysis, 
revealing objective and subjective measures as a true indication of effects taking 
place and would further support a mixed method design in future studies. The 
potential placebo effect occurring may still help to improve elements within QoL 
measures that are linked with chronic conditions by improving self-confidence and 
subsequently increasing levels of movement and participation in activity. Objective 
evidence for the specific benefits of the intervention is lacking in the results, however 
the significant improvements in stability and fatigue findings seem to suggest that 




their most symptomatic category to be pyramidal and sensory, both relating to 
muscle recruitment, weakness and sensation, improvements in these areas of 
stability and fatigue is likely to benefit their functional daily activities.   
The high variability found in the data resulted in abnormal distributions and could be 
an important aspect of how people with MS respond to manual therapeutics and 
therefore a larger sample size is required for a full representation of the data. The 
inadequate sample size and abnormal distribution of the data means that the results 
are less reliable and is therefore a limitation in the investigation. The full effects of 
this intervention would be beneficial to analyse with a higher number of participants. 
This effect is likely to require more treatment sessions, similar to previous studies 
who recommend benefits are seen after 12-15 sessions (Ferreira et al., 2009; 
Giovannelli et al., 2007; Negahban et al., 2013; Shum et al., 2013).  
Other specific self-reported measures may have been an interesting added element 
to test whether perceived stiffness change was different to actual stiffness change, 
or whether balance confidence was different to actual balance differences in the 
objective data. This could be an element to incorporate into future study.  
5.3.6 Study Limitations  
The study did not recruit the full number of participants necessary from the sample 
size calculation. Given the level of variability that already exists in the population, a 
large sample size may be necessary for a normal data distribution and more reliable 
statistical results. Due to time restrictions on the study, the testing could not test for 
longer than 4 sessions per participant, however a longer-term study with further 
treatment sessions may show a more cumulative effect.  
The lack of placebo in the trial means that the intervention is being compared to a 
different form of therapy and cannot negate a placebo effect taking place. Therefore, 
results may occur by chance. 7 participants from the previous study also participated 
in this study, and despite being blind to the treatment group they were in, would be 
aware of what treatment they were receiving based on their experience of the 




The therapist performing the treatment was not the same as the previous studies in 
this investigation due to practicality reasons. Despite training for the intervention 
treatment, differences in inter-therapist techniques could have provided some 
differences making the comparison of study two and study three results challenging.  
The participants recruited for the study had low levels of disability and low levels of 
pain and were therefore less likely to show a response in these measures. With an 
altered recruitment strategy, with better targeting for people with MS of a range of 
abilities, the more disabled category may be better represented in the study 
demographics. The study also could not recruit participants with an EDSS above 6 due 
to the balance tests required and therefore does not represent the more disabled 
population and the full range of disabilities with the MS population. 
Improvements in the stability measures may occur due to practice and increased 
confidence in the exercises as oppose to either treatment having a direct effect on 
these. Questionnaires around improved confidence may have useful information for 
this aspect of the analysis.  
5.4 Study Conclusions 
In conclusion, the results from this study show both treatments to have a significant 
improvement on stability measures and fatigue, and non-significant reductions on 
muscle stiffness and tone. With lack of distinctions between the treatment group 
effects, there is likely to be a benefit from either type of manual therapeutic, without 
specific benefit from the mobilisation technique.   
Though the study expected to find more trends within the data, there is potential for 
these measures to show more significant findings if continued to be collected for a 
longer period. Future studies with use of mixed methods to gain a full insight through 






General Discussion and Conclusions 
Analysis of the combined study results.  
 
6.0 Introduction   
The overall aim of this thesis was to report scientific findings on the investigation of 
a spinal mobilisation intervention already used in practice with MS patients with 
beneficial anecdotal reports. The lack of mobilisation intervention in MS literature 
provided a context for the investigation in MS rehabilitation and symptom 
management. As a unique form of mobilisations applied at a consistent low force, 
this was also an investigation to measure the forces, rate and timing that define the 
intervention and test it’s efficacy with scientific methods.  
The results from the pilot and two MS studies displayed some different findings in 
measures investigated around muscle response, stability, pain, and fatigue. These 
can be compared to each other to conclude results of the intervention for an 
immediate and cumulative response, with awareness of limitations. The differences 
between the studies created some limitations and their comparisons and were 
therefore less reliable. The key variable however in each study was muscle stiffness, 
as this was a variable repeatedly referred to in previous reports and has large 
associations with many aspects of daily life and functional independence.  
6.1 Myometer Measures 
6.1.1 Stiffness Changes and Correlations 
The stiffness results from these studies have an interesting and beneficial value both 
to MS and general physiotherapy research. The significant correlations between 
baseline and level of stiffness change found in all three studies are clear indications 
of how muscles respond to both inactivity and manual therapy based on resistance 
to change (muscle stiffness). Since people with higher levels of baseline stiffness are 
more likely to show a change in stiffness, they are also more likely to build-up 
stiffness during inactivity. This was deciphered in the pilot study and these trends 




lower levels of disability with an average EDSS of 2.78 between them, this could be 
an important indicator in their level of activity since sedentary time could be an 
important factor in terms of their muscle composition and levels of stiffness. Activity 
and lifestyle questionnaires may have helped with this and could be implemented in 
future studies. This could help to determine if a certain level of sedentary lifestyle is 
damaging for muscle in terms of promoting high levels of stiffness, and in determining 
their level of response to manual therapy.  
Since the myometer variables were the only ones tested in all 3 studies, these are the 
only variables that can be compared across all studies. Despite a hypothesis for a 
stiffness reduction in all three studies, the pilot study was the only one revealing a 
significant result. The lack of significance seen in this variable within the MS 
population is likely connected to the variability seen within the MS stiffness data and 
a larger range of values when compared to the pilot population. The study three 
results however show a 4% overall reduction in the massage group and 7% overall 
reduction in the intervention group, which is a similar level to the immediate 
reduction seen in the pilot study group. This would imply that people with MS are 
likely to require more than one session to see a reduction in stiffness, and more than 
four sessions to see a significant reduction. The similarity however in baseline 
stiffness and level of stiffness change between the studies, supports the notion that 
the mechanistic action between LBP and MS groups may be the same, however with 
greater variability levels in MS due to complications related to the condition.  
The variability in MS results may also indicate a wider range of individual response to 
manual treatments, where some participants respond positively, and others do not. 
The proposed changes to muscle spindle activity due to signalling adaptations may 
be a delayed response in MS patients who suffer from CNS lesions affecting this 
(Pickar & Bolton, 2012; Reed et al., 2013), which could be contributing to the data 
variability. This could also be connected to levels of spasticity within MS patients as 
this can occur due to signal disruption within the CNS and result in abnormally high 
levels of stiffness and tone within muscle. Muscle recovery may also be hindered due 




The association between pain and stiffness has been investigated previously where 
significant correlations in change of stiffness and change in pain occur because of 
mobilisation therapy. Lower levels of spinal activity and higher levels of spinal 
stiffness have been shown in people suffering from back pain (Shum et al., 2013). The 
oscillatory force produced during mobilisation therapy as previously discussed may 
stimulate mechanoreceptors, altering the signalling events for both pain and 
stiffness. The mechanical mechanisms that alter pain as seen in previous hypoalgesic 
results (Chaitow, 2015; George et al., 2006; Lascurain-Aguirrebena et al., 2016b; 
Pentelka et al., 2012; Schmid et al., 2008) may also target the signalling events that 
monitor and alter the cell spindle activity, and subsequently the muscle stiffness. 
These characteristics can then also go on to perpetuate each other in the long-term 
due to the build-up of stiffness with inactivity (Ferreira et al., 2009; Fritz et al., 2011; 
Shum et al., 2013). A pain and stiffness correlation were not supported in these 
results and could again be due to variability within the data. There were low levels of 
pain reported in most participants. Therefore, with more baseline variation in this 
variable and higher initial levels of pain, a greater difference in pain may have been 
revealed and this may be correlated with differences in stiffness.  
While significant differences between the intervention and a control arose in the pilot 
study, when compared to a general massage treatment, muscle stiffness displays 
similar trends in both treatment groups. Thus, the intervention was effective at 
reducing stiffness when compared to inactivity but did not appear to be different to 
another form of manual therapy. This implies that the mobilisation intervention could 
have the same or similar effect on muscle stiffness as any other type of manual 
therapy in the same area. Further studies could develop the investigation of different 
forces, rate, and timing of therapeutics, in terms of the effect they have on muscular 
response, either immediately or cumulatively. This has a large implication for MS 
symptom management as well as management of similar type conditions. An efficient 
and effective therapeutic for muscle stiffness should aid levels of daily activity and 
functional independence.   
The MyotonPRO proved to be a reliable, easy to use, non-invasive form of objectively 




Mannion, 2003; Pruyn et al., 2015; Viir et al., 2006; Zinder & Padua, 2011) and could 
be used further to investigate other trends within stiffness data.  
6.1.2 Tone and Elasticity 
Both tone and elasticity were not commented on anecdotally, however investigated 
previously with stiffness in myometer studies (Aird et al., 2012; Bailey et al., 2013; 
Fröhlich-Zwahlen et al., 2014; Viir et al., 2006; Wang et al., 2016). Their purpose 
within muscle function remains important for movement health.  
Tone results mimicked the same pattern as stiffness in all three studies, indicating 
their similarity in function and measurement, but with slightly different behaviours. 
The overall reduction in the third study showed tone reduced by 6% in the massage 
group and 4% in the intervention group. Again, despite not being a significant 
reduction, show a similar percentage level of reduction when compared to the 
immediate reduction in the pilot population. The effects of spasticity and other 
motor-based conditions associated with cell signalling disruption can lead to 
increased levels of muscle tone. Tone is responsible for the underlying electrical 
activity within the muscle, and abnormally high levels can lead to uncontrolled 
tendon jerks, a characteristic in several musculoskeletal conditions and associated 
with many movement difficulties (Dietz & Berger, 1983; Fröhlich-Zwahlen et al., 
2014). Therefore, in a similar manner to stiffness reduction, the implication of this 
within MS symptom management could be very beneficial, if further investigation 
clarified the clinically significant level of reduction and the manual therapy dosage 
required for this effect. Tone also mimicked the similarity in correlations comparing 
baseline levels to levels of change, except for study two. Therefore, this may be 
stronger relationship for stiffness than it is for tone.  
Elasticity results did not show a consistent pattern with different results in each 
study. Though study three results revealed many fluctuations within elasticity data, 
differences between the two treatments were apparent. Previous studies have also 
had inconsistent elasticity results (Bailey et al., 2013; Fröhlich-Zwahlen et al., 2014; 
Schneider et al., 2014) and therefore could be a variable worth investigating further 




Passive manual treatment may not be a successful way of improving elasticity and 
may require active movement or treatment to affect this positively. 
6.2 Balance Measures 
6.2.1 Body Sway Reductions 
Body sway measures were only gathered in the MS studies, meaning their results can 
be compared between an immediate and cumulative effect difference. In both 
studies, all body sway measures for the single stance test resulted in reductions. 
Though in the immediate effect study there were no significant reductions except in 
the AP path length (fig. 4.14), many of these variables then became significant in the 
cumulative effect study. This implies that improvements in single stance can be made 
after one therapy session, as much as a 9% reduction in body sway as seen in fig. 4.13 
after the intervention. This reduction can become significant after four treatment 
sessions, where both treatments revealed a 21% reduction in body sway. People with 
MS already show to have increased number of falls and increased level of body sway 
when compared to healthy controls. This could be because of many different types 
of symptoms that result in muscle weakness, visual difficulties, vestibular and balance 
difficulties, somatosensory loss, and spasticity. These can all be directly affected by 
nerve disruption and then collectively affect aspects of stability that lead to loss of 
muscular control and increased body sway (Kanekar et al., 2013; Ramdharry et al., 
2006; Stevens et al., 2013). 
Improvements in these measures, can have many implications for improved 
movement ability and reducing the risk of unexpected falls. With most participants 
in these studies displaying greater symptom level in pyramidal and sensory 
categories, this has a large implication on muscle control and recruitment. Both 
treatments revealed very similar trends and levels of significance in both MS studies 
for these measures. This either indicates that balance improvements occur regardless 
of manual therapy type, or that the learned effect has a greater effect on 
improvement than manual treatment. It is likely these result improvements are due 
to a combination of the treatment benefits and a learned effect. This would indicate 
that the benefit of these two effects, are greater than the specificities of the type of 




However, the other balance tests (forward lunge and sit-to-stand) did not have the 
same consistent reductions in body sway. Several of these measures even revealed 
increases, even though they were performed the same number of times as the single 
stance test. This could be because they are more complicated movements and 
require more complicated levels of coordination. Maintaining stability during 
movement requires less re-centring work than single leg balance, particularly 
because both lower limbs are involved in maintaining stability. There may therefore 
be less room for improvement in body sway within the designated testing times.  
The body sway measures used in this analysis were mainly derived from CoP using 
force plate analysis, which has been critical in the development of movement 
research (Adachi et al., 2012; Mancini & Horak, 2010; Raymakers et al., 2005; Rome 
et al., 2009; Wardoyo et al., 2016). A decrease in path length of body sway, should 
indicate less body sway and therefore improved balance. However, to improve 
balance, more recovery movements may be necessary, and a path length reduction 
would not necessarily represent this improvement. For these situations body sway 
velocity is a better indicator of this balance and control improvement (Ramdharry et 
al., 2006). Collecting both these variables is valuable and a reduction in both 
measures is ideal for balance improvement. Significant reductions in single stance 
path length together with velocity were only seen in the cumulative effect study with 
the massage treatment, despite having a similar reduction in path length to the 
mobilisation treatment. The difference in velocity and control of off-balance 
positions could therefore be an element in balance measures that helps to complete 
the story, where improvements can still be made.  
6.2.2 Body Weight Usage 
A reduction in percentage of body weight used in both movement tests for forward 
lunge and sit-to-stand would indicate an improved efficiency in these movements 
(Alkjær et al., 2009; Jonsson et al., 2004). Since all four outcome measures tested for 
these revealed an increase (fig 4.18 & fig. 5.15), it could be concluded that these 
movements did not improve in this respect, regardless of treatment or movement 
practice for one or for four sessions. This is supported by the increase in body sway 




for these movements. For these movements to improve, decreases in body sway 
measures and percentage of force used should go hand in hand to improve the 
element of control for these activities highly associated with daily life activities. This 
is also seen in the faster movements revealed for these tests with decreased contact 
time, associated with less controlled movement.   
People with MS and spinal lesions have even been clinically compared to people with 
a spinal cord injury based on their similarity of symptoms in muscle weakness and 
loss of sensation in lower extremities, spasticity and other symptoms affecting 
important aspects of gait (Giesser et al., 2007). This also coincides with the 
participants in this investigation and their most severe symptom categories within 
sensory and pyramidal types. Since improvements were seen in single stance tests 
but not the more dynamic movement tests, the margin for improvement may be 
smaller compared to the single stance, however also more likely to be mimicked in 
daily tasks and therefore an important area to focus on in terms of MS patient 
rehabilitation outcomes. 
6.2.3 Time Reductions 
The reduction in contact time measures for the forward lunge and sit-to-stand 
movements go hand in hand with the increases in body sway measures and relative 
force usage. Slower movement time of forward lunge and sit-to-stand have 
previously been used an indicator of movement deficiencies in disabled populations 
(Alkjær et al., 2009; Bowser et al., 2015). Although, within the context of these test 
situations, compared against their own previous movements and connected to the 
increase in body sway and force usage, this result appears to coincide with the faster 
less controlled movement. There may have been an element of this attributed to the 
testing situation and a desire to perform tests faster, leading to a loss of control. 
However, without testing session interviews or questionnaires to investigate this, the 
main conclusion derived must be that these movement tests did not improve. Further 
investigation into the relationship between these measures could be beneficial to 
target improvement for movement control. 
Whether changes in these measures occur from a centralised neural location directly 




there is potential for improvement in MS patient rehabilitation. Further targeted 
work to investigate more precisely how to improve these movements would be 
beneficial, as four sessions of manual treatment, regardless of the type of treatment, 
did not benefit this.    
6.3 Pain and Fatigue Measures 
6.3.1 Importance of Quality of Life Measures  
The self-reported measures for pain and fatigue were in fact the only variables that 
revealed a significant change in the intervention treatment compared to the massage 
treatment in the MS studies. This implies the mobilisation treatment may be more 
effective at reducing pain and fatigue compared to a general manual therapeutic. This 
could be from a placebo type effect giving participants a feeling of greater effect due 
to medicinal properties of the intervention rather than general manual touch. 
However, due to the small sample size and variability within results in both studies, 
these results could also still be due to chance.   
The pain results revealed a significant reduction in the intervention treatment 
compared to the massage treatment in study two with a 29% reduction between pre 
and post treatment, equivalent to approximately 0.5 reduction in VAS. This is in 
comparison to the massage treatment, revealing a non-significant reduction of 22%, 
and equivalent to 0.3 VAS reduction. However, when these reductions are compared 
to other spinal manual therapy studies investigating hypoalgesic effects, both are 
around a third of the clinically significant reduction in pain previously reported at 
approximately 1.5 VAS reduction, regardless of the severity of initial pain (Kelly, 2001; 
Shum et al., 2013). When compared to the study three results, neither treatments 
showed significant pain reductions, however both revealed reductions higher than 
50% of the initial value, again equating to approximately 0.5 VAS. Therefore, a 
significant reduction or high percentage reduction, may not be enough to be a 
clinically significant reduction. The proposed mechanical influences on pain reduction 
through altering afferent signalling previously discussed may occur but may require 
either participants with greater levels of pain to see a clinically significant difference 




The results for fatigue reduction were only investigated in study three and therefore 
cannot be compared to the other study results. However, in a similar manner to the 
results for pain in study two, the intervention treatment revealed a significant 
reduction with 35% decrease compared to the general treatment with a 15% 
decrease. As one of the symptoms that can be most disruptive for people in MS and 
can be affected by several other factors also linked to other symptoms, a clinically 
significant reduction in this area could have considerable impact for this population. 
If this reduction were also in synergy with pain and stiffness reductions, a centralised 
theory for mechanical modifications could be justified.  
A decrease in fatigue has also been found to have a significant correlation with 
increase in QoL because of the connection with mobility and daily activities (Backus 
et al., 2016). There is an unclear pathophysiology for fatigue in MS patients and likely 
to be individual differences for each person, both directly in a CNS affected manner 
and indirectly through other symptom effects. Primary fatigue can result as a direct 
consequence of nerve demyelination and disturbed cell signalling, requiring more 
energy compared to someone with a healthy nervous system (Hebert et al., 2011; 
Vucic et al., 2010). Indirect influence of fatigue relates to fatigue caused on a 
secondary level by symptoms such as reduced mobility, depression, anxiety, and 
sleep disorders, resulting in overall effects of general lifestyle (Hebert et al., 2011b). 
The lack of clarity on what causes fatigue, means that therapeutics to treat it are 
difficult, therefore future investigations on correlations and associations would be 
beneficial. The improvements in this measure may have an association with 
improvements in stability and body sway reductions. The way in which these aspects 
affect each other and could be affected by manual therapy is a potential area for 
further investigation.  
However as previously discussed, these self-perceived improvements were not 
supported by objective muscle measurements. Participants felt significantly better 
and this was an important aspect to measure as part of a full analysis. It has 
recognised an important area within this research to further investigate as the 
specificities of the intervention may induce a more meaningful result on QoL than 




their experience from the treatment and testing, proving another beneficial element 
for them taking part. Nevertheless, further investigation is needed within this 
intervention and population group for these results to positively complement each 
other.  
6.3.2 Other Objective Measures 
Other means of objectively measuring pain have been assessed with the use of PPTs, 
which measures pain threshold by applying pressure. This has been proven an 
effective measure of pain improvement in previous studies (Krouwel et al., 2010; 
Pecos-Martín et al., 2017; Thomson et al., 2009; Willett et al., 2010). This resource 
was not available for this investigation and could perhaps provide further information 
about the physiological element of pain experienced, taking out the psychological 
element, which could be driving the significance in results within this investigation.   
PPTs are often used to induce pain in participants who are not chronically ill or 
experiencing high levels of pain. Therefore, this measure could be used in MS studies 
with participants who do not experience a lot of pain, or in early/low disability levels 
of their condition. As this has generally been the case in this investigation, PPTs could 
be used for the investigation of analgesic effects of manual therapy. The investigation 
of mechanistic influence on central components connected to pain, stiffness, fatigue, 
and spasticity could be investigated in this manner with this population and within 
this context to explore these effects and help to provide evidence for this therapeutic 
benefit. This is beneficial for a condition and a population where health care and 
services may be limited because of the complexity of the condition.    
6.4 PhD Overall Results Summary   
The exploration in the pilot study revealed significant results that supported feasible 
use of the intervention for people with LBP when compared to a control and provided 
the intervention definitions. This included the significant finding of baseline stiffness 
as an influencing factor in level of stiffness change.  
The variability seen in the MS patient data were prevalent in the muscle data for both 
an immediate and cumulative effect study. The lack of immediate effect seen in the 
MS population could be its lack of effectiveness when compared to another manual 




Body sway measures improve significantly after four treatment sessions as well as 
self-perceived fatigue. People with MS without high levels of pain do not show a 
correlated reduction in stiffness and pain at a clinically significant level, though this 
relationship could be further investigated due to previous literature findings for this.  
The optimal level, dose or type of manual treatment that is most beneficial for these 
measures is still to be determined for the MS population and the management of 
their symptoms. It likely that any form of manual treatment has some benefits 
without being significantly different to each other.   
The development of MS physiotherapy research is growing but requires more 
investigation. Due to the heterogeneity of the MS condition and how it presents 
differently, an individual’s needs can be very diverse. They can respond in different 
ways and at different rates, supported by the level of variability seen in these study 
investigations. Further research into the objective impact of these therapeutics, can 
save time, money, and resources, as well as benefitting the patient more directly and 
effectively.   
6.5 Study Limitations   
As previously mentioned, the main limiting factor for this investigation was the 
restriction of time. It would have been beneficial to do a longer-term study with MS 
patients over more than four sessions and with more participants involved. However, 
decisions were made based on information knowledge at the time and the MS 
feasibility study allowed the MS study design to be improved.  
Both MS studies recruited 20 participants in each, however both required more from 
sample size calculations. Recruitment and testing were stopped at 20 participants in 
each study again due to timings, to enable analysis, new study design and writing to 
take place. MS patient recruitment was a slow process and if more successful within 
the designated time, a larger sample size may have produced improved results.    
Though the myometer provides results based on objective findings, there is an 
element of human error possible with the measurements taken. The exact location 




same location each time. However, the potential for human error means that there 
could be mild inconsistencies in this element.   
The lack of myometer data with MS participants meant that the pilot study data with 
LBP was used for sample size calculations and to inform the study design and 
feasibility. The lack of LBP within the MS population recruited then meant that these 
studies were comparing two different population groups. The variability within the 
MS population data meant that sample sizing was too small to elicit any significant 
results with a normal distribution within the data. This level of variability is likely to 
require a larger sample size to allow normal distribution and reliable results from this 
analysis.  
The therapist used between the two MS studies was different due to practicality 
issues, often a factor within human testing. Despite training on the intervention 
treatment specifics, inter-therapist differences may have still occurred which would 
create a challenge for comparison of study two and study three results.   
The general massage intervention was used as a comparable treatment, and ethically 
allowed participants to still receive treatment if they were attending the alternative 
treatment sessions. However, since this was not an actual placebo treatment, 
placebo effect on data results cannot be negated and some results may have 
occurred due to chance. 
The recruitment for MS participants and for many chronic conditions can be 
challenging due to the debilitating nature of their condition and the activity required 
for taking part in a research study. The participants who volunteered for the study, 
by nature tended to be people who are early in their condition and have lower levels 
of disability as seen in the EDSS results. People with a higher level of disability are 
more likely to show changes in these symptoms.  
6.6 Future Research Recommendations   
Several elements of the investigation would benefit from further research. Further 
research into body sway measures, with lifestyle questionnaires and whether their 
daily movements have improved would be valuable. This would not only help to 




to analyse whether confidence plays a significant role in these improvements. Further 
investigation into the clinically significant level of change for body sway, force usage 
and contact time for balance measures would be beneficial to define for MS patients, 
and how this may impact their daily movement function. The potential association 
between stability measures and fatigue and how these influence each other would 
be beneficial for rehabilitation research of many musculoskeletal conditions.  
Further investigation into the association between pain and stiffness could be done 
through objective forms of pain measurement. This could also be combined with 
analysis on baseline stiffness and help to determine predictors of response. Since this 
investigation did not find a significant difference between gender responses in MS 
data, this could be further investigated also to help determine whether physiological 
sex differences play a role in muscle response.  
Since four sessions resulted in an improvement on some elements of pain, fatigue 
and body sway, an investigation into the number of sessions and when this is most 
beneficial to muscle response would be valuable. Further investigation into different 
level of mobilisation forces used and different timings of the treatment used could 
contribute to this also and could help to establish a dose response. This could be 
variable for the patient depending on their needs. This would also help to analyse the 
potential benefit from specific types of manual intervention and when a slower, 
consistent mobilisation therapy is specifically more beneficial than a standard manual 
therapy with no specificities.   
The centre of any research involving physiotherapy and neurodegenerative disease 
should remain patient focussed, with a continual goal of improving experience of 
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DETAILS OF PROJECT 
 
1. Background information (300 words maximum; references should be cited and 
listed) 
Treatment of the spine can have significant impact on mobility of the whole body due to the 
mechanical, muscular and nerve influence (Bernitsas et al., 2015; Palastanga et al., 2006), 
particularly the lumbar spine showing a direct relationship between pain/stiffness and mobility 
(Shum et al., 2013). The main limiting factor for mobility in the lumbar region is muscular tension. 
There has been a strong association shown between neuromuscular impairment and spinal 
deformities, showing the connection between spinal muscular function and spinal mobility 
(Palastanga et al., 2006). Vertebral support from attaching muscles is also said to be important for 
prevention of spinal buckling during spinal loading, decreasing direct mechanical stress on the 
spine (Triano, 2001). 
Spinal mobilisation therapy (SMT) has shown to have an immediate effect on pain, stiffness and 
mobility, however the mechanisms for these changes have not been fully established (Shum et al., 
2013; Triano, 2001). The therapy consists of low velocity movements and can vary in the force, 
direction and point of contact with the spine (Triano, 2001). It can improve range of motion 
(ROM) within vertebral segments as well as the whole spine (Chiradejnant et al., 2003; Chou and 
Huffman, 2007). To address this gap of knowledge in biomechanical explanation, the study will 
investigate the effects of tissue stiffness in the erector spinae and lumbar multifidus muscles, 
expected to give results relevant for lumbar back mobility (Little et al., 2015). This will be tested 
on a general population who suffer with some level of lower back pain (LBP). LBP patients are 
commonly reported to have decreased spinal mobility due to pain and stiffness and previously 
shown to respond to SMT (Childs et al., 2001; Flynn et al., 2002; Shirley and Lee, 1993; Shum et 
al., 2013).  
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predication rule for classifying patients with low back pain who demonstrate short-term 
improvement with spinal manipulation. Spine, 27, 2835 – 2843.   
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Lewith, G. (2015). Alexander technique and Supervised Physiotherapy Exercises in back pain 
(ASPEN): A four-group randomised feasibility trial. Efficacy and Mechanism Evaluation, 1(2), 2050 




Palastanga, N, Field, D and Soames, R. (2006). Anatomy and human movement: structure and 
function, 4th Edition. Butterworth Heinemann.   
Triano, J. (2001). Biomechanics of spinal manipulative therapy. The Spine Journal, 1, 121 – 130.  
Shirley, D and Lee, M. (1993). A preliminary investigation of the relationship between lumbar 
postero-anterior mobility and low back pain. Journal of Manual and Manipulative Therapy, 1(1), 
22 - 25.  
Shum, G, Tsung, B and Lee, R. (2013). The immediate effect of posteroanterior mobilisation on 
reducing back pain and the stiffness of the lumbar spine. Archives of Physical Medicine and 
Rehabilitation, 94(4), 673 – 679.  
2. Aims & research questions 
- The proposed study has the intention of understanding better the biomechanical and 
physical effect of SMT by investigating the impact of SMT on spinal stiffness in LBP 
participants. The study will test the acute difference in spinal tissue stiffness.  
- Specifically to examine the acute difference in the muscular tone, dynamic stiffness 
and elasticity characteristics of erector spinae and lumbar multifidus muscle groups.  
- Investigation into category of pre-existing pain levels and anthropometric measures if 
any patterns arise in tissue stiffness differences.  
- Validation of the therapy will determine the potential use for further clinical 
populations such as Multiple Sclerosis (MS) patients.  
3. Participants  
• Number & nature of sample: Recommended number of participants for a 
repeated measures ANOVA is 44 participants. This shown by G-power with a 
large effect size (0.25) and power of 0.95. Based on an alpha level of 0.05 to 
compare 2 dependent group means. Therefore 44 participants with LBP will be 
recruited. 
• Inclusion/exclusion criteria: Inclusion criteria - participants suffering from lower 
back pain. This is defined as pain in the region between the 12th rib and the 
gluteal folds and can be present with or without leg pain. The study will include 
participants with either acute or chronic pain and can be pathological or non-
specific. Participants will be within the working age of 18 – 65. Exclusion criteria - 
participants on medication other than paracetamol. Participants responding 
positive to any absolute contraindications for spinal therapy. These include, 
fractures, dislocations, bone tumours, infectious diseases, osteomyelitis, 
segmental instability, cervical arterial dysfunctions, multilevel nerve root 
pathology, progressive neurological deficit, upper motor neuron lesions, spinal 
cord damage, or any skeletal condition. Participants responding positive to any 
relative contraindications will be excluded based on severity. These include the 
following conditions: osteoporosis, herniated disc, spinal instability, rheumatoid 
arthritis, pregnancy, local infection, inflammatory disease, active or history of 
cancer, hypermobility syndrome, connective disease, cervical anomalies, previous 
spinal surgery, respiratory problems, cardiovascular disease, open wounds, 
thrombosis, blood clot, segment hypermobility.  
• Recruitment of participants: Participants will be recruited via poster, social 
media and word of mouth. The poster and information sheet will be used 
electronically and in person when interest is shown to participate as a response 
from advertisement. When participants show interest in person the researcher will 
only cite information from the poster and explain the information sheet. No 
coercion will be added when speaking face to face and information will only be 
given after interest is shown. Questions regarding the study will be encouraged 




volunteering for the study. An invitation email has been attached to this application 
as an example email in response to participants who have shown interest in 
advertisement, or as recruitment within the University if approved to be sent to the 
staff population.    
4. Outline of methods & measurements (approx. 500 words) 
44 participants will be recruited and will be tested in both a control and manual therapy session 
over 2 different dates. The order of these sessions will be randomly assigned. Participants will be 
recruited from Edinburgh Napier University general population. All testing will take place in the 
afternoon to retain consistency in testing, at Edinburgh Napier University and temperature will be 
kept at room temperature (20°). A contraindications questionnaire will be completed by each 
participant to ensure participant safety in taking part. Anthropometric measures will be taken by 
the researcher for age, sex, weight, height and waist measurements. The Oswestry Low Back Pain 
Disability Questionnaire will be used to classify level of pain and disability for categorisation before 
testing (Fairbank, 2000; Krismer and Van Tulder, 2007). This will take approximately 20 minutes and 
allow for acclimatisation of the participant to the room temperature. The equipment will be set up 
by the researcher. The therapy session will consist of the therapy treatment and muscle stiffness 
testing before and after the treatment.      
All participants will be tested for spinal tissue stiffness before and after the treatment. Participants 
will lie in a prone position on a plinth and muscle stiffness measurements will be taken using a 
myometer digital palpation device (MyotonPRO, Myoton Ltd., London, UK). This is a handheld 
device held perpendicular to the muscle and collects measurements by calculating the response 
from small oscillations sent through the muscle (Andonian et al., 2015; Little et al., 2015; Viir et al., 
2006). Measurements will be taken on both sides of the spine on erector spinae muscles 
(longissimus) and lumbar multifidus, testing the lumbar extensor muscles. Measurements for 
oscillation frequency (Hz), dynamic stiffness (N/m) and the logarithmic detriment (elasticity) will be 
taken on muscles of either side of spine. This will take approximately 10 minutes pre and post 
treatment.  
The manual therapy will be conducted by a trained physiotherapist; Mr Chongsu Lee who is a 
chartered physiotherapist at Point One Clinic Ltd and will be working under his own liability policy. 
The physiotherapist will go through the contraindications questionnaire previously answered by the 
participant to ensure their safety. The physiotherapist will use palpation to determine an area of 
the spine where stiffness and tension is apparent. The treatment will then involve the mobilisation 
of 2 or 3 spinal joints for 30 minutes. The control experiment will involve no physical touch during 
the treatment. The participant will lie in a prone position and encouraged to relax for 30 minutes. 
Participants will be in the treatment room no longer than 2 hours for each session.    
References 
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Viir, R., Laiho, K., Kramarenko, J. and Mikkelsson, M. (2006). Repeatability of trapezius muscle 
tone assessment by a myometric method. Journal of Mechanics in Medicine and Biology, 6(2).  
5. Risks to participants 
Screening interview and Oswestry questionnaire - Emotional risk due to questions regarding 
conditions, pain levels and disabilities. Interview and questionnaire will be conducted in sensitive 
manner and not rushed. If the participant becomes emotional at any point during the session, the 
researcher and the physiotherapist will manage the situation sensitively. The participant will be 
encouraged to take their time when answering questions and are not required to answer 
questions felt too uncomfortable to answer. Participants will be made aware they are able to 
withdraw from the study at any point with no need for a reason. If the participant choses to 
withdraw from the study they will be encouraged to rest before leaving the study.  
Anthropometric measures - emotional risk due to measurements of a sensitive nature such as age 
and weight. Measurements will be taken in confidentiality.  
Lower back muscle stiffness testing - risk of discomfort in prone position. Participants can use a 
bolster under ankles for comfort and will be asked regarding comfort regularly.  
Spinal mobilisation therapy - risk of pain or discomfort during therapy. Physiotherapist use of 
patient feedback if any pain or discomfort felt during manual therapy. The physiotherapist is not 
present during the control treatment. The researcher will be available for assistance if discomfort 
felt during measurement collecting or treatment. Relaxation will be encouraged and Edinburgh 
Napier security staff who are first aid trained are reachable if required.  
6. Consent and participant information arrangements, debriefing 
Participants will be sent an information sheet in advance via email to read before attending 
investigation session. The protocol will be explained again in person and consent form given for 
participant to complete at their will. Once experiment is complete, a debrief sheet will be given to 
participant with further information and contact details regarding the project, as well as stating 
thanks for taking part.   
7. Ethical considerations raised by the project and how you intend to deal with 
them. 
Participants do not need to answer questions they are not comfortable with answering. Answers 
for Oswestry Low Back Pain Disability Questionnaire will be answered in written form and not 
spoken in person. If uncomfortable during the therapy researcher will be present to make any 
necessary adjustments.  
Participants recruited will be suffering from acute or chronic LBP, however will be recruited from a 
general population that continue with their typical routine and not severely affected. Participants 
will also adhere to the inclusion/exclusion criteria to eliminate any pathological danger from the 
spinal therapy.  
 
DECLARATION 
There is an obligation on the researcher to bring to the attention of the Faculty Research Ethics Approval Sub-Group any 
issues with ethical implications not clearly covered by this application form. 
 
I request ethical and governance approval for the research described in this application. I have 




research, and those of relevant professional bodies (e.g. BPS, BSA, IFPA, SIR, NMC) and agree to 
abide by these. 
 
A ☐ I consider that this project has no significant ethical implications to be brought to 
the attention of the Faculty Research Ethics Approval Sub-Group 
B ☒ I consider that this project may have significant ethical implications to be brought to 
the attention of the Faculty Research Ethics Approval Sub-Group 
 
Signature      Date 
 
 
I am the Director of Studies or supervisor for this research.  I have read this application and 
approve it.  I do not consider that any part of the research process will cause physical and/or 




Signature      Date 
 
 
• You must also attach Participant Information Sheet(s), Consent Form(s), as well as 
copies of any questionnaires, details of interview questions you plan to use, 
debrief sheets and notices advertising the study. You may need to create different 
versions of these materials (e.g. parental Participant Information Sheet and 
Consent Form if research involves children); if so, all the different versions should 
be attached. Materials should be printed on paper headed with the University logo. 
• If you will be recruiting participants via an outside organisation and/or will be 
conducting research on the premises of an outside organisation, you must 
provide a copy of written permission from the appropriate organisation(s). 
• Submit the completed and signed form (with supporting materials) to  
 an electronic 





Appendix  2 Study One Poster Advertisement  
  
 
PhD Study requires volunteers for: 
Impact of Spinal Mobilisation 
Therapy on Lower Back Pain 
 
Participants must be:  
• Aged within 18-80 
• Suffering from acute or chronic lower back pain 
• Taking no anti-inflammatory medication  
 
Participants will be required to take part in two testing sessions 
consisting of spinal mobilisation therapy and spinal muscular stiffness 
testing. This will take place at the Edinburgh Napier University Sighthill 
Campus.  
For more information regarding this study please contact Rebecca 





Appendix  3 Study One Exclusion Criteria Questionnaire   
Have you had a previous injury?       Yes/No 
If so what Injury? ________________________________________________________________ 
Do you have a current injury?       Yes/No 
If so what injury? ________________________________________________________________ 
Is your back pain related to a pathological condition?     Yes/No 
If so what condition? _____________________________________________________________ 
Are you on any medication?        Yes/No 
If so what medication? ___________________________________________________________ 
Are you currently pregnant?        Yes/No 
If so how long? __________________________________________________________________ 
Have you ever had any of the following? (Relative contraindications) 
Osteoporosis   
Herniated disc/spinal instability   
Rheumatoid arthritis   
Inflammatory disease  
Active or history of cancer  
Hypermobile syndrome/segment hypermobility  
Cardiovascular disease  
Connective tissue disease  
Cervical anomalies/Nerve root disorder  
Spinal surgery  
Respiratory problems  
Thrombosis  
Open wounds/local infection   
Fractures/dislocations   
 
If so please give details. 
 
Have you ever had any of the following? (Absolute contraindications)  
Segment instability  




Osteomyelitis   
Bone tumour  
Neurological deficit  
Upper motor neuron lesion  
Spinal cord damage   
Cervical arterial dysfunction  
 





Appendix  4 Study One Information Sheet 
Participant Information Sheet 
My name is Rebecca Hamilton and I am a research student from the School of Life, 
Sport and Social Sciences at Edinburgh Napier University.  As part of my degree 
course, I am undertaking a study for my PhD project.  The title of this study is: “The 
impact of spinal mobilisation therapy on sufferers of lower back pain”.  
This study will investigate the effect of spinal mobilisation therapy on lower back 
muscle stiffness. The difference in muscle stiffness will be tested before and after 
therapy session. I am looking for volunteers to take participate in the project. To be 
eligible you must be between the ages of 18 and 70 and a sufferer of lower back 
pain. You must not be on any anti-inflammatory pain medication. You must not 
respond positively to any of the absolute contraindications listed in Appendix A and 
any relative contraindications must be discussed.  
If you chose to take part you will attend 2 sessions lasting 45 minutes, one spinal 
therapy session and the other a control session. Anthropometric measures for age, 
weight, sex, height, and waist measurements will be taken. You will work through a 
lower back pain questionnaire to categorise your level of pain. Muscle stiffness 
measurements will be taken before receiving a 30-minute spinal therapy session, or 
a 30-minute control session. After which muscle stiffness measurements will be taken 
again. There is a risk that you will feel uncomfortable during the therapy. However you 
will be able to feedback to myself and the physiotherapist to modify anything 
uncomfortable. You will be free to withdraw from the study at any stage. You will not 
have to give a reason, and it will not affect your treatment.  
All data will be anonymised. Names will be replaced with a participant number or a 
pseudonym, and it will not be possible for your personal data to be identified in any 
reporting’s of the study. Any data collected will be kept in a secure place to which only 
the researcher has access. Personal data will be kept until the end of this study in 
October 2016 and will then be deleted. Summary data will then be used in the study 
and may be published in relevant journals.   
The findings of this project will be useful to a population with lower back pain in their 
pursuit of a therapeutic. The intention is to investigate the difference in spinal tissue 
stiffness and relate to improved quality of life and whole body mobility.  
If you would like to contact an academic supervisor of this project, you are welcome 
to contact Dr Susan Brown or Dr Claire Garden, whose contact details are below. If 
you would like to contact an independent person, who knows about this project but is 
not involved in it, you are welcome to contact Dr Anna Campbell. Her contact details 
are also given below. 
If you have read and understood this information sheet, asked any questions, and 








Contact details of researcher 
Name of researcher: Rebecca Hamilton 
Address:  
 
Email / Telephone:  
Contact details of supervisors 








Contact details of the independent adviser 





Contraindications   
Relative Contraindications Absolute Contraindications  
Osteoporosis Bone tumour 
Herniated disc Infectious disease 
Signs of spinal instability  Osteomyelitis  
Rheumatoid arthritis  Segmental instability  
Pregnancy  Healing fractures/dislocations  
Local infection Cervical arterial dysfunction 
Inflammatory disease Multilevel nerve root pathology 
Active or history of cancer Progressive neurological deficit  
Hypermobility syndrome  Upper motor neuron lesions 
Connective disease Spinal cord damage 
Cervical anomalies   




Respiratory problems   
Cardiovascular disease   
Open wounds   
Thrombosis   
Blood clot   






Appendix  5 Study One Consent Form 
 
Participant Consent Form 
“The impact of spinal mobilisation therapy on sufferers of lower back pain” 
I have read and understood the information sheet and this consent form.  I have had 
an opportunity to ask questions about my participation. 
I understand that I am under no obligation to take part in this study. 
I understand that I have the right to withdraw from this study at any stage without 
giving any reason. 
 
I agree to participate in this study. 
Name of participant:  _____________________________________ 
Signature of participant: _____________________________________ 
Signature of researcher: _____________________________________ 
Date:    _________________ 
 
Contact details of the researcher 
Name of researcher: Rebecca Hamilton 
Address:  
    





Appendix  6 Study One Oswestry Low Back Pain Disability Questionnaire 
Scoring instructions 
For each section the total possible score is 5: if the first statement is marked the section 
score = 0; if the last statement is marked, it = 5. If all 10 sections are completed the score is 
calculated as follows: 
Example: 16 (total scored) 
50 (total possible score) x 100 = 32% 
If one section is missed or not applicable the score is calculated: 
            16 (total scored) 
45 (total possible score) x 100 = 35.5% 
Minimum detectable change (90% confidence): 10% points (change of less than this may 
be attributable to error in the measurement).  
Interpretation of scores 
0% to 20%: minimal 
disability: 
The patient can cope with most living activities. Usually no 




The patient experiences more pain and difficulty with 
sitting, lifting and standing. Travel and social life are more 
difficult and they may be disabled from work. Personal 
care, sexual activity and sleeping are not grossly affected 
and the patient can usually be managed by conservative 
means. 
41%-60%: severe disability: Pain remains the main problem in this group but 
activities of daily living are affected. These patients 
require a detailed investigation. 
61%-80%: crippled: Back pain impinges on all aspects of the patient's 
life. Positive intervention is required. 
81%-100%: These patients are either bed-bound or exaggerating their 
symptoms. 
Instructions 
This questionnaire has been designed to give us information as to how your back or 
leg pain is affecting your ability to manage in everyday life. Please answer by 
checking ONE box in each section for the statement which best applies to you. We 
realise you may consider that two or more statements in any one section apply but 
please just shade out the spot that indicates the statement which most clearly 



















Participant Number: __________________ _Date of birth: ___________________ 
Sex:   Male/Female  Height (cm): __________________ 
Weight (Kg):  __________________ _Waist (cm): ___________________ 
 
ODI Scoring Results 
                              
Total Score   =  
Total Possible Score  =  
Final Percentage  = total score/total possible score *(100) 






Appendix  8 Study One Debrief Sheet 
 
Debrief Sheet 
Many thanks for your participation in the project. The aim of this project is to provide 
useful information with regards to spinal therapy and lower back pain.  
If you have any initial feedback from the therapy please feel free to pass it onto to the 
researcher. If you wish to know more about the project please feel free to ask any 
questions. The contact details of the researcher are provided below if you should wish 
to give feedback or ask any questions.  
 
Contact details of the researcher 
Name of researcher: Rebecca Hamilton 
Address:  
 






Appendix  9 Study Two Approved Ethics Application 
Project title: The immediate effect of spinal therapy in multiple 
sclerosis. 
Version no: 2 
Full name & title: Miss Rebecca Isabel Hamilton  School: School of Applied Sciences 
E-mail address:  Telephone:  
Postal address:   
 
Status:Staff (Edinburgh Napier University)☐Student (Edinburgh Napier University☐ 
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Research Scotland, Point One Clinic 
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text. 
 
YOU MUST ANSWER ALL QUESTIONS YES NO N/A 
1 
Will you describe the main procedures to participants in 
advance, so that they are informed about what to expect in your 
study? 
☒ ☐ ☐ 
2 Will you tell participants that their participation is voluntary? ☒ ☐ ☐ 
3 
Will your participants be able to read and understand the 
participant information sheet? 
☒ ☐ ☐ 
4 Will you obtain written consent for participation? ☒ ☐ ☐ 
5 
If the research is observational (including tape and video), will 
you ask participants for their consent to being observed? ☐ ☐ ☒ 
6 
Will you tell participants that they may withdraw from the 
research without penalty and without reason? 
☒ ☐ ☐ 
7 
With questionnaires and interviews, will you give participants the 





Will you tell participants that their data will be treated with full 
confidentiality and that, if published, it will not be identifiable as 
theirs? 
☒ ☐ ☐ 
9 
Are the data to be stored anonymously (i.e. the identity of the 
person is NOT linked directly or indirectly with their data)? 
☒ ☐ ☐ 
10 
Will you debrief participants at the end of their participation (i.e. 
give them a brief explanation of the study and an opportunity to 
ask questions)? 
☒ ☐ ☐ 
11 
Will the research involve deliberately misleading participants 
(deception) in any way?  
☐ ☒ ☐ 
12 
Is there any realistic risk of any participants experiencing either 
physical or psychological distress or discomfort?   
☒ ☐ ☐ 
13 
Is the information gathered from participants of a sensitive or 
contentious nature?  
☒ ☐ ☐ 
14 
Will any payment or reward be made to participants, beyond 
reimbursement or out-of-pocket expenses? 
☐ ☒ ☐ 
15 
Do participants fall into any of the following special groups? If 
the answer is YES, indicate which group(s) by checking the 
appropriate box(es). 
☒ ☐ ☐ 
 ☐ Children (under 18 years)  
☒ Clinical population  
☐ People with mental health 
issues 
☐ People in custody 
☐ People with learning or communication difficulties  
☐ People engaged in illegal activities (e.g. drug-
taking) 
NOTE: You may also need to obtain clearance from Disclosure Scotland or an 
equivalent authority. 
 
You must check either Box A or Box B below and provide all relevant information in 
support of your application in the Details of Project section. If you answered NO to any of 
questions 1-10, or YES to any of questions 11-15 (with a shaded background), then you 
must check Box B. 
DETAILS OF PROJECT 
 
8. Background information (references should be cited and listed) 
The management of individualised symptoms occurring within multiple sclerosis (MS) is a key 
element for management of the condition (Khan et al., 2007). Nerve signal disruption results in a 
wide variation of potential symptoms, mobility often being a main issue (Vollmer et al., 2002). It 
can be difficult for patients and health professionals to identify the most efficient rehabilitation 
programme to help manage their symptoms. Rehabilitation programmes often need regular re-
evaluation, and longer time to have an effect (Demaree et al., 1999; Dimitrov and Turner, 2014). 
Bernistas et al. (2015) showed a correlation between the atrophy of the spine and disability with 




symptomatic status (Kurtzke, 1983). The effects of MS on the lower extremities and core 
strength/balance are often related to spinal cord atrophy and could therefore also be affected by 
spinal treatment.  
Manual therapy (MT) over the spine has previously shown to have a positive effect on pain, 
stiffness and mobility without full understanding as to why (Chiradejnant et al., 2003; George et 
al., 2006). Measuring the effects of a therapeutic programme is often done with clinical outcomes 
using disability scales and pain scales, most of which are either subjective or secondary 
measurements. The interpretation of these results are then often dependent on many factors out 
of control of the researcher (Langdon and Thompson, 1999). Para-spinal muscles are said to 
contribute to spinal stability, functionality and prevention of buckling of the spine (Triano, 2001). 
By alleviating pain and stiffness in spinal tissue over time, improved para-spinal muscle usage can 
enhance neuromuscular associations in the long-term.  
 
Spinal mobilisations is an MT technique introduced into physiotherapy in the 1960s by Geoffery 
Maitland. This method, still used today, is particularly common for the treatment of back pain 
(Piekarz and Perry, 2016; Maitland et al., 2014). Often tested in sessions for under 7 minutes, at a 
rate of 2-3 Hz, it describes a low velocity and high amplitude therapy with oscillatory manual 
contact (Perry and Green, 2008; Shum et al., 2013). Whereas manipulation therapy applies thrusts 
with high velocity, mobilisations work by separating facet joints, and stretching the para-spinal 
muscles (Maigne and Vautravers, 2003; Lee and Evans, 2000). The spine experiences movement 
by rotation of pelvis and thoracic cage, compression of skin and tissues, and movement of spinal 
joints (Chansirinukor et al., 2003; Shum et al., 2013).  
Spinal mobilisation therapy has been used within Point One Clinic at a slower rate for a longer 
period of time with positive feedback from MS patients. This provided a rationale for a 
biomechanical analysis on the intervention to scientifically investigate its effect on this people 
group. Specifically, the study will provide information on para-spinal stiffness with the use of a 
myometer, Myoton Pro. This has not been investigated with an MS population before, however 
has been tested with similar chronic conditions such as Parkinson’s disease and stroke (Marusiak 
et al., 2012; Chuang et al., 2012). The information for para-spinal stiffness, elasticity and tone data 
will contribute to bridging the gap between neurophysiological response and mobility outcome 
measures. These are said to be key elements of the biomechanical make-up and functionality of 
muscles (Schneider et al., 2015). The Myoton Pro is a handheld, non-invasive device and has 
previously been validated and given reliable results for investigation into stiffness, elasticity and 
tone of soft tissue (Pruyn et al., 2015; Schneider et al., 2015). The biomechanical information 
based on para-spinal soft tissue and walking gait that can be gathered in this study will provide an 
objective contribution to understand spinal therapy and rehabilitation. This will then facilitate 
improved therapeutics for the MS sufferer. 
The study will also test functional stability in single leg stance and lunge using measurements for 
centre of pressure and body sway. This analysis is often used in clinical testing and will help 
analyse the potential effect on lower extremity stability (Ramdharry et al., 2006). Tests for pain in 
basic lumbar movements will be used, which is common practice in lower back therapy (Goodsell 
et al., 2000; Shum et al., 2013). Though this is not an objective measurement it is often referred to 
as a useful measure for effect in lower back therapy and produced many results in promoting an 
analgesic effect. The mobilisation intervention has been previously tested with a positive 
immediate effect on para-spinal stiffness with lower back pain participants and therefore has 
potential to show similar results with an MS population. 
This study proposes an investigation as a feasibility study, to assess the protocol of testing manual 
therapy over the spine with MS patients, and gather data to analyse the results as an immediate 
effect. The information gathered in this study will be used to design a study for a long-term 




definition for a clinical trial describes an investigation looking to enable health care decisions 
about the safety and efficacy of a new treatment, and adding to medical knowledge. Since a 
feasibility study is not providing knowledge for the final outcome, but rather information to assess 
the protocol, it will not be tested as a clinical trial. This is said to be crucial for efficient study 
design management of a clinical randomised controlled trial (Rajadhyaksha, 2010; Tickel-Degnen, 
2013) It is therefore clinical research but not governed by the same regulations as medical trials.     
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9. Aims & research questions 
The aim of this study is to investigate the immediate effect of a particular model of a spinal 
mobilisation intervention, with an MS population group. The effect will be tested on para-spinal 
stiffness, levels of lumbar pain and ground reaction forces in stability. The intervention will be 
tested against a placebo therapy to test the differences that are occurring are due to specific 
techniques within mobilisation therapy. The intention of this study is to act as a feasibility study 
for an investigation with MS patients and a long term spinal mobilisation intervention.   
Does the intervention have an immediate effect on para-spinal stiffness? 
Does the intervention have an immediate effect on pain during lumbar movements? 
Does the intervention have an immediate effect on functional stability? 
10. Participants  
• Number & nature of sample: Recommended number of participants for repeated 
measures, within factors ANOVA is 24. This is shown in G-power with a large 
effect size (0.25), a power of 0.95 and significance level of 0.05. This is an 
appropriate number of participants for a feasibility study (Julious, 2005) and 




• Inclusion/exclusion criteria: Inclusion criteria; must be female, must have an 
MS diagnosis, must be diagnosed within the range of 2 and 6 in the Expanded 
Disability Status Scale (EDSS) which ranges from minimal disability within the 
disease up until requiring a simple walking aid for mobility (Kurtzke, 1983), must 
be within the ages of 18-70, must be able to stand on one leg for approximately 3 
seconds. Exclusion criteria; must not be connected with Point One Clinic, must not 
respond positive to spinal therapy absolute contraindications which include bone 
tumour, inflammatory/infectious/metabolic disease affecting the spine, dysplasia, 
healing fractures/dislocations, spinal cord damage, cauda equine syndrome, aortic 
dysfunction and severe haemophilia. Participants responding positive to any 
relative contraindications will be excluded based on severity, these include spinal 
disc prolapse, spondylosis, spondylolisthesis, inflammatory arthritides, 
osteoporosis, hypermobile syndrome, pregnancy, cancer, cardiovascular disease, 
respiratory disease, healing injury and adverse reaction to previous spinal 
treatment (Maitland et al., 2014). The physiotherapist will not be able to comment 
on safety of participant’s involvement due to the conflict of interest. Therefore, 
participants responding positive to any relative contraindications will be asked to 
request permission from their GP whether it is safe for them to take part. The 
physiotherapist will be made aware of any relative contraindications before 
treatment. All treatments will be gentle and low grade.    
• Recruitment of participants, including details of formal permissions from 
another organisation (where appropriate): Participants will be recruited via 
poster, social media (Facebook, Twitter and Instagram) and word of mouth. 
Physiotherapy and health centres will be contacted by email or in person to ask if 
there is interest in the study to put up a poster advertisement. Requests have 
been made to advertise within charities for MS. Once ethical approval has been 
acquired, further enquiries into charity and private based health and therapy 
centres will be made, either over the phone, email or in person. The poster and 
information sheet will be used electronically and in person when interest is shown 
to participate as a response from advertisement. When interest is shown in person 
the researcher will only cite information from the poster and explain the 
information sheet. No coercion will be added when speaking face to face. 
Questions regarding the study will be encouraged and participants will be 
encouraged to read through the information sheet before volunteering for the 
study. 
• Details of any relationship with participants which may affect the research: If 
the participant is known by the researcher the results for VAS pain scale could be 
biased due to pressure of success in the study. However honest answers for VAS 
scale will be encouraged and data for ground reaction forces (GRF) and para-
spinal stiffness cannot be biased as they will be generated by mechanical 
equipment. 
11. Outline of methods & measurements  
24 female participants will be recruited to take part in this study. Due to the results from a 
previous study showing significant male and female differences (Owens et al., 2007) and previous 
research showing the need for gender specific interventions (Kehoe et al., 2015). The male to 
female ratio of MS prevalence is approximately 1:2.4 in the UK (Mackenzie et al., 2013); therefore 
female participants were chosen so that the study is gender specific and relevant to current MS 
prevalence.  
After a participant has shown interest in the study and agreed to take part, a link to the Novi 
Survey created will be sent to collect information about their MS condition and any contra-
indications they may positively respond to. They will be given a participant number in order to 




this information. If the participant does not meet the inclusion criteria they will be informed they 
are unable to participate. If the participant responds positively to one of the relative contra-
indications, they will be informed that they require written permission from their GP and sent the 
GP information sheet for this. If all inclusion criteria are met, the researcher will then randomly 
allocate the participant to a group and organise suitable times for their sessions.  
Participants will be tested on two separate occasions, once during a placebo therapy and once 
during spinal mobilisation intervention. Participants will be blind as to which therapy they are 
receiving. The participants will be randomly allocated to group A or group B by a random group 
generator on excel. Group A will take part in the placebo therapy first and then the intervention 
therapy and vice versa. Taxi arrangements will be made by the researcher to pick up and drop off 
the participant for the testing. All testing will take place at the Edinburgh Napier University 
Sighthill campus and temperature will be kept at room temperature (20-25°C).  
Participants will have the opportunity to read through the information sheet again and the 
researcher will run through the order of events. Participants will be invited to ask any questions 
about the study before consent forms are given. Once the participant has given written consent, 
anthropometric measures will be taken by the researcher for age, weight and height. The results 
from their Novi questionnaire will be reviewed in person to go through their MS information and 
any contraindications. Participants will complete a visual analogue scale (VAS) for lumbar 
movements for flexion, extension, lateral flexion and rotation rating their pain during these 
movements on a scale of 0 – 10. Force plates will be used in single leg stance tests and single leg 
lunge tests for each side. Para-spinal stiffness testing will be done with participants lying in a 
prone position on a plinth using a myometer digital palpation device (MyotonPRO, Myoton Ltd., 
London, UK). This is a handheld device held perpendicular to the muscle and collects 
measurements by calculating the response from small oscillations sent through the muscle 
(Andonian et al., 2015; Viir et al., 2006). Measurements will be taken on both sides of the spine on 
erector spinae muscles (longissimus). Measurements for oscillation frequency (Hz), dynamic 
stiffness (N/m) and the logarithmic detriment (elasticity) will be taken both sides of the spine. The 
side that results in a higher stiffness value will be the side receiving therapy. 
The chartered physiotherapist working under their own liability will then perform a 30 minute 
therapy session of either spinal mobilisations or a placebo therapy. Mobilisation therapy will 
consist of oscillatory movement over L1-L5 region of the spine, at a rate less than 1Hz and grade 
less than 1. During this therapy the physiotherapist’s manual contact is constant and is not lifted 
from the participant’s spine. This is a very gentle therapy with less force being felt than sitting on 
a massage chair. The placebo therapy will consist of a light massage over the L1-L5 region, where 
manual contact, rate and force is not constant. This is similar to placebo therapy from previous 
studies also testing mobilisations (Perry and Green, 2008; Haas et al., 2014). The plinth will be 
mounted over the force plates to quantify and compare the forces applied in both therapies.  
Once therapy is complete participants will then be tested again for para-spinal stiffness, balance 
tests on the force plates and VAS scale for lumbar movements. Once both testing sessions have 
been completed, participants will be thanked for their contribution and given a debrief sheet with 
contact details and information regarding the study to give to their GP or carer if they wish.  
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12. Risks to participants’ and researcher’s safety & wellbeing 
Anthropometric measures – emotional risk to participant regarding condition, disabilities, age and 
weight. The MS questions and measurements will be conducted in a sensitive manner and not 
rushed. If the participant becomes emotional at any point during the session, the researcher will 
manage the situation sensitively. The participant will be encouraged to take their time when 
answering questions and are not required to answer questions they do not feel comfortable to 
answer. 
VAS pain scale testing – physical risk from lumbar movements and emotional risk in description of 
pain. Participant will be encouraged to only move within their capabilities and the researcher will 
be present to assist them if needed. Participant will be encouraged to rest when they feel is 
necessary or when feeling tired.  
GRF testing – physical risk from single leg balance tests. Participant will be encouraged to only 
move within their capabilities and the researcher will be present to assist them if needed. 
Participant will be encouraged to rest when they feel is necessary or when feeling tired.  
Para-spinal stiffness testing - risk of discomfort in prone position. Participants can use a bolster 
under ankles for comfort and will be asked regarding comfort regularly.  
Spinal mobilisation/placebo therapy - risk of pain or discomfort during therapy. Physiotherapist 
use of patient feedback if any pain or discomfort felt during manual therapy. The researcher will 
be available for assistance if discomfort felt during measurement collecting or treatment. 
Relaxation will be encouraged and Edinburgh Napier security staff who are first aid trained are 
reachable if required.   
13. Consent and participant information arrangements, debriefing, withdrawal from 
the study 
Participants will be sent an information sheet and contraindications questionnaire in advance via 




consent form given for participant to complete at their will. Once experiment is complete, a 
debrief sheet will be given to participant with further information and contact details regarding 
the project, as well as stating thanks for taking part.  
Participants will be made aware that they are able to withdraw from the study at any time with no 
need for a reason. If the participant choses to withdraw from the study they will be encouraged to 
rest before leaving the study. Their data will be deleted and an extra participant will be attempted 
to be recruited.  
14. Anonymity and confidentiality  
All data collected and information given will be done so in confidentiality with the researcher, 
which will be made clear to the participant. The physiotherapist will only be present during the 
therapy session and not present in the collection of any data. Participant names will be replaced 
with number in collective data and not identifiable to them personally.    
15. Data protection arrangements 
All data collected during testing will be inputted to an excel spread-sheet with the participant's 
name replaced by a random number and will therefore be unidentifiable. The contact details and 
code for participant numbers will be stored on separate file. This will be kept on the V:drive of a 
University password protected computer which only the researcher has access and anti-virus 
software will be kept up to date. This will be backed up regularly to an external hard drive that is 
stored in a locker with a lock and key, which only the researcher has access to. The medical data 
collected will be kept in the Novi software which is also password protected and unidentifiable. 
The computer will be locked when the researcher is away from the desk and anti-virus software 
will be kept up to date.  Any reports or publication for the study will not disclose identifiable 
information of the participants and will only use summary data.  
16. Ethical considerations raised by the project and how you intend to deal with 
them 
Participants do not need to answer questions they are not comfortable with answering and 
do not need to continue with any form of testing they are not comfortable with. The will be 
encouraged to take their time in the testing and made aware they can withdraw from the 
study without any need to give a reason. Participants will adhere to the inclusion/exclusion 
criteria to eliminate any pathological danger from either spinal therapies. If they do not 
respond to positively to any contraindications, GP permission is not required as MS 
patients will often self-refer to therapeutics beneficial for symptomatic based treatment. 
Participants will be allowed a friend/family/carer to accompany them for ease and to make 
them more comfortable.  
 
DECLARATION 
There is an obligation on the researcher to bring to the attention of the School Research Integrity Committee any issues 
with ethical implications not clearly covered by this application form. 
 
I request ethical and governance approval for the research described in this application. I have 
read Edinburgh Napier University’s policies and guidelines relating to ethics and governance in 
research, and those of relevant professional bodies (e.g. BPS, BSA, IFPA, SIR, NMC) and agree to 





A ☐ I consider that this project has minor/no significant ethical implications to be 
brought to the attention of the School Research Integrity Committee 
B ☒ I consider that this project may have significant ethical implications to be brought to 
the attention of the School Research Integrity Committee 
 
Signature      Date 
 
 
I am the Director of Studies or supervisor for this research.  I have read this application and 
approve it.  I do not consider that any part of the research process will cause physical and/or 




Signature      Date 
 
 
• You must also attach the following documentation, where appropriate (please tick 
to confirm or provide information as to why the materials are not available): 
Research materials (questionnaire, 
interview schedule, experimental stimuli, 
etc.) 
 
Recruitment materials (poster, leaflet, 
social media message, covering letter, 
etc.) 
 
Participant information sheet  
Consent form  
Debrief sheet  




• You may need to create different versions of these materials (e.g. parental 
Participant Information Sheet and Consent Form if research involves children); if 
so, all the different versions should be attached. Materials should be printed on 
paper headed with the University logo. 
• Submit the completed and signed form (with supporting materials) to  
; an 





Appendix  10 Study Two Poster Advertisement 
           
 
PhD Study requires volunteers for: 
The Immediate effect of Spinal Therapy 
with Multiple Sclerosis Patients 
 
Participants must be:  
• Female 
• Diagnosed with MS 
• Aged within 18-80 
• Ability to walk independently  
 
Participants will be required to take part in two testing sessions consisting of spinal 
manual therapy and lower back muscle quality, stability and movement tests. This 
will take place at the Edinburgh Napier University Sighthill Campus.  
For more information regarding this study please contact Rebecca 























Appendix  12 Study Two Information Sheet 
Participant Information Sheet 
Study Title: The immediate effect of spinal therapy in multiple sclerosis.   
Study Summary 
My name is Rebecca Hamilton and I am a PhD researcher from Edinburgh Napier 
University. I am carrying out a study that will test the immediate effect of manual 
therapy over the spine on multiple sclerosis patients. This is to collect information 
that will enable us to develop a study to investigate what happens in a long-term 
spinal therapy intervention. This study is funded by Medical Research Scotland and 
Point One Clinic; both interested in finding out more scientific information on spinal 
therapy in multiple sclerosis.  
Who can take part in the study? 
I am looking for 24 volunteers to take part. To be suitable you must be between the 
ages of 18 and 70, be female, you must have an MS diagnosis, you must have an 
EDSS rating less than 6, and you must be able to stand on one leg for 
approximately 3 seconds. If you are interested you should read through the contra-
indications listed in table A and B. If you have had any of the conditions listed in 
table A, you will not be able to take part in the study. If you have had any conditions 
listed in table B, you should ask permission from your GP in order to take part. I can 
provide you with a GP information sheet and you can use this information sheet, to 
answer any questions your GP has regarding your involvement in the study. Contact 
details are also provided below to answer any further questions. If you have a 
connection with Point One Clinic you will not be able to take part either due to a 
conflict of interest.   
What will the study involve?  
The study will look at the effects of two different spinal manual therapy techniques. I 
will test you in 3 areas before and after each of these therapies in order to 
investigate their immediate effect. These will be stiffness levels in your lower back 
muscles, pain during lower back movements and stability in single leg standing and 
lunging.   
If you chose to take part you will attend 2 sessions that suit your availability, lasting 
a maximum of 2 hours. In your first session I will gather basic information about your 
MS condition, and measurements for your weight, height and age. You will perform 
a single leg lunge on each side which will test stability, basic movements using your 
lower back muscles to test your levels of pain and the stiffness in your lower back 
muscles will be measured. You will then receive a 30-minute, low grade, spinal 
manual therapy. You will not know which technique you are receiving. This will be 
revealed to you at the end of both sessions. Once therapy is complete you will be 
tested in the same measurements again. There is a risk that you will feel 
uncomfortable during the therapy or testing. However, you will not be required to 
answer or perform any tests which you are not comfortable with and can give 
feedback to myself to modify anything uncomfortable. You will be free to withdraw 
from the study at any stage. You will not have to give a reason, and it will not affect 







By taking part in the study I cannot guarantee that it will help with the rehabilitation 
in your MS condition, however it will give you the opportunity to try 2 different types 
of spinal manual therapy and see if there is any immediate effect in your stiffness, 
pain and stability. Your contribution will also help with gathering knowledge about 
physiotherapy within MS and could benefit others in the wider MS community. 
Although I cannot provide you with any financial gift for participating, there will be 
taxi arrangements made to pick you up and drop you off in order to attend, unless 
you prefer your own method of transport. 
Possible Disadvantages  
There is always a possibility that you will be uncomfortable during the therapy, or 
during the testing. However, you do not need to continue with any part of these 
which you are not comfortable with and you can withdraw from the study at any 
time. The information collected from your testing will not be kept if you chose to 
withdraw from the study.  
Further Information  
All the information about yourself will not be identifiable to you as your name will be 
replaced with number. It will not be possible for anyone other than myself to identify 
your personal information during the study. This information will be kept in a safe 
place to which only I have access. Personal information will be kept until the end of 
this study in September 2017 and will then be destroyed. The combined information 
from all participants will then be used in the study report and may be published in 
relevant journals. The findings of this study will contribute to the research in 
rehabilitation within MS sufferers in finding a therapy that makes a difference in pain, 
stiffness and mobility.   
If you would like to contact an academic supervisor for this project, you are welcome 
to contact Dr Susan Brown or Dr Claire Garden, whose contact details are provided. 
If you would like to contact an independent person, who knows about this project but 
is not involved in it, you are welcome to contact Dr Geraldine Jones.  
If you have any other questions, please do not hesitate to contact me using the 
details for Rebecca Hamilton provided. 
Contact details of researcher 
Name of researcher: Rebecca Hamilton 
Address:  
 
Email / Telephone:  
Contact details of supervisors 











Contact details of the independent adviser 
Name of adviser: Dr Geraldine Jones 
Address:   
 
Email/Telephone:  
Table A. Absolute Contraindications 
Condition category  Further details, these include: 
Serious bone related condition Tumour (benign or malignant) 
 Infectious disease  (e.g. tuberculosis) 
 Metabolic (e.g. osteomalacia, softening of bones) 
 Birth defect (dysplasia) 
 Inflammatory (e.g. severe rheumatoid arthritis) 
 Traumatic (healing fractures/dislocations) 
Serious neurological condition 
(excluding MS) 
Spinal cord/spinal nerve compression  
 Spinal cord damage 
 Cauda Equina syndrome (spinal cord nerve swelling) 
Serious vascular condition (relating 
to blood vessels) 
Aortic dysfunction (e.g. aneurism/blood clot) 
 Severe haemophilia (causing bleeding into joints)  
 
Table B. Relative Contraindications  
Condition  Further details  
Spinal disc prolapse  Spinal disc herniation, tear in disc cartilage causes it to 
bulge out pressing on nerve  
Spondylosis Degeneration of spinal discs  
Spondylolisthesis Spinal instability/displacement of discs  





Osteoporosis Decreased bone strength, low level bone mass  
Hypermobile syndrome  Segment or joint hypermobility  
Pregnancy Current pregnancy, previous problematic pregnancy 
Abnormal cell growth Active or history of cancer 
Cardiovascular disease History of thrombosis or using blood clot prevention 
medication   
Respiratory disease Pneumonia, bronchitis, asthma  
Current healing injury Local infection, open wounds, fractures, dislocations 






Appendix  13 Study Two Consent Form 
Participant Consent Form 
Study Title: The immediate effect of spinal therapy in multiple sclerosis. 
Participant Identification number:  
         Please initial box 
 
1. I confirm that I have read and understood the information sheet for 
the study titled above. I have had the opportunity to consider the 
information, ask questions and had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time without needing to give any reason. I 
understand that the way in which I am treated throughout the study 
will not be affected if I chose to withdraw. 
 
3. I understand that the information collected about me will be used to 
support other research in the future, and may be shared 
anonymously with other researchers.   
 
4. I agree to take part in the above study.  
 
____________________ ____________________ ____________________ 
Name of participant  Date    Signature 
____________________ ____________________ ____________________ 
Name of researcher  Date    Signature 
 
Contact details of the researcher 
Name of researcher: Rebecca Hamilton 
Address:      
    










Appendix  14 Study Two Testing Sheet 
Participant number:    Participant Group:  
Anthropometrics  
Height (m) Weight (N)  Weight (Kg) BMI DOB Dominant 
side 
      
 
Erector spinae mark length (cm) Erector spinae mark width (cm) 
  
Session 1 date:  
Testing side: 




VAS score: post lumbar 
movements pre 
massage 
VAS score: post lumbar 
movements post 
massage 
ROM in lumbar 
movements post 
massage 















 left side right side  left side right side 
1   1   
2   2   
3   3   
Mean   Mean   
Session 2 date: 
Testing side:  




VAS score: post lumbar 
movements pre 
massage 
VAS score: post lumbar 
movements post 
massage 
ROM in lumbar 
movements post 
massage 


















 left side right side  left side right side 
1   1   
2   2   
3   3   















Appendix  16 Study Two and Three Intervention and General Massage Force Sample 
Graphs 
 
Figure 16. 1 Intervention force data recorded equates to mobilisations at threshold of 80N and 0.37Hz 
(22 beats per min on the metronome).  
 



































Appendix  17 Study Two Debrief Sheet 
 
Debrief Sheet 
I would like to thank you for your participation in this study. The aim of this study is to 
provide useful information with regards to spinal manual therapy and rehabilitation 
within MS. The different techniques of therapy you received were a mobilisation 
therapy which uses light passive oscillatory movements around the spine in a 
consistent motion, and a placebo which was a light grade massage with no consistent 
movements. The reasons for these 2 techniques is to scientifically investigate 
mobilisations over in the spine which requires testing against a placebo in similar 
condition but without the consistent movement.  
Your contribution in this study is greatly appreciated and assists in the further 
investigation of spinal therapy with multiple sclerosis patients. If you experience any 
adverse side effects or have any initial feedback please get back in touch or contact 
your GP. If you have any more questions regarding the study feel free to ask. Contact 
details for myself, academic supervisors and the independent advisor are provided 
below. 
Contact details of researcher 




Contact details of supervisors 
Supervisor:  Dr Susan Brown 
Address:  
 
Email/Telephone:   




Contact details of the independent adviser 








Appendix  18 Study Three Approved Ethics Application 
Project title: Investigating the effect of spinal therapy in people 
with Multiple Sclerosis. 
Version no: 2 
Full name & title: Miss Rebecca Isabel Hamilton  School: School of Applied Sciences 
E-mail address:  Telephone:  
Postal address:   
 
Status:Staff (Edinburgh Napier University)☐Student (Edinburgh Napier University☐ 
External Applicant ☐   Please provide additional details below: 
Other researchers (name, role & affiliation): 
Dr Susan Brown, Director of Studies, School of 
Applied Sciences, Edinburgh Napier University, 
Dr Claire Garden, Supervisor, School of Applied 
Sciences, Edinburgh Napier University 
Matriculation Number: 40100069 
Degree programme: Research Degree 
Level of study: MRes/MPhil/PhD 
Financial support from outside Edinburgh Napier University (amount & source): Medical 
Research Scotland, Point One Clinic 
Project start date: 24/09/2018 Project duration: 6 months 
Date application submitted: 07/09/2018 Ref no. (LEAVE BLANK): Click here to enter 
text. 
 
YOU MUST ANSWER ALL QUESTIONS YES NO N/A 
1 
Will you describe the main procedures to participants in 
advance, so that they are informed about what to expect in your 
study? 
☒ ☐ ☐ 
2 Will you tell participants that their participation is voluntary? ☒ ☐ ☐ 
3 
Will your participants be able to read and understand the 
participant information sheet? 
☒ ☐ ☐ 
4 Will you obtain written consent for participation? ☒ ☐ ☐ 
5 
If the research is observational (including tape and video), will 
you ask participants for their consent to being observed? ☐ ☐ ☒ 
6 
Will you tell participants that they may withdraw from the 
research without penalty and without reason? 
☒ ☐ ☐ 
7 
With questionnaires and interviews, will you give participants the 





Will you tell participants that their data will be treated with full 
confidentiality and that, if published, it will not be identifiable as 
theirs? 
☒ ☐ ☐ 
9 
Are the data to be stored anonymously (i.e. the identity of the 
person is NOT linked directly or indirectly with their data)? 
☒ ☐ ☐ 
10 
Will you debrief participants at the end of their participation (i.e. 
give them a brief explanation of the study and an opportunity to 
ask questions)? 
☒ ☐ ☐ 
11 
Will the research involve deliberately misleading participants 
(deception) in any way?  
☐ ☒ ☐ 
12 
Is there any realistic risk of any participants experiencing either 
physical or psychological distress or discomfort?   
☒ ☐ ☐ 
13 
Is the information gathered from participants of a sensitive or 
contentious nature?  
☒ ☐ ☐ 
14 
Will any payment or reward be made to participants, beyond 
reimbursement or out-of-pocket expenses? 
☐ ☒ ☐ 
15 
Do participants fall into any of the following special groups? If 
the answer is YES, indicate which group(s) by checking the 
appropriate box(es). 
☒ ☐ ☐ 
 ☐ Children (under 18 years)  
☒ Clinical population  
☐ People with mental health 
issues 
☐ People in custody 
☐ People with learning or communication difficulties  
☐ People engaged in illegal activities (e.g. drug-
taking) 
NOTE: You may also need to obtain clearance from Disclosure Scotland or an 
equivalent authority. 
 
You must check either Box A or Box B below and provide all relevant information in 
support of your application in the Details of Project section. If you answered NO to any of 
questions 1-10, or YES to any of questions 11-15 (with a shaded background), then you 
must check Box B. 
DETAILS OF PROJECT 
 
17. Background information (references should be cited and listed) 
The management of individualised symptoms occurring within multiple sclerosis (MS) is a key 
element for management of the condition (Khan et al., 2007). Nerve signal disruption results in a 
wide variation of symptoms, with mobility often a main issue (Vollmer et al., 2002). It can be 
difficult for patients and health professionals to identify the most efficient rehabilitation 
programme to help manage their symptoms. Rehabilitation programmes often need regular re-
evaluation, and longer time to have an effect (Demaree et al., 1999; Dimitrov and Turner, 2014). 
Effects of therapeutics are often measured using clinical outcomes and disability scales, mostly 




on many factors out of control of the researcher (Langdon and Thompson, 1999). Therefore an 
objective form of analysis for manual therapeutics can help to determine the specifics of their 
effects and when they are most useful.   
Manual therapy (MT) over the spine has previously shown to have a positive effect on pain, 
stiffness and mobility without full understanding as to why (Chiradejnant et al., 2003; George et 
al., 2006). Spinal mobilisations is an MT technique used within physiotherapy practice for many 
years and still common today (Piekarz and Perry, 2016; Maitland et al., 2014). Often tested in 
sessions for under 7 minutes, at a rate of 2-3 Hz, it describes a low velocity and high amplitude 
therapy with oscillatory manual contact (Perry and Green, 2008; Shum et al., 2013). The spine 
experiences movement by rotation of pelvis and thoracic cage, compression of skin and tissues, 
and movement of spinal joints (Chansirinukor et al., 2003; Shum et al., 2013). Spinal mobilisation 
therapy has been used within Point One Clinic at a slower rate (0.4 Hz) for a longer time (30 mins) 
with positive anecdotal feedback from MS patients.   
Para-spinal muscles are said to contribute to spinal stability, functionality and prevention of 
buckling of the spine (Triano, 2001). By alleviating pain and stiffness in spinal tissue over time, 
improved para-spinal muscle usage can enhance neuromuscular associations in the long-term. 
Para-spinal muscles can be a main limiting factor for movement of the whole body when highly 
tense and stiff, contributing to clinical disability status (Bernistas et al.,2015). The information for 
para-spinal muscle quality data will contribute to bridging the gap between neurophysiological 
response and mobility outcome measures (Schneider et al., 2015). Specifically, the study will 
provide this with use of a myometer, Myoton Pro. This has not been investigated with an MS 
population before this project, however has been tested with similar chronic conditions such as 
Parkinson’s disease and stroke, where it has been previously validated with reliable results 
(Marusiak et al., 2012; Chuang et al., 2012).  
Information on body sway and balance will also be gathered to help analyse the potential effect of 
this intervention on lower extremity stability. The study will test functional stability in single leg 
stance and lunge using measurements for centre of pressure and body sway, often used for 
clinical testing (Ramdharry et al., 2006). Tests for pain in basic lumbar movements will be used, 
which is common practice in lower back therapy (Goodsell et al., 2000; Shum et al., 2013). Though 
this is not an objective measurement it is often referred to as a useful measure for effect in lower 
back therapy and can be used for comparison across the objective measures. 
The biomechanical information based on para-spinal soft tissue and walking gait that can be 
gathered in this study will provide an objective contribution to understand spinal therapy and 
rehabilitation, facilitating improved therapeutics for patients. This is a key element for symptom 
management, aiding in improved physical mobility and subsequently improving quality of life. 
This spinal mobilisation technique has been tested as an intervention firstly in a lower back pain 
(LBP) population and then with an MS population, both testing for immediate effects. The MS 
population did not show any significant findings in contrast to the LBP population who did, 
providing rationale for testing a longer-term effect as MS patients may take longer to show a 
response. This study proposes an investigation into the effects of the spinal mobilisation 
intervention after repeated sessions, as a contribution to research in MS rehabilitation and 
therapeutics.  
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18. Aims & research questions 
The aim of this study is to investigate the effect of a particular spinal mobilisation intervention 
after 4 weekly sessions, with an MS population group. The effect will be tested on para-spinal 
muscle response (stiffness, tone, elasticity), body sway, stability and levels of lumbar pain. The 
intervention has not had effect previously after a single session, therefore the study is analysing 




intervention will be tested against a placebo therapy to test the differences that are occurring are 
due to specific techniques within mobilisation therapy. 
Does the intervention have an effect on para-spinal muscle characteristics after 4 sessions? 
Does the intervention have an effect on functional stability after 4 sessions? 
Does the intervention have an effect on lower back pain after 4 sessions? 
 
19. Participants  
• Number & nature of sample: Recommended number of participants for repeated 
measures, between factors ANOVA is 36, with 18 people in each group. This is 
shown in G-power with a large effect size of 0.4 (using partial eta squared), a 
power of 0.8 and significance level of 0.05. The study will aim to recruit as close to 
this number as possible, however with the time restrictions on the study this may 
not be possible.  
• Inclusion/exclusion criteria: Inclusion criteria; must have an MS diagnosis, must 
be diagnosed less than 6 in the Expanded Disability Status Scale (EDSS) which 
ranges from minimal disability within the disease up until requiring a simple 
walking aid for mobility (Kurtzke, 1983), must be within the ages of 18-80. 
Exclusion criteria; must not be connected with Point One Clinic, must not respond 
positive to spinal therapy absolute contraindications which include bone tumour, 
inflammatory/infectious/metabolic disease affecting the spine, dysplasia, healing 
fractures/dislocations, spinal cord damage, cauda equine syndrome, aortic 
dysfunction and severe haemophilia. Participants responding positive to any 
relative contraindications will be excluded based on severity, these include spinal 
disc prolapse, spondylosis, spondylolisthesis, inflammatory arthritides, 
osteoporosis, hypermobile syndrome, pregnancy, cancer, cardiovascular disease, 
respiratory disease, healing injury and adverse reaction to previous spinal 
treatment (Maitland et al., 2014). Participants responding positive to any relative 
contraindications will be asked to request permission from their GP whether it is 
safe for them to take part. The therapist will be made aware of any relative 
contraindications before treatment. All treatments will be gentle and low grade.    
• Recruitment of participants, including details of formal permissions from 
another organisation (where appropriate): Participants will be recruited via 
poster, social media (Facebook, Twitter and Instagram) and word of mouth. 
Physiotherapy and health centres will be contacted by email or in person to ask if 
there is interest in the study to put up a poster advertisement. Contacts were 
made to MS charities and health centres in recruitment of last study which will be 
used again. Once ethical approval has been acquired, further enquiries into 
charity and private based health and therapy centres will be made, either over the 
phone, email or in person. The poster and information sheet will be used 
electronically and in person when interest is shown to participate as a response 
from advertisement. When interest is shown in person the researcher will only cite 
information from the poster and explain the information sheet. No coercion will be 
added when speaking face to face. Questions regarding the study will be 
encouraged and participants will be encouraged to read through the information 
sheet before volunteering for the study. 
Details of any relationship with participants which may affect the research: If 
the participant is known by the researcher they may feel pressured to participate 
in the research even if they don’t feel comfortable. However honesty and 
questions will be encouraged by the researcher and they will be informed they can 




objective gathered from biomechanical devices and therefore cannot be affected 
by any relationship with the participant and researcher.  
20. Outline of methods & measurements  
36 participants will be recruited to take part in this study. After a participant has shown interest in 
the study and agreed to take part, a link to the Novi Survey 
(https://survey.napier.ac.uk/n/zz35j.aspx) created will be sent to collect information about their 
MS condition and any contra-indications they may positively respond to. They will be randomly 
placed in a placebo or intervention group by an excel random group generator and given a 
participant number in order to maintain security on their personal medical information. Only the 
researcher will have access to this information. If the participant does not meet the inclusion 
criteria they will be informed they are unable to participate. If the participant responds positively 
to one of the relative contra-indications, they will be advised to request permission from their GP 
and sent the GP information sheet for this. If all inclusion criteria are met, the researcher will then 
organise suitable times for their sessions.  
Participants will be tested on 4 separate occasions. The first session will consist of a spinal 
treatment session and measurement testing pre and post the intervention. The following 3 
sessions will then have measurement testing only post the spinal treatment. Travel arrangements 
will be offered and arranged by the researcher to enable participants to come into the campus 
facilities for the sessions. All testing will take place at the Edinburgh Napier University Sighthill 
campus and temperature will be kept at room temperature (21°).  
Participants will have the opportunity to read through the information sheet again and the 
researcher will run through the order of events. Participants will be invited to ask any questions 
about the study before consent forms are given. Once the participant has given written consent, 
anthropometric measures will be taken by the researcher for age, weight and height. The results 
from their Novi questionnaire will be reviewed in person to go through their MS information and 
any contraindications. Measurements for lower back pain will be taken using a visual analogue 
scale (VAS) scale. This a subjective measure of pain, however shown to be common practice in the 
gathering of data for lower back therapeutics and can therefore be compared to the objective 
measures. Force plates will be used in single leg stance tests and a sit-to-stand test. Para-spinal 
stiffness testing will be done with participants lying in a prone position on a plinth using a 
myometer digital palpation device (MyotonPRO, Myoton Ltd., London, UK). This is a handheld 
device held perpendicular to the muscle and collects measurements by calculating the response 
from small oscillations sent through the muscle (Andonian et al., 2015; Viir et al., 2006). 
Measurements will be taken on both sides of the spine on erector spinae muscles (longissimus). 
Measurements for oscillation frequency (Hz), dynamic stiffness (N/m) and the logarithmic 
detriment (elasticity) will be taken both sides of the spine. The side that results in a higher 
stiffness value will be the side receiving therapy. 
The massage therapist working under their own liability will then perform a 30 minute therapy 
session of either a spinal mobilisation intervention, or a placebo general massage. The 
intervention consists of oscillatory movement over L1-L5 region of the spine, at a rate less than 
0.37 Hz and grade less than 1. During this therapy the therapist’s manual contact is constant and 
is not lifted from the participant’s spine. This is a very gentle therapy with less force being felt 
than sitting on a massage chair. The general massage will consist of only effleurage movements at 
grade 1 and will have no consistent region or pressure rate.  
Once all testing sessions have been completed, participants will be thanked for their contribution 
and given a debrief sheet with contact details and information regarding the study to give to their 
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21. Risks to participants’ and researcher’s safety & wellbeing 
Anthropometric measures – emotional risk to participant regarding condition, disabilities, age and 
weight. The MS questions and measurements will be conducted in a sensitive manner and not 
rushed. If the participant becomes emotional at any point during the session, the researcher will 
manage the situation sensitively. The participant will be encouraged to take their time when 
answering questions and are not required to answer questions they do not feel comfortable to 
answer. 
GRF testing – physical risk from single leg balance tests. Participant will be encouraged to only 
move within their capabilities and the researcher will be present to assist them if needed. 
Participant will be encouraged to rest when they feel is necessary or when feeling tired.  
Para-spinal stiffness testing - risk of discomfort in prone position. Participants can use a bolster 
under ankles for comfort and will be asked regarding comfort regularly.  
Spinal treatment - risk of pain or discomfort during therapy. Physiotherapist use of patient 
feedback if any pain or discomfort felt during manual therapy. The researcher will be available for 
assistance if discomfort felt during measurement collecting or treatment. Relaxation will be 
encouraged and Edinburgh Napier security staff who are first aid trained are reachable if required.   
22. Consent and participant information arrangements, debriefing, withdrawal from 
the study 
Participants will be sent an information sheet including information on contraindications in 
advance via email to read before attending the session. The protocol will be explained again in 




complete, a debrief sheet will be given to participant with further information and contact details 
regarding the project, as well as stating thanks for taking part.  
Participants will be made aware that they are able to withdraw from the study up until the point 
when their data is anonymised and analysed. If the participant choses to withdraw from the study, 
they will not need to give a reason for their withdrawal and will be encouraged to rest before 
leaving the study. Their data will be deleted and an extra participant will be attempted to be 
recruited.  
23. Anonymity and confidentiality  
All data collected and information given will be done so in confidentiality with the researcher, 
which will be made clear to the participant. The therapist will only be present during the therapy 
session and not be involved in the collection or analysis of data. Participant names will be 
replaced with number in collective data and not identifiable to them personally.    
24. Data protection arrangements 
All data collected during testing will be pseudonymised on an excel spread-sheet with the 
participant's name replaced by a random number and will therefore be unidentifiable. The contact 
details and code for participant numbers will be stored on separate file. This will be kept on the 
V:drive of a University password protected computer which only the researcher has access and 
anti-virus software will be kept up to date. This will be backed up regularly to an external hard 
drive that is stored in a drawer with a lock and key, which only the researcher has access to. The 
medical data collected will be kept in the Novi software which is also password protected and 
unidentifiable. The computer will be locked when the researcher is away from the desk and anti-
virus software will be kept up to date.  Any reports or publication for the study will not disclose 
identifiable information of the participants and will only use summary data.  
25. Ethical considerations raised by the project and how you intend to deal with 
them 
Participants do not need to answer questions they are not comfortable with answering and 
do not need to continue with any form of testing they are not comfortable with. The will be 
encouraged to take their time in the testing and made aware they can withdraw from the 
study without any need to give a reason. Participants will adhere to the inclusion/exclusion 
criteria to eliminate any pathological danger from either spinal therapies. If they do not 
respond to positively to any contraindications, GP permission is not required as MS 
patients will often self-refer to therapeutics beneficial for symptomatic based treatment. 
Participants will be allowed a friend/family/carer to accompany them for ease and to make 
them more comfortable.  
 
DECLARATION 
There is an obligation on the researcher to bring to the attention of the School Research Integrity Committee any issues 
with ethical implications not clearly covered by this application form. 
 
I request ethical and governance approval for the research described in this application. I have 
read Edinburgh Napier University’s policies and guidelines relating to ethics and governance in 
research, and those of relevant professional bodies (e.g. BPS, BSA, IFPA, SIR, NMC) and agree to 





A ☐ I consider that this project has minor/no significant ethical implications to be 
brought to the attention of the School Research Integrity Committee 
B ☒ I consider that this project may have significant ethical implications to be brought to 
the attention of the School Research Integrity Committee 
 
Signature      Date  
 
 
I am the Director of Studies or supervisor for this research.  I have read this application and 
approve it.  I do not consider that any part of the research process will cause physical and/or 




Signature      Date 
 
 
• You must also attach the following documentation, where appropriate (please tick 
to confirm or provide information as to why the materials are not available): 
Research materials (questionnaire, 
interview schedule, experimental stimuli, 
etc.) 
 
Recruitment materials (poster, leaflet, 
social media message, covering letter, 
etc.) 
 
Participant information sheet  
Consent form  
Debrief sheet  




• You may need to create different versions of these materials (e.g. parental 
Participant Information Sheet and Consent Form if research involves children); if 
so, all the different versions should be attached. Materials should be printed on 
paper headed with the University logo. 
• Submit the completed and signed form (with supporting materials) to  
; an 





Appendix  19 Study Three Poster Advertisement  
           
 
PhD Study requires volunteers for: 
The effect of a spinal therapy in 
people with Multiple Sclerosis  
 
Participants must be:  
• Diagnosed with MS 
• Aged within 18-80 
• Ability to walk independently  
 
Participants will be required to take part in four testing sessions consisting of spinal 
therapy and lower back muscle quality, stability and movement tests. This will take 
place at the Edinburgh Napier University Sighthill Campus. Transport can be 
provided for people to come to the facilities.   
For more information regarding this study please contact Rebecca 





Appendix  20 Study Three Information Sheet 
Participant Information Sheet 
Study Title: Investigating the effect of spinal therapy in people with multiple 
sclerosis.   
Study Summary 
My name is Rebecca Hamilton and I am a PhD researcher from Edinburgh Napier 
University. I am carrying out a study that will test the effect of a spinal therapy on 
people with multiple sclerosis (MS). This is to collect information that will contribute 
to knowledge in MS therapeutics. We are testing 2 different types of spinal therapy, 
one a general, low grade massage, and the other a mobilisation therapy working at 
a specific rate and specific pressure. This study is funded by Medical Research 
Scotland and Pacla Medical; both interested in finding out more scientific information 
on spinal therapy in MS.  
Who can take part in the study? 
I am looking for 38 volunteers to take part. To be suitable you must be between the 
ages of 18 and 80, you must have an MS diagnosis, you must have an EDSS rating 
less than 6, and you must be able to walk independently. If you are interested you 
should read through the contra-indications listed in table A and B. If you have had 
any of the conditions listed in table A, you will not be able to take part in the study. If 
you have had any conditions listed in table B, you are advised to ask permission 
from your GP in order to take part. I can provide you with a GP information sheet 
and you can use this information sheet, to answer any questions your GP has 
regarding your involvement in the study. Contact details are also provided below to 
answer any further questions. If you have a connection with Point One Clinic you will 
not be able to take part either due to a conflict of interest.   
What will the study involve?  
The study will look at the effects of 2 different spinal therapy techniques. You will be 
randomly allocated to a group to receive 4 sessions with one of these therapy types. 
I will test you in 3 different aspects to investigate whether the therapy has an effect 
on these areas. These will be lower back muscle stiffness, lower back pain and 
lower limb stability.  
If you chose to take part you will attend 4 sessions that suit your availability. We will 
aim to have these sessions once a week and they will each last a maximum of 2 
hours. In your first session I will gather basic information about your MS condition, 
and measurements for your weight, height and age. You will perform a single leg 
stance and sit-to-stand tests to test stability, you will rate your lower back pain on a 
VAS scale, your fatigue, and your lower back stiffness will be tested. You will then 
receive a 30-minute, low grade, spinal manual therapy. Once therapy is complete 
you will be tested in the same measurements again. For the following 3 sessions 
you will only be tested after receiving therapy and not before. There is a risk that you 
will feel uncomfortable during the therapy or testing. However, you will not be 
required to answer or perform any tests which you are not comfortable with and can 
give feedback to myself to modify anything uncomfortable. You will be free to 
withdraw from the study up until the point when your information has been 




reason and it will not affect your treatment. You can tell me you wish to withdraw 
verbally or by email and all information associated with you will be destroyed.   
Possible benefits 
By taking part in the study I cannot guarantee that it will help with the rehabilitation 
in your MS condition, however it will give you the opportunity to try a type of spinal 
therapy and see if there is any effect in your stiffness, pain and stability. Your 
contribution will also help with gathering knowledge about physiotherapy within MS 
and could benefit others in the wider MS community. Although I cannot provide you 
with any financial gift for participating, travel arrangements will be made for you, 
unless you prefer your own method of transport. 
Possible Disadvantages  
There is always a possibility that you will be uncomfortable during the therapy, or 
during the testing. However, you do not need to continue with any part of these 
which you are not comfortable with and you can withdraw from taking part in the 
study when you like. The information collected from your testing will not be kept if 
you chose to withdraw from the study before it has been anonymised and analysed.  
Further Information  
All the information about yourself will not be identifiable to you as your name will be 
replaced with number. It will not be possible for anyone other than myself to identify 
your personal information during the study. This information will be kept on a 
password protected file on a university server, to which only I have access. Personal 
information will be kept until the end of this project on October 2019 and will then be 
destroyed. The anonymised information from all participants will then be used in the 
report of the study in my PhD thesis and may be published in relevant journals. This 
information will be retained in the University for 10 years after which it will be 
destroyed. The findings of this study will contribute to the research in rehabilitation 
within MS sufferers in finding a therapy that makes a difference in pain, stiffness and 
mobility.   
If you would like to contact an academic supervisor for this project, you are welcome 
to contact Dr Susan Brown or Dr Claire Garden, whose contact details are provided. 
If you would like to contact an independent person, who knows about this project but 
is not involved in it, you are welcome to contact Dr Geraldine Jones.  
If you have any other questions, please do not hesitate to contact me using the 
details for Rebecca Hamilton provided. 
Contact details of researcher 
Name of researcher: Rebecca Hamilton 
Address:  
 
Email / Telephone:  
Contact details of supervisors 












Contact details of the independent adviser 





Table A. Absolute Contraindications 
Condition category  Further details, these include: 
Serious bone related condition Tumour (benign or malignant) 
 Infectious disease  (e.g. tuberculosis) 
 Metabolic (e.g. osteomalacia, softening of bones) 
 Birth defect (dysplasia) 
 Inflammatory (e.g. severe rheumatoid arthritis) 
 Traumatic (healing fractures/dislocations) 
Serious neurological condition 
(excluding MS) 
Spinal cord/spinal nerve compression  
 Spinal cord damage 
 Cauda equina syndrome (spinal cord nerve swelling) 
Serious vascular condition (relating 
to blood vessels) 
Aortic dysfunction (e.g. aneurism/blood clot) 
 Severe haemophilia (causing bleeding into joints)  
 
 
Table B. Relative Contraindications  
Condition  Further details  
Spinal disc prolapse  Spinal disc herniation, tear in disc cartilage causes it to 
bulge out pressing on nerve  




Spondylolisthesis Spinal instability/displacement of discs  
Inflammatory arthritis Rheumatoid arthritis, Ankylosing spondylitis, Psoriatic 
arthritis, osteoarthritis 
Osteoporosis Decreased bone strength, low level bone mass  
Hypermobile syndrome  Segment or joint hypermobility  
Pregnancy Current pregnancy, previous problematic pregnancy 
Abnormal cell growth Active or history of cancer 
Cardiovascular disease History of thrombosis or using blood clot prevention 
medication   
Respiratory disease Pneumonia, bronchitis, asthma  
Current healing injury Local infection, open wounds, fractures, dislocations 







Appendix  21 Study Three Consent Form 
Participant Consent Form 
Study Title: The immediate effect of spinal therapy in multiple sclerosis. 
Participant Identification number:  
         Please initial box 
 
1. I confirm that I have read and understood the information sheet for the 
study titled above. I have had the opportunity to consider the information, 
ask questions and had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw without needing to give any reason. I understand that the way in 
which I am treated throughout the study will not be affected and my 
information will be destroyed if I chose to withdraw.  
 
3. I understand that the information collected about me will be anonymised, 
used to support other research in the future, and retained for at least 10 
years at the University.  
 
4. I agree to take part in the above study.  
 
____________________ ____________________ ____________________ 
Name of participant  Date    Signature 
____________________ ____________________ ____________________ 
Name of researcher  Date    Signature 
 
Contact details of the researcher 
Name of researcher: Rebecca Hamilton 
Address:      
    










Appendix  22 Study Three Fatigue Sheet 
 
Modified fatigue impact scale – 5 item 
 












1. I have been less alert.      
2. I have been limited in my 
ability to do things away 
from home. 
     
3. I have trouble maintaining 
physical effort for long 
periods. 
     
4. I have been less able to 
complete tasks that 
require physical effort.  
     
5. I have had trouble 
concentrating.  





Appendix  23 Study Three Testing Sheet 
Testing document 
Participant number:      
Anthropometrics  
Height (m) Weight (N)  Weight (Kg) BMI DOB EDSS Most symptomatic FS 
       
 






     
 













 left side right side  left side right side 
1   1   
2   2   
3   3   
Mean   Mean   
Pre VAS   Post VAS   
 
Session 2 date: 
Post massage Stiffness (N/m) Stiffness (N/m) 
 left side right side 
1   
2   
3   
Mean   








Session 3 date: 
Post massage Stiffness (N/m) Stiffness (N/m) 
 left side right side 
1   
2   
3   
Mean   
Post VAS   
 
Session 4 date:  
Post massage Stiffness (N/m) Stiffness (N/m) 
 left side right side 
1   
2   
3   
Mean   






Appendix  24 Study Three Debrief Sheet 
Debrief Sheet 
I would like to thank you for your participation in this study. The aim of this study is to 
provide useful information with regards to spinal manual therapy and rehabilitation 
within MS. You received 4 sessions of either a mobilisation therapy, which uses light 
passive oscillatory movements around the spine in a consistent motion, or a general 
low grade massage without consistent pressure and movements.  
The study is based around positive reports from the mobilisation therapy claiming to 
have improvements in lower back pain and stiffness. Gentle lower back massage has 
also shown to be beneficial in these areas. You may therefore find benefits in your 
lower back muscle stiffness, stability and function after these 4 treatments. The 
purpose of exploring these techniques was to test whether the consistency of the 
mobilisation technique shows a better effect than a general massage.     
Your contribution in this study is greatly appreciated and assists in the further 
investigation of spinal therapy with MS patients. If you experience any adverse side 
effects or have any initial feedback please get back in touch or contact your GP. If you 
have any more questions regarding the study feel free to ask. Contact details for 
myself, academic supervisors and the independent advisor are provided below. 
Contact details of researcher 




Contact details of supervisors 
Supervisor:  Dr Susan Brown 
Address:  
 
Email/Telephone:   




Contact details of the independent adviser 
Adviser:   Dr Geraldine Jones 
Address:  
 
Email/Telephone:  
 
